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Abstract 
Efficient folding of proteins frequently requires the introduction of disulfide 
bonds.  The insertion of disulfide bonds could result in native disulfides, which 
can be found in the correctly folded and functional protein structure, and non-
native disulfides which are not present in the native protein.  The resolution of 
non-native disulfides is absolutely required for cells to fold secreted proteins 
correctly and to remove misfolded proteins to alleviate cell stress.  The pathways 
for disulfide formation are well characterised.  However, our understanding of the 
reduction of non-native disulfides is still limited.  How the reducing equivalents 
are transferred across the ER membrane and whether there are additional 
components needed in the reduction pathway either in cytosol or ER lumen are 
the questions we need to address.   
Microsomes including redox-sensitive green fluorescence protein (roGFP) were 
used to address which membrane protein was involved in the ER reductive 
pathway.  We demonstrated that a membrane protein is required for the reduction 
of microsomal proteins by the membrane impermeable reducing agent Tris(2-
carboxyethyl)phosphine (TCEP) or a reconstituted thioredoxin/thioredoxin 
reductase (Trx/TrxR) pathway.   
Previous research in our group suggests that ERp57 has a specific role in the 
isomerisation of non-native disulfide bonds in specific glycoprotein.  We optimised 
the determination of redox state of ERp57 in semi-permeabilised (SP) cells.  It was 
found that the reduction of ERp57 in SP cells required reducing equivalents 
generated by the Trx/TrxR pathway and the reduction was dependent on catalytic 
cysteines in the Trx motif.  It was also shown by proteinase experiments that 
different membrane proteins are required for the transduction of electrons from 
TCEP and the Trx/TrxR pathway.   
In addition, we took advantage of an in vitro translational system supplemented 
with SP cells.  A post-translationally folding assay was developed to evaluate the 
ability of the cytosolic components to resolve non-native disulfides in nascent 
polypeptides proteins in the ER.  We showed that the minimal components in the 
cytosolic Trx/TrxR pathway are sufficient for disulfide rearrangement in the ER 
and that the reduction process is Trx - dependent.  
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Chapter 1 Introduction 
1.1 Protein biogenesis 
In mammalian cells, most proteins in the secretion pathway and membrane 
proteins need to translocate into the endoplasmic reticulum (ER) to undergo a 
series of modifications to obtain their native and functional structure (Figure 1-1).  
The correctly folded proteins will be transported to the Golgi apparatus or other 
intracellular organelles and then finally trafficked to their target location.  
Misfolded proteins will be retained and identified by the ER quality control system 
and then translocated back to the cytosol and degraded by the ER associated 
degradation system (ERAD) (Sitia and Braakman, 2003).  The whole process is 
called protein biogenesis (Hegde and Lingappa, 1999).   
 
Figure 1-1  Protein biogenesis of membrane proteins and secretion proteins.  The ribosome 
sits on the Sec61 translocon to support co translational translocation of the nascent chain into the 
ER lumen.  After folding and modifications, the correctly folded proteins are delivered to the Golgi 
apparatus and other intracellular organelles by vesicular transport.  Misfolded polypeptides are 
recognised by the ER quality control (ERQC) system and transported to the cytosol and finally 
degraded by the ER associated degradation (ERAD) ubiquitin-proteasome system (Sitia and 
Braakman, 2003).   
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1.2 Endoplasmic reticulum 
The ER is a large membrane-enclosed cellular organelle which can be found in all 
eukaryotic cells (English and Voeltz, 2013, Kleizen and Braakman, 2004).  The ER 
contacts with the plasma membrane, mitochondria, Golgi, endosomes, and 
peroxisomes at different sites.  It is the entry site of the secretion pathway and 
plays crucial roles in protein synthesis and transport, protein folding, lipid and 
steroid synthesis, drug and carbohydrate metabolism and calcium storage (Lin et 
al., 2008, Schwarz and Blower, 2016).  It has been demonstrated that a third of 
all proteins coded by human genome enter the ER where they undergo protein 
folding and modification to help them obtain their native structure and function 
(Braakman and Bulleid, 2011). 
The ER can be divided into different domains, such as the nuclear envelope, 
peripheral tubular ER and peripheral cisternae which are required for different 
cellular processes (Figure 1-2) (English and Voeltz, 2013).  The nuclear envelope 
is a double membrane bilayer surrounding the nucleus acting as a barrier that 
selectively controls the transporting of molecules in and out.  The peripheral ER 
(peripheral tubular ER and peripheral cisternae) branches out from outer nuclear 
membranes as an interconnected network.  The ER cisternae is generally localised 
closer to the nuclear envelope than ER tubules (Puhka et al., 2012).  The 
peripheral tubular ER and peripheral cisternae is historically named smooth ER 
and rough ER due to the attachment of ribosomes (West et al., 2011).  Compared 
with the ER tubulars, the cisternae has more ribosomes and a larger luminal 
volume to surface which is specialised for the protein folding process.   
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Figure 1-2  Structure of ER.  ER is a continuous membrane system in all eukaryotic cells 
(Encyclopædia Britannica).  It contains functionally and structurally distinct domains such as the 
nuclear envelope, peripheral tubular ER and peripheral cisternae which are required for different 
cellular processes, like the biosynthesis, processing, and transport of proteins and lipids.  Due to the 
attachment of ribosomes, the peripheral tubular ER and peripheral cisternae are also named as 
smooth ER and rough ER.  Figure obtained from (https: //www.britannica.com/science/endoplasmic-
reticulum#/media/1/187020/114952). 
a) Microsomes 
ER derived microsomal membrane are universally used in in vitro protein 
biogenesis research.  Microsomes are ER derived vesicles with a diameter of 100 – 
200 nm which and are isolated from homogenates of liver and other tissues 
(Claude, 1943, Kriechbaumer, 2018) or cultured cells (Sukhodub and Burchell, 
2005) by differential centrifugation (Figure 1-3).  Microsomes are composed of 
rough ER, smooth ER and ribosomes.  Numerous enzyme activities are associated 
with the microsomal fraction due to the chaperones and folding enzymes which 
are contained in the lumen of microsomes.  The microsomes can still carry out 
protein synthesis, protein translocation, protein folding, and modifications as 
happens in intact cells (Palade and Siekevitz, 1956, Sabatini, 2014).  Because the 
microsomes are RNA rich (Yamada et al., 1960), nuclease treatment of microsomes 
is performed to remove endogenous RNA before it is used in protein synthesis 
experiments (Robinson et al., 2017).   
Chapter 1  4 
 
Figure 1-3  Schematic preparation of microsomes.  Microsomes are prepared from ER by 
differential centrifugation.  (Kriechbaumer, 2018) 
b) Semi-permeabilised cells 
The semi-permeabilised SP cells are prepared from cultured cells by treatment 
with the mild non-ionic detergent digitonin which was initially used in the nuclear 
protein import assay (Adam et al., 1990).  The digitonin can permeabilise the 
membrane by creating pores in the plasma membrane by replacing cholesterol 
(Aits et al., 2015) (Figure 1-4).  In eukaryotic cells, the cholesterol content differs 
in different membranes, such as 40-90% of total cellular cholesterol in plasma 
membrane (Liscum and Munn, 1999), but only 0.5% in ER membrane (Lange et al., 
1999).  The cholesterol content of the Golgi is lower than plasma membrane but 
higher than ER membrane in a cis-to-trans firection (Ikonen, 2018).  The huge 
differences of cholesterol content between the plasma membrane and intracelluar 
membrane ensure the permeabilization of plasma membrane but leaves the 
membrane of the intracellular organelles, like ER and Golgi, intact if the 
incubation time and concentration of digitonin are accurately controlled (Figure 
1-4) (Litvinov et al., 2018).  It was proved that the digitonin treatment 
(concentration range 20-40 µg/ml) for 5 min on ice can permeabilise the plasma 
membrane but allow the ER and cis/medial-Golgi to retain their function and 
morphologically intactness (Plutner et al., 1992).   
Subsequently, an efficient in vitro translational system using RRL with the addition 
of digitonin-permeabilised cells acting as an ER source was developed to study the 
in vitro protein biogenesis (Wilson et al., 1995).  The SP cells are added into an in 
vitro translocation system like wheatgerm or RRL.  The membrane and secreted 
proteins can be translated following the addition of an RNA template and the 
protein efficiently translocated, folded, and modified in the ER.   
Centrifuge 
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Figure 1-4  Schematic preparation of SP cells.   The digitonin treatment can permeabilise the 
plasma membrane but leaving the membrane of intracellular organelle intact, like ER, Golgi 
apparatus.   
1.3 Eukaryotic translation  
a) In vivo translation 
In eukaryotic cells, translation happens in the cytosol and the process of cytosolic 
translation contains four steps: initiation, elongation, termination and recycling 
(Figure 1-5) (Schuller and Green, 2018).  The whole process of translation starts 
with initiation involving the formation process of an elongation-competent 80S 
ribosome complex.  At least 9 eukaryotic initiation factors (eIFs) are involved to 
facilitate the formation of 80S ribosome complex (Jackson et al., 2010).  During 
the initiation stage, the anticodon loop of initiator methionyl-tRNA (Met-tRNA iMet) 
base-pairs with the start codon (AUG) on the messenger RNA (mRNA) in the P site 
of 80S ribosome complexes, which is following by the elongation stage in a 5’ to 
3’ direction.   
 
Figure 1-5  Translation in eukaryotic cells.   In eukaryotic cells, translation happens in cytosol and 
the process of cytosolic translation contains four steps: initiation, elongation, termination and 
recycling (Schuller and Green, 2018).   
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Polypeptide is synthesised during elongation with the help of eukaryotic 
elongation factors (eEFs), aminoacyl-tRNAs (aa-tRNAs), and the peptidyl-
transferase (PT) (Dever and Green, 2012).  The anticodon of aa-tRNA recognises 
and pairs with the codon in the open reading frame (ORF) of mRNA in the ribosomal 
A site.  A peptide bond forms between the α-amino group of aa-tRNA in A site and 
the carbonyl carbon of the peptidyl-tRNA (pp-tRNA) in the P site (Beringer and 
Rodnina, 2007).  The reaction is catalysed by peptidyl-transferase (PT).  The new 
peptide which is one amino acid longer is transferred into the A site.  The 
deacylated tRNA and pp-tRNA are translocated to E and P site in the 80S ribosomal 
complex respectively.  The deacylated tRNA is then released from the E site and 
a new cycle of elongation process will repeat with the exposure of a new codon in 
the ribosomal A site until the stop codon is exposed in A site (Schuller and Green, 
2018).   
In eukaryotes, the translation process stops when the stop codon (UAG, UAA and 
UGA) at the end of ORF is recognised in the ribosomal A site with the recruitment 
of eukaryotic release factors 1 (eRF1) and eukaryotic release factors 3 (eRF3) 
(Dever and Green, 2012).  The eRF1 is also responsible for the hydrolysis of pp-
RNA to release the nascent polypeptide (Alkalaeva et al., 2006).  eRF3 promotes 
the activity of eRF1 by the interaction with eRF1 in the presence of GTP (Frolova 
et al., 1996).   
After termination of translation, the ribosome complex is split into subunits (40S 
and 60S) that will be reused in the next cycle of translation, which is named the 
recycling process (Nurenberg and Tampe, 2013).  This process links the successful 
termination process in the last translation and a new initiation process of next run 
of translation.  In eukaryotic cells, the ribosome recycling needs an ATP energised 
factor, ATP-binding cassette (ABC) protein (ABCDE1) (Nurenberg-Goloub et al., 
2018).   
b) Cell-free protein synthesis 
To study proteins structure and function, usually a large amount of homogeneous 
proteins is required.  However, the overexpression of some toxic or membrane 
proteins in vivo can be harmful for cells and can disrupt protein homeostasis.  As 
an alternative, cell-free protein synthesis (cell-free translation) has been 
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universally used in protein structure and function research in molecular biology 
due to its timesaving and easy-to-use features (Katzen et al., 2005, Chong, 2014).   
The cell-free translation system was first established using lysate (extract) from 
E. coli by Marshall Warren Nirenberg (Nirenberg and Matthaei, 1961).  Extracts 
from wheat germ (Roberts and Paterson, 1973) and rabbit reticulocyte lysate (RRL) 
(Pelham and Jackson, 1976) were then used to develop alternative cell free 
translation systems.  These three kinds of lysates became the most popular lysates 
which are commonly used for cell-free translation.  Recently, cell extracts from 
mammalian cells, like Hela cells  (Mikami et al., 2006), have been used to develop 
a cell-free translation system with supplements of translation factors.   
An efficient cell free lysate contents components for translation, such as 
ribosomes, tRNAs, amino acids (AA),  enzymes and factors (Figure 1-6) (Katzen et 
al., 2005).  Transcription products, mRNA, is added to the system to be the 
translation template.  In addition, the template for cell-free translation can be 
DNA (plasmid DNA or PCR product) in a coupled cell-free transcription/translation 
synthesis system with the addition of RNA polymerase.  Compared with in vivo 
translation, the conditions are easy to adjust and a variety of different reagents 
like protein disulfide isomerase (PDI) and chaperones can be supplemented to the 
cell free protein synthesis reactions to assist folding.  The addition of ER derived 
microsomal membranes or SP cells allows the translocation from cytosol into ER 
lumen where glycosylation can occur, opening up more possibilities for protein 
research.   
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Figure 1-6  Cell-free translation system.  Cell-free translation system has two forms: coupled 
(transcription and translation) cell-free protein synthesis which use plasmid DNA, or PCR product as 
template and uncoupled (only translation) that use the transcription product (mRNA) as template 
(Rosenblum and Cooperman, 2014).   
1.4 Protein Translocation across ER membrane in 
eukaryotes  
In eukaryotic cells, an indispensable step for secretory proteins and the majority 
of membrane proteins is their translocation from the cytosol to the ER lumen 
where protein folding and modifications can occur (Braakman, 2006). This process 
called protein translocation can be divided into two types: co-translationally and 
post-translationally that depends on whether the translocation happens at the 
same time with translation or after translation is completed (Figure 1-7) 
(Rapoport, 2007).   
The newly synthesised polypeptides are translocated from the cytosol to the ER 
lumen by a protein-conducting channel named the Sec61 complex which is formed 
of three subunits, α , β and γ (Rapoport et al., 2017).  Two halves of α subunit 
form the pore of the Sec61 channel and the γ subunit is responsible for linking the 
two halves of α subunit while the dispensable β subunit is attached to the 
periphery outside of the α subunit (Zimmermann et al., 2011).  The Sec61 channel 
is a passive channel and the polypeptide can slide in or out of the channel in both 
directions which means that a driving force is necessary to ensure the right 
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direction of translocation of the nascent polypeptide chain.  The driving force is 
provided by the translocation partners, ribosomes in co-translational 
translocation, the Sec62/63 membrane complex and the ER luminal chaperone BiP 
that is a member of Hsp70 ATPase family for post-translational protein 
translocation.   
The co-translational translocation starts with the association of signal recognition 
particle (SRP) with signal sequence (7-15 residues) at the N-terminal of secretory 
proteins or the transmembrane sequence (TM) (≧20 residues) in the membrane 
proteins during translation at ribosomes (Figure 1-7A) (Rapoport et al., 2017, Halic 
and Beckmann, 2005).  The SRP is then recognised by the signal recognition 
receptor (SRP receptor) and the ribosome interacts with the Sec61 channel 
(Luirink and Sinning, 2004).  The growing polypeptide inserts as a loop into the 
Sec61 channel with translocation being driven by the elongation of translation and 
signal peptide cleavage.  The nascent polypeptide chain is then released into the 
lumen after the translation is fully finished.  For some membrane proteins, the 
certain segments do not insert to the channel rather they stay in the cytosol.   
Post-translational translocation occurs when nascent polypeptide chains destined 
for the secretory pathway are not recognised by the SRP during their translation 
(Figure 1-7B) (Ng et al., 1996).  These polypeptides need to remain in an unfolded, 
reduced state to ensure the successful translocation into the ER lumen.  In this 
case, the signal sequence is targeted and bound to the Sec61 channel with the 
help of cytosolic chaperones.  The polypeptide then inserts into the channel.  The 
membrane complex Sec62/63 and ER luminal BiP (Hsp70 ATPase) interacts with 
the channel to facilitate the translocating process by a ratcheting mechanism to 
ensure the direction of polypeptide insertion (Deshaies et al., 1991, Panzner et 
al., 1995).  Once the polypeptide is fully translocated into the ER lumen, the 
conversion from ADP to ATP allows the release of BiP (Matlack et al., 1999).  The 
post-translational translocation process is then completed.   
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Figure 1-7  Models of eukaryotic protein co- and post- translational translocation.  A.  Co-
translation translocation.  The signal peptide of a nascent polypeptide chain is recognised by the 
signal recognition receptor (SRP receptor).  The ribosome interacts with the Sec61 channel.  The 
growing polypeptide inserts as a loop into the Sec61 channel with translocation being driven by the 
elongation of translation and signal peptide cleavage.  The nascent polypeptide chain is then 
released into the lumen after the translation is fully finished.  B.  Post-translational translocation.  The 
translation of the polypeptide is completed in the cytosol.  The cytosolic chaperones maintain the 
nascent chain in the reduced state.  With the facilitation of the cytosolic chaperones, the signal 
peptide is recognised by the Sec61 complex and inserted into the channel.  The tetrameric 
Sec62/Sec63 complex and the ATP dependent ER luminal chaperone BiP ensure the correct 
direction of the translocation.  (Rapoport, 2007) 
1.5 Protein folding 
It has been demonstrated that a third of all proteins coded by the human genome 
enter the ER to undergo protein folding and modification, which will allow these 
proteins to obtain their native structures and functions (Braakman and Bulleid, 
2011, Braakman and Hebert, 2013).  The nascent polypeptide chains are 
translocated into the ER with only correctly folded proteins transported to Golgi 
apparatus to be delivered to the cell surface or other cellular destinations.  
Misfolded proteins are retained in the ER and after being identified by the ER 
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quality control system, they will be retranslocated back to the cytosol to be 
degraded by the proteasome in a process called ER-associated degradation (ERAD).  
To ensure the efficiency of the protein folding and modification, the ER is highly 
specialised and it contains several chaperones, folding enzymes and co-
chaperones to fulfil different tasks, like folding, assembly, modification, quality 
control and recycling (Braakman and Bulleid, 2011).   
The protein folding process has two types: co-translational folding as protein 
folding process can occur during the synthesis process on ribosome-translocon 
complex, and post-translational folding which happens when the nascent 
polypeptide chain is released from ribosomes and fully translocated into ER lumen 
(Figure 1-8) (Ellgaard et al., 2016, Braakman and Hebert, 2013).  It is worth noting 
that protein folding is a continuous process and there is no clear termination time 
point (Braakman and Bulleid, 2011).   
Proteins folding begins once there is sufficient space (Braakman and Bulleid, 2011, 
Kleizen and Braakman, 2004).  It has been demonstrated that the translocon 
complex can provide enough space for the formation of an α-helix, but the folding 
will be fully finished in the ER lumen (Woolhead et al., 2004).  The newly 
synthesising polypeptide chain is surrounded by chaperones and folding enzymes 
in the ER lumen once it exits the translocon.  The rate of co-translational folding 
is relatively slow because of the limited space of the protective environment 
which is shielded by the folding factors.  The environment can separate nascent 
chains from each other to avoid the aggregation.  Due to the rate of formation of 
the majority of secondary structures being faster than the rate of translation, the 
translational rate (4-5 residues/s in eukaryotic cells) can influence the rate of co-
translational folding (Braakman et al., 1991).   
In eukaryotic cells, post-translational folding predominates over co-translational 
folding (Ellgaard et al., 2016).  This is due to the fact that it only takes ~ 2 min to 
synthesize an ~ 50-kDa protein (Influenza virus hemagglutinin (HA)), whereas the 
average half-time for protein folding is around 30 to 60 min (Braakman et al., 
1991).  In addition, a half of known structures of single-domain proteins and a lot 
of multidomain proteins have N- and C- proximity.  This kind of folding cannot be 
completed until translation is fully terminated and the C-terminus of the nascent 
chain is released from the ribosome and translocon complex.   
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Figure 1-8  Co- and post-translational folding.  A. The nascent polypeptide chain is synthesising 
by the ribosome (grey) and it is translocated into the ER lumen by Sec61 channel (orange) with the 
aid of BiP (green).  Disulfides form with the assistance of PDI (purple).  The glycans (three structure) 
is added to the Asn site on the newly synthesised polypeptide chain catalysed by oligosaccharyl 
transferase (OST).  The N- terminal signal peptide is cleaved by signal sequence peptidase complex 
(SPC) (light blue).  The terminal glucose residue (orange triangle) is removed from the N-linked 
glycan by the Glucosidase I (GlsI) and the nascent chain is bound to the membrane localised lectin, 
malectin (dark blue).  The second glucose is removed by Glucosidase II (GlsII).  The 
monoglucosylated glycan structure is bound to calnexin (CNX, green), a lectin chaperone associated 
with the oxidoreductase ERp57 (pink) until the last glucose is removed by Glucosidase II (GlsII).  B.  
Co- and post- translational folding factors.  These factors are involved in protein maturation and ER 
quality control processes.  Calreticulin (CRT) is a soluble paralogue of calnexin, UGT1 is an UDP-
glucuronosyltransferase.  (Braakman and Hebert, 2013) 
Protein folding during and after translation needs assistance from folding factors 
including folding enzymes and chaperones in the ER lumen.  They work or are 
assumed to work (because of their homology with known folding factors) in 
complexes to affect the reactions during protein folding.  Based on the folding 
steps that they catalyse and the intermediate they formed during protein folding, 
the protein folding factors are classified into different types: chaperones or co-
chaperones (mainly heat shock proteins), peptidyl prolyl cis/trans isomerases 
(PPIases), oxidoreductases, and glycan-binding proteins (Braakman and Bulleid, 
2011, Englander and Mayne, 2014).  Some folding factors are multifunctional 
leading to overlapping functions between different folding factors.  For instance, 
BiP is involved in translocation (Rapoport, 2007), regulation of unfolded protein 
A 
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response (UPR) (Bertolotti et al., 2000) and stabilisation of folding intermediates 
(Fourie et al., 1994).  In addition, PDI can catalyse the insertion of disulfide bonds 
(Bulleid and Ellgaard, 2011) and reduction of non-native disulfide bonds in 
misfolded proteins (Coe and Michalak, 2010).  This overlapping function of protein 
folding factors ensures that the protein folding proceeds normally when one 
enzyme cannot function.   
1.6 Protein modification 
Protein modifications which can change the physical features of the polypeptide 
chain happen to the nascent polypeptide chain from the beginning of translation 
until the protein obtains its native structure and leaves the ER (Braakman and 
Bulleid, 2011, Braakman and Hebert, 2013).  The well-known modifications 
include disulfide bond formation, N-linked glycosylation, proline hydroxylation.  
These modifications are crucial for protein folding, and the folding of the 
polypeptide chain can influence the modification.   
1.6.1 N-linked glycosylation 
In eukaryotic cells, N-linked glycosylation occurs when a block of 14 sugars, is co- 
or post-translationally added to a N-X-S/T sequon (N indicates Asparagine, S 
indicates Serine, T indicates Threonine, X can be any amino acid residue except 
proline) in the nascent polypeptide chain in the ER lumen (Helenius and Aebi, 
2001, Ellgaard et al., 2016).  The core of the glycan (Glc3Man9GlcNAc2) is 
composed of three branches and is the precursor for glycosylation in the ER.  The 
biogenesis of N-linked  glycans includes three main steps: the synthesis of lipid-
linked precursor, the core glycan is added to the asparagine residue in nascent 
polypeptide chain which is catalysed by the oligosaccharyltransferase (OST) 
enzyme complex, and the trimming of three glucose by glucosidase I and II and 
the removing of the terminal mannose by mannosidases in ER (Figure 1-9) 
(Helenius and Aebi, 2001, Aebi, 2013, Schwarz and Aebi, 2011).  The glycans in 
the ER are relatively simple and homologous but they become more heterogenous 
after further modification in the Golgi apparatus.   
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Figure 1-9  Schematic of N-linked glycosylation.  The biogenesis of N-linked glycans includes 
three main steps: the synthesis of lipid-linked precursor, the core of glycan is added to the asparagine 
residue in nascent polypeptide chain which is catalysed by the oligosaccharyltransferase (OST) 
enzyme complex, and the trimming of three glucose residues by glucosidase I and II and the removal 
of the terminal mannose by mannosidases in ER. Triangle indicates glucose, circle indicate 
mannose, and square indicates N-acetyglucosamine (Helenius and Aebi, 2001) 
Glycosylation has a significant effect on protein folding (Aebi, 2013).  The addition 
of the glycan can stabilise the native structure of proteins by preventing the 
misfolding and aggregation of the nascent polypeptide chains.  In addition, 
proteins with glycans are targeted to the calnexin/calreticulin (CNX/CRT) cycle.  
The interaction of CNX/CRT with a thiol oxidoreductase, ERp57, promotes protein 
folding: the correctly folded protein can leave ER while the misfolded protein 
enters another CNX/CRT cycle and is retained in the ER lumen.  The misfolded 
glycoprotein is finally degraded by ERAD system also controlled by the N-linked 
glycan structure.   
1.6.2 Disulfide bond formation and isomerisation  
Disulfide bonds play important roles (Berkmen, 2012).  First, disulfide bonds are 
essential for the stabilisation of protein structure and function of proteins.  
Second, disulfide bonds are important in the signalling of the redox environment 
by conformation change, like roGFP proteins.  Third, disulfide bonds have 
functions in catalysis, like the disulfide bonds in oxidoreductases which can 
oxidise, reduce or isomerise their substrate proteins by accepting or donating 
electrons.  Efficient disulfide bond formation commonly occurs in highly 
specialized compartments: the periplasm in bacterial (Collet and Bardwell, 2002), 
the mitochondria (Herrmann and Köhl, 2007) and the ER in eukaryotes (Tu et al., 
2000).   
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a) In prokaryotes  
The prokaryotic mechanisms of disulfide bond formation and isomerisation are 
relatively better characterised than eukaryotic (Berkmen, 2012).   
In E. coli, the proteins containing disulfide bonds are secreted from the cytoplasm 
to the periplasm where disulfide bonds are formed, reduced and isomerised with 
the help of the Dsb system (Figure 1-10).  Disulfide formation in the substrate 
protein is catalysed by DsbA protein via disulfide exchange with the oxidised active 
sites (CXXC) in DsbA (Bardwell et al., 1993).  After the disulfide bond exchange 
with the substrate protein, the reduced DsbA is reoxidised by membrane protein 
DsbB to its active oxidised state (Kadokura et al., 2003).  The electrons are finally 
donated by DsbB to ubiquinone (UQ) or menaquinone (MQ) during aerobic or 
anaerobic respiration.  Because the DsbA tends to co-translationally oxidise 
adjacent cysteines in growing polypeptide chain (Kadokura et al., 2004), proteins 
which do not need consecutive disulfides bonds are misfolded.  These mis-folded 
proteins will be degraded or isomerised to their native state.   
Any non-native disulfide bonds formed during the oxidation process are corrected 
to their oxidised state by DsbC (Figure 1-10) (Shevchik et al., 1994).  The reduced 
state of the active site in DsbC is maintained by the membrane protein DsbD to 
which the electron is ultimately received from cytoplasmic NADPH via thioredoxin 
(Trx) (Rietsch et al., 1997).   
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Figure 1-10  Disulfide bond formation and isomerisation in bacterial periplasm.  Disulfide 
formation process (①②③);  Disulfide isomerisation process (④⑤⑥), in yellow box.  ①  Translation, 
Sec, translocon Sec61;  ②  Disulfide formation by the disulfide shuttle with DsbA, Prot RED, reduced 
state of protein, Prot OXI, oxidised protein with correct disulfide bonds, Prot MIS-OXI, protein containing 
non-native disulfide bonds;  ③  Reoxidisation of DsbA by DsbB, MQ, menaquinone, UQ, ubiquinone;  
④  Isomerisation of the non-native disulfide bond by DsbC;  ⑤  The reduced state of DsbC is 
maintained by membrane protein DsbD;  ⑥  DsbD accepts the electron from the ultimate electron 
donor, cytoplasmic NADPH, via a cytoplasmic thioredoxin (TrxA system).  The protein containing 
non-native disulfide bonds (Prot MIS-OXI).  Disulfide formation process (①②③ );  Disulfide 
isomerisation process④⑤⑥.  (Berkmen, 2012) 
b) In mammalian cells 
In mammalian cells, disulfide bonds are formed between two free cysteine and 
they can be formed in both ER and mitochondrial intermembrane space (IMS) but 
in different mechanisms (Riemer et al., 2009b).   
The introduction of disulfide bond in IMS rely on two important proteins 
mitochondrial intermembrane space import and assembly protein 40 (MIA40) 
(Chacinska et al., 2004) and FAD-linked sulfhydryl oxidase ERV1 (ERV1) (Mesecke 
et al., 2005).  In this MIA40-Erv1 oxidation system, the oxidised MIA40 can insert 
disulfide bond into the polypeptide chain and then will be reoxidised by the Erv1 
which can pass the electron to FAD (Mordas and Tokatlidis, 2015).   
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Unlike mitochondria, the ER is highly specialised for disulfide bond formation and 
reduction in two important aspects: the redox buffer consisted by reduced 
tripeptide, glutathione (γ-L-glutamyl-L-cysteinylglycine) (GSH) and its oxidised 
form (GSSG) which directly or indirectly involved in the disulfide bond formation 
and isomerisation process (Chakravarthi et al., 2006) and enzymes which facilitate 
disulfide formation and isomerisation, like PDI (Ellgaard and Ruddock, 2005).  In 
the ER, disulfide bonds are inserted by a disulfide exchange mechanism with the 
oxidised form of PDI (Figure 1-11).  The introduction of disulfide bonds potentially 
results in either native or non-native linkages.  We can find native disulfide bonds 
in the final correct structure of proteins whereas the non-native disulfide need to 
be removed before the protein can fold correctly or be targeted for degradation.  
The reduced form of PDI can isomerise the non-native disulfide bonds by disulfide 
exchange with substrate protein (Figure 1-11) (Bulleid and Ellgaard, 2011).  The 
disulfide formation pathways are relatively more well-characterised than the 
pathway for disulfide isomerisation (Bulleid and Ellgaard, 2011). 
 
Figure 1-11  Disulfide formation and isomerisation.  The disulfide bonds are inserted by disulfide 
exchange with the oxidised form of PDI.  The introduction of disulfide bonds may result in native or 
non-native disulfides.  The reduced form of PDI can isomerise the non-native to native disulfide.  
(Bulleid and Ellgaard, 2011) 
Each PDI member contains one or more thioredoxin domains (CXXC) where the 
disulfide bonds are shuttled from the oxidised form of the CXXC motif to the 
dithiol in the substrate proteins.  The disulfide transfer from the PDI to their client 
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protiens will reduce the active sites of the CXXC motif which have to be oxidised 
later for the next disulfide exchange with the client proteins in the future.  At 
least 5 pathways were identified as the potential pathways which contribute to 
the in vivo disulfide formation in ER (Figure 1-12) (Bulleid and Ellgaard, 2011).  
These pathways are named by their key enzyme(s): ERO1 pathway (Frand and 
Kaiser, 1999, Tu and Weissman, 2004), peroxiredoxin (PRDX) 4 pathway (Tavender 
et al., 2010, Zito et al., 2010), glutathione peroxidase (GPX) 7 and GPX8 (Nguyen 
et al., 2011), quiescin sulfhydryl oxidase (QSOX) (Kodali and Thorpe, 2010), and 
vitamin K epoxide reductase (VKOR) pathway (Schulman et al., 2010).   
 
Figure 1-12  Disulfide formation pathways in vivo.  The insertion of disulfide bonds is catalysed 
by PDI family.  After the disulfide exchange with the substrate protein, the active sites of CXXC motif 
are reduced.  The reduced active sites need to be reoxidised to catalyse further disulfide formation 
reactions.  Several potential pathways, ERO1 pathway, PRDX 4 pathway, GPX 7/8 pathway, and 
VKOR pathway, have been identified as the potential disulfide bond formation pathways.  ERO1 and 
QSOX sulfhydryl oxidases that introduced disulfide bond to the substrate protein via the oxidation 
FADH2 and the electron was finally passed to the O2 (QSOX can directly introduce disulfide bond  
into the substrate not via PDI).  PRDX4 result in disulfide bonds by the oxidation of sulfenic acid 
coupling with the metabolisation of H2O2 (Tavender and Bulleid, 2010).  GPX7/8 can also oxidise PDI 
by reducing the H2O2.  DHA can accept electrons to produce ascorbate.  VKOR participate the 
formation of disulfide via the reduction of vitamin K.  In the dash box, the enzymes are hypothesised 
to contribute for the disulfide formation process with in vitro experiments, but which did not show in 
vivo evidence (Bulleid and Ellgaard, 2011).  By 2012, in vivo evidence showed that the VKOR 
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contribute disulfide formation (Rutkevich and Williams, 2012).  The reduced form is shown in blue 
and oxidised form is indicated in red color. 
Like what happened in prokaryotes, non-native disulfide bonds that are contained 
in proteins in mammalian cells can prevent correct folding and post-translational 
modification processes leading to misfolding and protein aggregation.  They must 
be reduced/isomerised to allow correct native-disulfides to be formed again 
(Kosuri et al., 2012).  In bacterial periplasm, the non-native disulfide is isomerised 
by the DsbCD system (Figure 1-10).  There must be similar systems in the ER 
ensuring the reduction and isomerisation of the non-native disulfide bonds.   
It has been shown that PDI family members can reduce or isomerise the non-native 
disulfides by dithiol-disulfide exchange with client protein in the ER.  PDI member 
is characterised by the presence of Trx homologous domain and at least 17 PDI 
family members have been identified (Ellgaard and Ruddock, 2005, Kozlov et al., 
2010).  One PDI family member, ERp57, is required for the correct folding of 
glycoproteins (Jessop et al., 2007).  Another PDI member, ERdj5, has been shown 
to promote the degradation of proteins with non-native disulfide bonds (Ushioda 
et al., 2008).  This indicates that other PDI family members are likely to be 
involved in the reduction pathway of non-native disulfides.  The reduction 
function is dependent on the reduced state of the active sites of PDI family 
member.  How the PDIs are reduced after the reduction of substrates is still to be 
addressed.  It is not clear whether the electron is delivered from cytosol or ER 
lumen.   
Two hypotheses are raised based on the link between the reduction of the 
disulfide bonds inside the ER lumen with the cytosolic electron donor NADPH by a 
reduced and oxidised glutathione system (GSH and GSSG) or a cytosolic 
thioredoxin/ thioredoxin reductase (Trx/TrxR) system (Figure 1-13) (Bulleid and 
van Lith, 2014).  In the hypothetic reductive pathway constituted by glutathione 
and glutathione reductase, the reduction of the active sites in PDI are coupled 
with the oxidisation of GSH.  It is unknown how the GSH is recycled from GSSG in 
the ER lumen.  It is possibly directly reduced by an ER-localised glutathione 
reductase or the GSSG is reduced by a cytosolic GSH reductase and then 
transported back to the ER lumen (Figure 1-13 A).  In the hypothetic reduction 
model of PDI mediated by thioredoxin reductase (TrxR), the reduction of the 
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active sites in PDI is driven by an ER-localised or a cytosolic thioredoxin reductase 
(Figure 1-13 B).  The ER-localised TrxR and the membrane protein which can 
shuttle electrons from the cytosol to ER lumen is unknown.  Recently, a study in 
our group demonstrated that the addition of G6P can recycle NADPH which is 
required for the reduction of Trx by TrxR and the robust cytosolic Trx/TrxR 
pathway is necessary for the correct disulfide bond formation suggesting a link 
between the cytosolic electron donor and the ER electron acceptor (Poet et al., 
2017).  However, how the electron is transferred into the ER is unknown.  Whether 
other components are needed in this reductive pathway and whether a membrane 
protein which can transfer the electron from the cytosol into the ER lumen remain 
to be addressed.   
 
Figure 1-13  Potential ER reductive pathways of non-native disulfide bonds.  A.  Hypothetic 
reduction model of PDI by glutathione (GSH).  GSSG, oxidised glutathione.  B.  Hypothetic reduction 
model of PDI mediated by thioredoxin reductase (TrxR).  (Bulleid and van Lith, 2014) 
A. 
B. 
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1.7 Protein disulfide isomerase 
Protein disulfide isomerase (PDI) is a soluble 55-kDa ER-localised proteins which 
has been considered a multifunctional enzyme (Parakh and Atkin, 2015).     
PDI contain four domains: a, b, b’, and a’ domain (Pirneskoski et al., 2001) plus 
an signal peptide, an acidic C terminal extension c and an ER retention sequence 
(K/H)DEL (Norgaard et al., 2001).  The a and a’ domains are thioredoxin (Trx) 
homologues which have catalytic motif sites CXXC.  Through thiol change, they 
can act as simple thiol: disulfide oxidoreductases.  The b and b’ domains do not 
have Trx-like catalytic motifs.  Thus, they cannot catalyse disulfide exchange 
reactions like a and a’ domains, but these two domains are the sites where 
substrate proteins bind.  The full function of PDI needs the cooperation of all 
domains (Darby et al., 1998).   
PDI are multifunctional enzymes (Wilson et al., 1998).  They can catalyse the 
formation, reduction and isomerisation of disulfide bond in the ER compartment, 
which is critical for the efficient and correct folding of secreted and membrane 
proteins in the mammalian cells (Zheng and Gilbert, 2001).  PDI can act as one 
subunit of prolyl 4-hydroxylases (P4H) which is essential for collagen synthesis 
(Kivirikko and Myllyharju, 1998) and PDI can associate with the M subunit to form 
an heterodimer, microsomal triglyceride transfer protein (MTP) that is responsible 
for lipid transfer (Hussain et al., 2012, Wetterau et al., 1990).  In addition, the 
PDI is also a molecular chaperone.  It was suggested that the PDI participates in 
protein preparation for ERAD as an redox state dependent chaperone (Molinari et 
al., 2002).   
1.7.1 ERp57 
ERp57, also named as glucose-regulated protein 58 (GRP58), ER-60, Q2, ERp58, 
ERp61, and 1,25D3-MARRS, is a multifunctional member of PDI family in the ER 
(Turano et al., 2011).  This protein is coded by the PDIA3 gene which localised on 
chromosome 15.  It contains 505 amino acids and the structure of ERp57 can be 
divided into four domains: a domain, b domain, b’ domain and a’ domain 
(Pirneskoski et al., 2001).  The a and a’ domain have thioredoxin (Trx) homologous 
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sequence with CXXC active site motifs.  As these are redox active sites, the ERp57 
has oxidoreductase function.  The b and b’ domains do not contain trx-like redox 
active sites, thus they cannot catalyse redox reactions.  The four domains in ERp57 
form a U-shape conformation where the a and a’ domains come close to each 
other in order to interact with substrate proteins and the b and b’domain can bind 
with the calreticulin or its membrane-bound homologoue calnexin to facilitate the 
function of a and a’ domains (Pirneskoski et al., 2001).   
ERp57 is involved in glycosylated protein folding and quality control process in the 
ER in association with calreticulin or calnexin (Oliver et al., 1997, Frasconi et al., 
2012).  The ERp57 can promote the formation of disulfide bonds and also isomerise 
the misformed disulfide bonds (Oliver et al., 1997, Bulleid, 2009).  It was also 
demonstrated that the ERp57 participitates in the assemble of major 
histocompatibility complex class 1 (MHC1) where it forms a complex with tapsin 
to ensure fidelity of peptide loading (Peaper et al., 2005).  Besides, this protein 
can play a role as a chaperone in prevention of protein aggregation (Castillo et 
al., 2015).  To ensure its normal function, the redox state of ERp57 should be 
regulated.  In intact Hela cells, the ERp57 is mostly in a reduced form (Mezghrani 
et al., 2001).  After catalysing disulfide bond reduction, it remains unclear how 
the cell reduces the oxidised ERp57 in the ER.   
1.7.2 ERdj5 
ERdj5 is the largest PDI family member and is particularly abundant in cells 
optimised for secretion (Adams et al., 2019, Cunnea et al., 2003).  ER stress can 
induce the transcription of ERdj5.  ERdj5 contains, a N-terminal DnaJ domain that 
can interact with BiP via adenosine triphosphate (ATP)-dependent cycle; 6 
thioredoxin domains, 4 with redox active CXXC motifs; and a C-terminal ER 
retention KDEL motif (Figure 1-14  Domains of mouse ERdj5.Figure 1-14) (Ushioda 
et al., 2008, Hagiwara et al., 2011).  The six thioredoxin domains in ERdj5 are 
divided into two cluster and the thioredoxin domain 3 and 4 in the C-terminal 
cluster are responsible for the reductase function (Hagiwara et al., 2011).   
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Figure 1-14  Domains of mouse ERdj5.  It contains thioredoxin domains with active redox sites 
(CXXC motifs), a DnaJ domain and a C-terminal KDEL motif.  (Hagiwara et al., 2011) 
Envidence showed that ERdj5 can reduce several other PDI family members and it 
can not be reduced by the PDI members (Riemer et al., 2009a), because ERdj5 has 
one Trx domain which is lower than the other PDI family member suggesting that 
the ERdj5 function as a reductase (Hagiwara et al., 2011).In addition, ERdj5 can 
prevent multimer formation and reduce non-native disulfide bonds in misfolded 
glycosylated proteins recognised by ER degradation-enhancing a-mannosidase-like 
protein 1 (EDEM1) (Htm1/Mnl1p in yeast) and facilitate the retrotranslocation of 
the ERAD substrate proteins in association with the chaperone BiP in an ATP-
dependent manner (Ushioda et al., 2008, Hagiwara et al., 2011).  A remaining 
question is how ERdj5 receives its reducing power.   
1.8 ER quality control system  
In mammalian cells, secreted proteins and membrane proteins need to enter the 
ER lumen to attain their correct folding and modification to obtain their native 
function.  Because misfolded proteins will disrupt protein homeostasis and form 
aggregates which could have cytotoxic effects on cells, there is an ER quality 
control system to evaluate and determine the structural integrity of proteins 
(Hurtley and Helenius, 1989, Adams et al., 2019).  The proteins with native 
structure will pass the quality control system and be transported to the Golgi 
apparatus or other cellular destinations.  The ER can also recognise misfolded 
proteins and try to retain and repair them in the ER lumen.  If not, the proteins 
with non-native structures will be delivered back to the cytosol and degraded by 
the cytosolic ubiquitin-proteasome system (McCaffrey and Braakman, 2016).   
The ER quality control is supported by many different ER localised factors.  They 
are divided into three main groups (Adams et al., 2019). First category is the 
classical molecular chaperone systems, including different heat shock families 
(Hsps), like Hsp 70 (also named BiP and GRP 78) (Schlecht et al., 2011, McCaffrey 
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and Braakman, 2016).  It has been shown that ATP-dependent BiP can prevent the 
misfolding of nascent polypeptide during translocation and is required to regulate 
the unfolded protein response (UPR) (Johnson et al., 2013).  The second category 
is the glycan-dependent molecular chaperone systems, such as glycoprotein 
glucosyltransferase 1 (UGGT1) (Sousa and Parodi, 1995), calnexin and calreticulin.  
These group of factors facilitate the quality control of glycosylated proteins and 
decide on the retention or exportation of glycoproteins (Caramelo and Parodi, 
2015).  The third category is thiol-dependent oxidoreductases including different 
PDI family members (more than 20 members) like ERp57, ERdj5, and ERp44 (Anelli 
et al., 2003).  PDIs catalyse the oxidation, reduction, and isomerisation of 
disulfide bonds via the catalytic CXXC motif sites to promote proper folding of the 
substrate protein.  The various factors work together to maintain protein 
homeostasis in ER.   
The accumulation of proteins which fail to obtain their native structure in the ER 
membrane and ER lumen (misfolded and mutated proteins) can break protein 
homeostasis and cause ER stress that can result in cell death.  The clearance of 
these harmful proteins is achieved by the ERAD pathway (Olzmann et al., 2013).  
ERAD is a complicated process which can be divided into different steps: 
recognition, retrotranslocation, ubiquitylation, and degradation (Figure 1-15) 
(Olzmann et al., 2013, Ruggiano et al., 2014).  The misfolded proteins are first 
recognised as ERAD substrates by molecular chaperones and lectins and 
subsequentially retrotranslocated to the cytoplasm.  The cytosolic side of the 
membrane protein and misfolded secreted proteins are ubiquitinylated, by the 
attachment of ubiquitin (a 76 amino acids proteins) (Figure 1-15).  The 
ubiquitination is catalysed by a membrane-associated ubiquitin ligase (also named 
E3 ligase) via an ATP-dependent process.  These substrate proteins are then 
released in the cytoplasm and degraded by the proteasome.   
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Figure 1-15  Key Steps in ERAD.  ERAD is a complicated process which can be divided into 
different steps: recognition, retrotranslocation, ubiquitylation, and degradation.  The different steps 
in ERAD process are coordinated by the ubiquitin ligase complex (also called E3 ligase complex).  
(Ruggiano et al., 2014) 
1.9 Membrane transport 
The ER is formed by a continuous lipid bilayer membrane which relates to the 
nuclear envelope.  Thus, the ER lumen is completely enclosed and disconnected 
with the cytosol.  However, cytosolic processes are essential for numerous enzyme 
activities in the luminal of the ER, such as the metabolism of carbohydrate and 
steroid, biotransformation, and protein folding and modification (Csala et al., 
2007).   
The ER membrane is selectively permeable (Figure 1-16) (Bruce Alberts, 1994, 
Yeagle, 2016).  Different molecules pass the membrane at different speeds.  
Water can cross the membrane through a specific water channel called aquaporins 
by passive diffusion (Stillwell, 2013).  Some small molecules, like O2, and CO2, can 
pass the membrane directly at a high speed (simple diffusion).  Larger molecules, 
such as glucose, can cross the membrane with the facilitation of a transporter 
protein at a slower speed (passive or active transport) and some large proteins 
cannot pass through the membrane at all.  The transport rate of certain substrates 
is the rate-limiting step for certain enzyme activities in the ER lumen.  Hence, it 
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is important to identify the ER membrane protein involved in the transportation 
process.  Only a limited number of membrane proteins involved in the 
transportation process are identified.  Most membrane proteins that facilitate 
molecule transport are yet to be identified with better and more developed 
technologies.  Based on the previous research in our group, it was shown that the 
ultimate electron donor of the disulfide formation in the ER is cytosolic NADPH 
indicating a pathway linking the cytosol and ER lumen (Poet et al., 2017).  We 
assumed that an ER membrane protein is likely involved in the ER reductive 
pathway for the transportation of the electron.   
 
Figure 1-16  Different membrane transport.  A molecule can cross the lipid bilayer membrane by 
simple diffusion or by diffusion in the absence or the presence of facilitation of the channel or carrier 
proteins following the electrochemical gradient (passive transport).  On the contrary, the transport of 
a molecule against the electrochemical gradient needs energy and carrier protein (active transport).  
(Bruce Alberts, 1994) 
1.9.1 Lipase maturation factor 1 
Lipase maturation factor 1 (LMF1) is an ER membrane-bound protein (Doolittle et 
al., 2010).  It has been shown that LMF1 is essential for folding and assembly of 
lipases, such as lipoprotein lipase (LPL), hepatic lipase (HL) and endothelial lipase 
(EL).  Instead of playing a role at the transcription level, LMF1 is involved in the 
post–translational maturation process of these secreted lipases.  The mutation of 
LMF1 results in the deficiency of lipase (LPL, HL and EL) and disrupts lipid 
homeostasis in mice and humans (Peterfy, 2012).   
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The LMF1 contains 5 transmembrane segments and 6 domains (Figure 1-17) 
(Doolittle et al., 2010).  N-terminal domain, loop B domain and loop D domain are 
in the cytoplasm.  The loop A, loop C and C-terminal domain are in the ER lumen.  
The function of each domain in LMF1 has not been clearly clarified except loop C 
domain and the C-terminal domain.  The highly conserved loop C domain (CLD) 
can specifically bind with homodimer lipases like LPL, HL and EL rather than 
pancreatic lipase (PL), a monomer lipase.  The C-terminal domain was 
demonstrated to play a critical role in lipase maturation.  The mutations at the 
CLD, Y439X and W464X sites cause significant activity loss of LMF1 in lipase 
maturation that can result in severe human hypertriglyceridemia (Peterfy et al., 
2007, Cefalu et al., 2009).  A recent study suggests that the LMF1 plays a critical 
role in the ER redox state homeostasis and reduction of non-native disulfides 
(Roberts et al., 2018).  It is unknown if the LMF1 can shuttle electrons from the 
cytosol to facilitate reduction of non-native disulfide bonds in the ER lumen.   
 
Figure 1-17  Structure of ER transmembrane protein, LMF1.  There are five transmembrane 
segments in LMF1 that divide the protein into six domains.  The loop C domain is the binding site of 
homodimer lipases like LPL, HL and EL.  The C-terminal domain is where the lipases achieved their 
post-translational maturation.  The mutation of cld, Y439X and W464X can cause the failure of the 
lipase maturation.  (Doolittle et al., 2010) 
1.9.2  Selenoprotein N 
In the human proteome, there are 25 selenoproteins (Kryukov et al., 2003).  The 
rare amino acid selenocysteine (Sec) is added to the selenoproteins co– 
translationally in response to a stop codon (UGA codon) (Schweizer and Fradejas-
Villar, 2016).  The mRNA of selenoproteins in bacteria contains a selenocysteine 
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insertion sequence (SECIS) element following the UGA codon in the opening 
reading frame, whereas, in eukaryotes, the SECIS element is localised in 3’ 
untranslated region (UTR) and the addition of the Sec needs SECIS-binding 
proteins.  The known selenoproteins, like glutathione peroxidase 1 (GPx1), 
thioredoxin reductases (TrxR) and methionine sulfoxide reductase (MsrB1), have 
been found in oxidoreductase reactions that are essential for redox state 
homeostasis and antioxidation.  The selenoproteins are either directly or 
indirectly related to calcium homeostasis and ER Stress (Pitts and Hoffmann, 
2018).   
Selenoprotein N (SEPN1) is a member of selenoprotein family, that is encoded by 
SEPN1 gene.  This protein is a 70 kDa ER resident transmembrane glycosylated 
protein which contains one Sec (Petit et al., 2003).  The SEPN contains a redox 
active motif (S-C-U-G) which is similar with the redox active motif CXXC in TrxR.  
It suggests that the SEPN can potentially act as a oxidoreductase (Pitts and 
Hoffmann, 2018).  The mutation of SEPN1 results in muscular dystrophy that 
suggests its critical role in maintaining the redox state in the skeletal cell 
(Moghadaszadeh et al., 2001).  It is shown that the SEPN1 is also involved in ER 
redox as an ERO1 inhibitor and calcium homeostasis with interaction with ER 
calcium sarcoplasmic reticulum Ca2+ ATPase (SERCA2) import pump (Marino et al., 
2015).  SEPN1 is another potential candidate ER membrane protein that links the 
cytosol and ER lumen reductive pathway for non-native disulfide bond reduction.   
1.10 Green fluorescence protein 
The green fluorescence protein (GFP) which was first found in a jellyfish, 
Aequorea Victoria, (Johnson et al., 1962, Shimomura et al., 1962) and there are 
now hundreds of GFP variants that have been developed (Pedelacq, 2019).  
Currently, they are widely used as a reporter and protein labels, such as pH 
indicator (Miesenböck et al., 1998, Hanson et al., 2002), calcium indicators (Mank 
and Griesbeck, 2008) and redox sensitive GFPs (Meyer and Dick, 2010) in biological 
studies.   
The wild type Aequorea victoria GFP (AvGFP) protein consists of 238 amino acids 
that form an 11–stranded barrel structure (also called β-can) surrounding a central 
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helix (Figure 1-18 A) (Weichsel et al., 1996, Pedelacq, 2019).  Around 9–13 residues 
are located in each β-can strand (Figure 1-18 B).  The cyclisation, dehydration, 
and oxidation of the amino acid residues, Ser 65, Tyr 66, and Gly 67, within the 
central helix results in the chromophore.  The correct folding is essential for the 
fluorescence properties.  The emission of fluorescence of AvGFP is at 525 nm.  The 
excitation spectrum of AvGFP shows two peaks at 396 – 398 nm (maximum 
excitation peak) and 476–478 nm (lower secondary peak).  The maximum peak 
corresponds to the neutral state of Tyr 66 in the chromophore whereas the 
secondary peak results from the deprotonated anionic state of Tyr 66 in the 
chromophore.   
 
Figure 1-18  Schematic structure of AvGFP.  A.  The key feature of the AvGFP structure is 11-
stranded - barrel wrapped around a single central helix that contains a chromophore (representing 
by a ball and stick model).  B.  The fold of AvGFP.  The numbers indicate the beginning and ending 
residues in the secondary structure.  N, indicating N-terminus of AvGFP;  C,  indicating COOH-
terminus of AvGFP.  (Weichsel et al., 1996) 
In order to overcome the weak brightness and to optimise the excitation 
efficiency, different mutations, such as S65T, F64L, are incorporated into the 
AvGFP (Cormack et al., 1996).  This GFP variant is converted to human codons 
which can encode the enhanced – GFP (eGFP) that have a much higher 
fluorescence intensity that the wild type AvGFP.  To solve the solubility and 
overcome the folding defects when the GFP was fused to other proteins, 
superfolder GFP (sfGFP) is engineered by incorporating folding mutations, like 
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S30R which has been found to have a significant role on the stabilisation of the 
GFP structure and decrease the influence of fusion proteins on GFP correctly 
folding (Pédelacq et al., 2006).  These sfGFPs can be expressed in pro- and 
eukaryotes and provide the possibility for diverse applications in mammalian cells.   
Redox–sensitive GFP (roGFP) are GFP variants that are engineered with cysteines 
on adjacent strands that can or can not form a disulfide bond which modify the 
properties of the GFP fluorescence.  Depending on the redox potential of the 
disulfide bonds in roGFP, it can be used to monitor the redox state change in living 
mammalian cells, such as in the cytosol (Ostergaard et al., 2001), the 
mitochondria (Hu et al., 2008), the ER (van Lith et al., 2011) and the later stages 
of the secretory pathway (Austin et al., 2005).  Because of the more oxidising 
environment in the ER lumen, the disulfides need to have a higher reduction 
potential than that in the cytosol and mitochondria.  My colleagues engineered 
one roGFP variant which can monitor the redox status change in real time based 
on the GFP variant (roGFP1-iL) (van Lith et al., 2011) which has a more similar 
disulfide reduction potential suitable for the use in the ER lumen (Lohman and 
Remington, 2008).  To ensure ER-localisation in mammalian cells, a signal peptide 
from ERp57, was fused to the N-terminal of the roGFP1-iL and the ER retrieval 
sequence (KDEL) was incorporated to the C-terminal of the roGFP1-iL (van Lith et 
al., 2011).  One of the known two cysteines (C49 and C71) that can independently 
form dimers by an interchain disulfide in roGFP1-iL is mutated to Ser (C49S), which 
allows roGFP1-iL-KDEL to respond to the redox state change in the ER lumen in 
real-time.  To obtain a more stable and brighter roGFP variant, ER-SFGFP-iE, 
superfolder mutations (Pédelacq et al., 2006) were incorporated into the roGFP1-
iL-KDEL.  In addition, the ER-SFGFP-iE is human codon optimised for more efficient 
expression.  Herein, ER-SFGFP-iE was used to monitor the microsomal redox status 
in our experiments.   
1.11 Project Aims 
Based on the work carried out previously, we have an unknown connection 
between the ultimate electron donor (NADPH) in the cytosol and the final acceptor 
in the ER.  While the initial and final steps in the pathway are identified, we do 
not know the number of intermediate steps or the identity of a putative disulfide 
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transporter in the ER membrane.  The gaps in our knowledge are indicated by 
question marks (Figure 1-19).  Based on the different locations in cells, the 
knowledge gap is divided into three questions:   
1.  Are there additional components needed in the cytosolic reduction pathway?  
2.  What is the putative disulfide transporter in the ER membrane?  
3.  Which components are involved in the conversion of non-native to native 
disulfides in the ER? 
 
Figure 1-19  Hypothetical disulfide reductive pathway between thioredoxin in the cytosol and 
PDI in the ER.  The potential connections between the electron donor (NADPH) in the cytosol and 
the ultimate electron acceptor in the ER are depicted. While the initial and final steps in the pathway 
are identified we do not know the number of intermediate steps or the identity of a putative disulfide 
transporter in the ER membrane. The gaps in our knowledge are indicated by question marks. 
The goal of our research is to address the ER reductive pathway for disulfide 
reduction which is driven by the cytosolic ultimate donor NADPH via a robust 
cytosolic Trx/TrxR pathway.  The three aims in each chapter to achieve this goal 
are as followed: 
1.  Reconstitute a cytosolic Trx/TrxR system using purified components and assess 
if these are the minimal components that are required for the reduction of 
proteins within a microsomal membrane system.   
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2.  Evaluate if the minimal cytosolic Trx/TrxR system can reduce the oxidised ER–
localised ERp57, a member of PDI, that plays a critical role in the reduction of 
disulfide in glycoprotein.   
3.  Develop a post-translational folding assay using RRL can be used to analyse the 
ability of the purified components to reduce disulfide bonds in the ER.   
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Chapter 2 Materials and Methods 
2.1 Cell lines 
The HT1080 cell line, a fibrosarcoma cell line, and Hela cell line was cultured in 
75m2 filter capped flasks and in Dulbecco's Modified Eagle Medium (DMEM) (Gibco) 
at 37oC under 5% CO2.  HT1080 cell lines which stably over expressed V5-tagged 
ERp57 and roGFP were cultured as above in presence of antibiotic G-418 sulfate 
(Promega).  The HEK 293 wild type and HEK 293 LMF1 KO cell lines are gifts from 
Saskia B Neher’s lab (Roberts et al., 2018) and the Hela wild cell line and Hela 
SEPN1 KO cell lines are obtained from Ester Zito (Varone et al., 2019).   
2.2 Reagents 
If not specifically mentioned, chemicals were purchased from Sigma-Aldrich. 
2.3 Preparation of SP cells 
SP-cells were prepared as described previously (Wilson, Allen et al., 1995).  The 
sub-confluent cells were rinsed twice with 10 ml PBS (Gibco) to remove the 
medium which inhibits trypsin.  Trypsin solution (2 ml) (prewarmed to RT) was 
added into the flask and incubated for at 37 oC for 3 min to detach the cells.  KHM 
buffer (8 ml) (20 mM HEPES buffer pH 7.2, including 110 mM KOAc, 2 mM MgOAc) 
was used to resuspend the cells and soybean trypsin inhibitor (final concentration 
100 µg/ml) was added into the solution to inactivate the trypsin.  The cell 
suspension was then transferred to a 15 ml tube tube which was pre-cooled on the 
ice.  The cells were pelleted by centrifugation at 250 ×g at 4 oC for 3 min.  The 
pellet was resuspended in 6 ml KHM buffer including 40 µg/ml digitonin 
(Calbiochem) and incubated on ice for 5 min to permeabilise the plasma 
membrane.  The volume was made up to 14 ml and the cells were pelleted by 
centrifugation as above.  The cells were resuspended in 14 ml ice-cold HEPES 
buffer (KOAc 50 mM, HEPES 20 mM, pH 7.2) and incubated on ice for 10 min.  After 
centrifugation as above, the cell pellet was resuspended in 1 ml KHM buffer and 
10 µl of cell suspension was transferred into an eppendorf tube which contained 
10 µl Trypan Blue (Sigma).  The SP cells were counted and checked for 
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permeabilization using a Cell Counter (Countess Ⅱ FL).  SP cells were pelleted by 
centrifugation as above and resuspended in KHM buffer containing CaCl2 (5 mM) 
and treated with Stapylocossus aureus nuclease (Calbiochem) (final concentration 
150 U/ml) at RT for 12 min to remove the endogenous mRNA.  A final concentration 
4.5 mM of ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
(EGTA, Sigma) was added into the solution to inactivate the nuclease.  SP cells 
were pelleted by centrifugation as above and resuspended in 100 µl KHM buffer 
ready for the translation reactions or determination of the redox state 
experiments.  For ERp57 redox state determination experiments, the nuclease 
treatment was not included during the preparation.  In certain experiments, the 
SP cells were prepared from cells expressing V5-tagged ERp57.   
2.4 Preparation of Adam 10 disintegrin domain DNA 
The human Adam10 construct codes for residues 456 – 550 and contains the human 
- β2M signal sequence residues (1-20).  The generation of this construct and its 
transcription and translation were as described previously (Robinson et al., 2020).  
The plasmid DNA was used as a template for polymerase chain reaction (PCR) using 
a forward primer that adds a T7 promoter and a reverse primer that adds five 
methionine codons but lacks a stop codon.  A reaction mixture (49 µl) (DNA 
template (50 – 100 ng), 5 µl 10 × Accubuffer (Bioline), 2 µl MaCl2 (50 mM), 2 µl 
dNTPmix (100 mM), 2 µl forward primer (10 mM), 2 µl reverse primer (10 mM), 
distilled H2O up to 49 µl) in the absence of ACCUZYME DNA polymerase (Bioline) 
was set up to do a hot-start PCR in order to obtain a more specific amplification 
of DNA.  After the initial denaturation at 95 oC for 2 min, the DNA polymerase was 
added into the PCR reactions.  The PCR cycle conditions in each cycle were as 
followed: denaturation at 95 oC for 30 s, annealing at 72 oC for 1 min, and 
extension at 72 oC for 1 min.  To obtain sufficient target DNA, the PCR was carried 
out x 29 cycles.  The DNA was precipitated by the addition of 0.1 volume 
NaAcetate (300 mM, pH 5.0) and 3 volumes ethanol absolute and the tube was 
centrifuged at 14,800 rpm for 10 min to isolate the DNA.  The pellet was washed 
by 200 µl 70% ethanol and dried at RT for 5-10 min.  The DNA was redisolved in 50 
µl distilled water.  The solution (2 µl) was mixed with 3 µl water and 1 µl 5 × Gel 
Loading Dye (Biolab).  The samples were run on a 1% agarose gel which was 
dissolved in 1 × TAE buffer (40 mM Tris Base, 1.74 glacial acetic acid, 12.7 mM 
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ethylenediaminetetraacetic acid (EDTA).  The gel was scanned in Azure c600 
(Cambridge Bioscience) to obtain the image.   
2.5 Transcription 
RNase ZapTM (Invitrogen) was used to destroy RNases on the bench where a 50 µl 
of transcription system was set up. The reaction system for transcription were as 
followed: DNA template (5 – 10 µg), 5 µl 10 × transcription buffer (Promega), 2 µl 
DTT (100 mM), 6 µl 4 nucleotide mix (each at 25mM) (Biolabs), 1 µl RNasin 
(Promega), 2 µl T7 or SP6 RNA polymerase (Promega), distilled H2O up to 50 µl.  
The transcription was carried out in a water bath at 37 oC for 2 h.  The RNA was 
precipitated, and the quality of RNA was checked as described for DNA (2.4).   
2.6 Translation 
Translation reaction was carried out in the Flexi® Rabbit Reticulocyte Lysate (RRL) 
System (Promega).  Each 25 µl translation reaction system contained 16.5 µl RRL 
(Promega), 1 µl RNA template, ～105 SP cells or 1 µl microsomes (50 unit/ µl), 20 
mM amino acids minus methionine (Promega), 40 mM KCl, and 0.5 µl EasyTagTM 
EXPRESS 35S Protein Labelling Mix (PerkinElmer).  In certain experiment, RRL were 
treated with TrxR inhibitor, auranofin (AF) (20 µM), at RT for 15 min.  The 
translation was carried out in the absence or presence of 5 mM glucose 6-
phosphate (G6P) at 30 oC in water bath for different times depending on RNA 
template (15 min for Adam 10 disintegrin domain and 60 min for β1-integrin).  A 
final concentration of 25 mM N-ethylmaleimide (NEM, Thermo Scientific) was 
added to terminate the reaction by blocking free thiols in translation products, 
while NEM was not added to translations which were subsequently used in post-
translational assays later.   
2.7 Post-translational folding assay 
The translation products translated in the absence of G6P were used to carry out 
a post-translational folding assay with the purified cytosolic components, such as 
NADPH, G6P, G6PDH, Trx, TrxR.  SP cells or microsomes were pelleted by 
centrifugation at 14,800 rpm (cells for 30 s, microsomes for 10 min).  KHM buffer 
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(HEPES buffer (20 mM, pH 7.5) for microsomes) was used to wash the pellet to 
remove the excess RRL.  Post translational folding assays were carried out in fresh 
RRL (treated or not treated with AF as above), cell extract or KHM buffer, with or 
without 5 mM G6P or the reconstituted Trx/TrxR system (1 mM NADPH, 25 µM 
human Trx, 16.25 nM human TrxR (IMCO) or 600 nM yeast TrxR (purified by Jana 
Rudolf), 1.25 mM G6P, 10 mU G6PDH) in the absence or presence of Trx.  The 
post-translational reactions were stopped by the addition of NEM (final 
concentration 25 mM).  After centrifugation, the pellet was ready for 
immunoisolation.   
2.8 Immunoisolation 
The translation product was washed with KHM buffer (SP cells) or HEPES buffer 
(microsomes) to remove RRL or other background proteins.  After centrifugation, 
the pellet was resuspended in 1 ml immunoprecipitation (IP) buffer (50 mM Tris-
HCl pH7.5, 1% Triton X-10, 150 mM NaCl, 2 mM EDTA, 0.5 mM PMSF, 0.02% Na-
azide) containing 50 µl 10% recombinant Protein A Sepharose FF Resin (PAS) 
(Generon).  The solution was incubated on a roller at 4 oC for at least 30 min.  The 
beads were centrifuged at 14,800 rpm for 30 s.  The supernatant was then 
transferred into a new tube contained 50 µl 10% PAS.  A specific antibody, such as 
JB1A (Merck) and 9EG7 (BD Biosciences) for β1-integirn and anti-V5 antibody 
(Invitrogen) for Adam 10 disintegrin domain, was added into the supernatant.  The 
solution was incubated on roller at 4 oC overnight.  The beads were pelleted by 
centrifugation as above followed by three times washing using 1ml IP buffer.  The 
target protein was eluted from the beads by 5 min boiling at 105 oC with 35 µl 4 × 
SDS-PAGE loading buffer (200 mM Tris/HCl pH 6.8, containing 40% glycerol, 8% 
SDS, 0-4% bromophenol blue).  The samples were separated by SDS-PAGE under 
reducing or non-reducing condition.  The gel was fixed for 30 min in 10% acetic 
acid/10% methanol and then washed three times using distilled water.  The gel 
was laid on wet filter paper and then dried at 80 oC for 1 h.  The dried gel was 
exposed to a phosphorimage plate or BioMax MR film (Kodak).  A FLA-7000 
bioimager (Fujifilm) was used to scan the plate to obtain the image.   
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2.9 Preparation of competent cells 
Competent cells were prepared from E. coli XL-1 or BL21-DE3.  One colony from 
an agar plate of XL-1 or BL-21 was picked and cultured in 10 ml LB (not containing 
any antibiotic) at 37 oC overnight.  All bacterial culture was transferred into 500 
ml LB and cultured for another 2.5-3 h at 37 oC, 180 × g until the OD600 reached 
0.5.  The solution was cooled down on ice for 15 min.  The bacteria were pelleted 
in 10 × 50 ml tubes by centrifuge at 3,000 × g, 4 oC for 10 min.  The supernatant 
was discarded while the pellet was resuspended in 30 ml (3 ml in each 50 ml tube) 
Tfb1 buffer (RbCl 100 mM, MnCl2-4H2O 50 mM, potassium acetate 30 mM, CaCl2-
2H2O 10 mM, 15% glycerol).  The solution was transferred into one 50 ml tube and 
placed on ice for 15 min.  The bacteria were centrifuged at 4,000 rpm at 4 oC for 
10 min.  The pellet was resuspended in 6 ml Tfb2 buffer (Mops 0.2 M, RbCl 10 mM, 
CaCl2-2H2O 75 mM, 15% Glycerol) and aliquoted into eppendorf tubes.  The 
aliquots were frozen in liquid nitrogen and stored in - 80 oC freezer. 
2.10 Transformation 
The competent cells were thaw on ice for 20 - 30 min.  DNA (usually 10 pg to 100 
ng, around 1-50 µl) were added into 20 - 50 µl competent cells.  The solution was 
mixed gently by flicking the bottom of eppendorf tube with fingers for 5 times and 
incubated on ice for 20-30 min.  The mixture was heat shocked in water bath at 
42 oC for 30 - 90 s (Usually 45 s was ideal, but the heat shock time also varied 
depending on the competent cells).  The tube was immediately placed on ice and 
incubated for 2 min.  A volume of 200-800 µl Luria Broth (LB) (bactotryptone 10 
g, yeast extract 5 g and NaCl 10 g in per 1 L water) (without antibiotic) was added 
into the tube.  The tube was incubated at 37 oC for 45-60 min at 225 rpm/min in 
an incubator shaker (Innova 4400).  Appropriate volume (50-200 µl) of solution was 
pipetted to the LB agar plate (containing 15% agar) including antibiotic (ampicillin 
100 µg/ml).  The plates were dried, inverted and incubated at 37 oC overnight.  
After overnight culture, single colonies were selected and cultured overnight in 
liquid LB.  The bacterial culture was preserved at -80 oC with 30% glycerol.   
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2.11 Expression of Trx 
2.11.1 Small scale protein expression 
A small scale of protein expression was carried out to investigate whether the 
transformation was successful.  A transformed BL21-DE3 colony was picked from 
the agar plate with antibiotic and cultured overnight in 5 ml LB (containing 100 
µg/ml Amp) at 37 oC, 225 × g in a shaker incubator (Innova 4400).  A volume of 50 
µl overnight culture was added to 5 ml fresh LB (containing 100 µg/ml Amp) and 
cultured for 3-4 h until the OD600 reached 1.  A volume of 1 ml bacterial culture 
was centrifuged at 18,000 × g for 10 min.  The pellet was resuspended in SDS-
loading buffer and boiled at 105 oC for 5 min (for example, if the OD600= 1, 100 µl 
SDS-loading buffer was used to resuspend the pellet).  This sample was loaded on 
the gel as the uninduced control of protein expression.  The remaining bacterial 
culture was induced by the addition of isopropyl β-D-1-thiogalactopyranoside 
(IPTG) (final concentration 2 mM) for 3 - 4 h.  Another 1 ml solution was measured 
at 600 nm, centrifuged, and resuspended in SDS-loading buffer as above.  The 
samples were loaded on a 15% SDS-PAGE gel (running conditions, 300 V, 25 mA, 2 
h).  Coomassie staining was carried out to visualize the protein.   
2.11.2 Large scale protein expression 
A colony was picked and cultured overnight in 10 ml LB in the presence of 100 
µg/ml Amp at 37 oC.  Bacterial culture (5 ml) was added to 500 ml fresh LB with 
antibiotic and cultured for 3-4 h until the OD600 reached 1.  Before the addition of 
IPTG, a 1 ml of culture was collected and after centrifugation, the pellet was 
resuspended in SDS-loading buffer as a uninduced control.  The remaining 
bacterial culture was incubated with 2 mM IPTG for another 3 - 4 h to allow protein 
expression.  The OD600 of a 1ml bacterial culture after induction was measured 
and the bacteria was isolated by the centrifugation at 14,800 rpm for 10 min as a 
control for expression.  The rest of bacterial culture was split into 250 ml flat 
bottom screw cap centrifuge bottles and centrifuged at 4 oC, 3,000 × g for 15 min 
(Beckman, rotor JA17).  The supernatant was discarded.  The bacteria were 
pelleted and washed three times with PBS (40 ml/tube).  The pellet was stored -
20 oC.  Samples before and after induction were loaded on a 15% SDS-PAGE gel 
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(running conditions, 300 V, 25 mA, 2 h) under reducing conditions.  Coomassie 
staining was carried out to visualize protein expression.   
2.12 Colloidal Coomassie blue stain 
After SDS-PAGE analysis, the gel was stained with Coomassie blue (10% phosphoric 
acid (H3PO4), 10% ammonium sulphate (NH4)2SO4, 0.12% Coomassie G250 (brilliant 
blue), 20% Methanol) for at least 1 h.  Gel was de-stained using distilled H2O 
overnight and scanned to obtain image the next day. 
2.13 Purification of Trx 
2.13.1 His tag affinity chromatography 
The bacteria pellet after induction by IPTG was thawed on ice and then 
resuspended in 20 ml His-Buffer A (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM 
imidazole).  The cells were disrupted three times in a French Press cell disrupter 
(Thermo) at 950 Psi.  After centrifuged at 10,000 × g, 4 oC for 30 min, the 
supernatant was filtered through a Minisart® Syringe Filter (Pore Size, 0.45 µm) 
(Sartorius).  The sample was then loaded to a HisTrap HP histidine-tagged protein 
purification column (5ml) (GE Healthcare) at 2 ml/min which was pre-equilibrated 
by His-Buffer A.  After the sample was applied, His-Buffer A was used to remove 
unbound proteins (flow rate at 2 ml/min).  The His-tagged protein was eluted 
(flow rate at 0.4 ml/min) from the column by a linear gradient of 5-500 mM 
imidazole which is a mixture of His-Buffer A and His-Buffer B (50 mM Tris pH7.5, 
150 mM NaCl, 500 mM imidazole).   
2.13.2 Gel filtration 
The eluted samples from His tag affinity chromatography were concentrated to a 
final volume 1 ml at 3,500 rpm, 4 oC for 30-60 min using a Vivaspin Turbo 15 
centrifugal concentrator (100,000 MWCO PES) (Sartorius) which was washed with 
10 ml distilled water and equilibrated by 15 ml GFC buffer (20 mM Tris pH 7.5, 
100 mM NaCl).  The sample was applied (flow rate at 0.4 ml/min) in the 
equilibrated gel filtration column (Superdex 200 10/300) (GE Healthcare).  The 
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column was washed (flow rate at 0.4 ml/min) by GFC buffer until the UV 
absorbance curve became flat.  Purity of protein was analysed after gel filtration 
using SDS-PAGE (15% SDS gel) under reducing conditions with an Coomassie 
stained.  The fractions containing target protein were collected and concentrated 
until the protein concentration reached 500 mM/ml.  The protein concentration 
was measured at an absorbance of 280 nm (Cary 300 Bio UV-Vis, Varian).  The 
absorbance of the solution was measured at 280 nm in water including 1% SDS.  
The concentration of proteins were calculated using the equation: c = A / (e × b) 
(A is the value of A280, e is extinction coefficient of the protein, and the b is the 
path length (cm)).  The aliquots of purified protein were frozen in liquid nitrogen 
and then stored -80 oC. 
2.14 Preparation of the cell extract and the microsomes 
2.14.1 Cell extract preparation 
The cell extract was prepared as previously described (Mikami et al., 2006).  Cells 
were cultured using cell culture roller bottles (1700 cm2, filter screw cap) 
(Greniner Bio-one) in an CO2 incubator (Galaxy S, Wolf laboratories) (5% CO2) at 
37 oC in DMEM.  The confluent cells were detached from the roller bottles by 
incubation with 100 ml PBS containing 1 mM EDTA for 10 -15 min at 37 oC.  These 
cells then were pelleted by centrifugation at 250 ×g for 3 min and washed three 
times with washing buffer (35 mM HEPES–KOH pH 7.5, 140 mM NaCl, and 11 mM 
glucose) to remove the remaining DMEM and EDTA thoroughly.  After washed once 
in extraction buffer (20 mM HEPES–KOH pH 7.5, 135 mM potassium acetate, 30 mM 
KCl, and 1.65 mM magnesium acetate), the cells were harvested by centrifugation 
at 2000 × g for 3 min.  An equal volume of extraction buffer (less extraction buffer 
could be used to obtain a more concentrated cell extract) was used to resuspend 
the cells.  The cells were disrupted in a Mini-Bomb Cell disruption chamber 
(KONTES) using a nitrogen pressure of 1.0 MPa for 30 min on the ice.  Cell 
homogenates were centrifuged at 6000 × g for 5 min at 4 oC and the post nuclear 
supernatant was retained.  To pellet the membrane, the supernatant was 
centrifuged at 50,000 × g (Rotor TL100.3) (OptimaTM Max-XP Ultracentrifuge, 
Beckman Coulter) for 15 min at 4 oC.  The supernatant was removed to a new 
eppendorf tube.  The aliquots of the supernatant were frozen in liquid nitrogen 
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and stored at -80 °C.  The membrane was used to prepare microsomes.  In some 
experiments, a half of cell extract was treated with PD-10 desalting columns (GE 
healthcare) to remove small molecular weight compounds.   
2.14.2 Microsomes preparation 
The membrane pellet was resuspended in buffer A (50 mM Tris-HCl pH7.4, 0.25 M 
Sucrose, 50 mM KCl, 6 mM MgOAc, 1mM EDTA) to give an A280 value of 50 units/µl 
(the absorbance was determined in water in the presence of 1% SDS).  If needed, 
a nuclease treatment of microsomes was carried out by the incubation with 
Stapylocossus aureus nuclease (Calbiochem) (final concentration 150 U/ml) in the 
presence of CaCl2 (5 mM) at RT for 12 min to remove the endogenous mRNA.  The 
nuclease was inactivated by the addition of EGTA (final concentration 4.5 mM).  
Sucrose cushion buffer (50 mM HEPES-KOH pH 7.5, 100 mM KCl, 0.5 M Sucrose) was 
added to the thickwall polycarbonate tubes (Beckman Coulter) and nuclease 
treated microsomes were then layered over the sucrose cushion buffer.  The 
microsomes were isolated by centrifugation at 60,000 × g (Rotor TL100.3) for 15 
min at 4 oC.  The microsomes were resuspended in Buffer A (50 mM Tris-HCl pH7.4, 
0.25 M Sucrose, 50 mM KCl, 6 mM MgOAc, 1 mM EDTA) and aliquoted into 
eppendorf tubes (50 µl/tube).  The microsomes aliquots were frozen in liquid 
nitrogen and stored -80 °C.   
2.15 Protein concentration measurement 
The Bio-Rad Protein Assay was used to measure total protein concentration of the 
cell extract or microsomes.  The Dye Reagent concentrate (Bio-Rad) was diluted 
5 times using distilled water (1 ml Dye reagent with 4 ml water).  The diluted dye 
was filtered through a Minisart filter (pore size 0.2 μm, Sartorius) to remove 
particulates.  Five dilutions of a bovine serum albumin (BSA) standard were 
prepared to generate a standard curve (BSA concentration range was from 0.05 
mg/ml to 0.5 mg/ml).  The BSA solutions and samples were normally assayed in 
triplicate.  BSA dilutions and samples were pipetted into Greiner-Bio Cell 96 Well 
black Cell Culture Microplates (10 μl/well) (Greiner Bio).  The samples were 
incubated with 200 μl diluted dye reagent at RT for at least 10 min.  The 
absorbance was measured at 595 nm (SPECTROstar Nano, BMG LABTECH).   
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2.16 Measurement of changes of the redox state of roGFP 
in microsomes 
Microsomes were pipetted into Dulbecco's phosphate-buffered saline (PBS) (1.5 μl 
microsomes in 48.5 PBS) in the absence or presence of 0.1% Triton X-100 (Thermo 
Fisher).  The solution was added into a CELLSTAR™ 96 Well Polystyrene Flat Bottom 
Cell Culture Microplate (Greiner Bio-One) (final volume 50 μl/well) (three wells 
per condition).  The emission fluorescence intensities at 525 nm of microsomes 
were measured at both excitations wavelengths, 390 nm and 460 nm, using 
PHERAstar® FS microplate reader (BMG LABTECH).  After 10 min of measurement 
to obtain the baseline, DTT, diamide or varied concentrations of Tris-(2-
Carboxyethyl)phosphine (TCEP) (Thermo) were injected into microplate wells.  
The emission fluorescence intensity at two different excitation wavelengths were 
continuously recorded for another 50 min. 
In certain experiments, the same amount of microsomes were untreated or 
treated with DTT, diamide, immobilised TCEP Disulfide Reducing Gel (Thermo) 
which has been neutralised and washed twice with PBS to remove soluble TCEP, 
or the PBS that had been preincubated with TCEP beads for 60 min.  After 60 min 
incubation, the TCEP beads were isolated by the centrifuge at 1,000 × g for 3 min.  
The supernatant of each sample which contained microsomes was then transferred 
into microplate wells to measure the emission fluorescence intensity at 525 nm at 
excitation wavelengths, 390 nm and 460 nm.   
2.17 Western blot 
SDS-PAGE was performed as above.  Proteins were transferred from gel to 
nitrocellulose blotting membrane (AmershamTM ProtranTM 0.45 μm NC) (GE 
Heathcare) in transfer buffer (25 mM Tris pH 8.3, 0.192 M Glycine, 0.0013 M SDS, 
10-20% Methanol).  The transfer conditions were 300 V, 250 mA for 1 h, 300 V, 150 
mA for 2 h, or 300 V, 25 mA for overnight.  The membrane was blocked by 
incubating with 10 ml 3% w/v dried skimmed milk (Marvel) in TBST buffer (Tris-
HCl pH 8.0, NaCl 150 mM, Tween-20 0.5%) at RT for 1-16 h (generally 1 h).  The 
membrane was incubated in 5 ml TBST including primary antibody overnight at 4 
oC or RT for 1 h (incubation time varied depending on the primary antibody).  After 
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primary antibody incubation, membrane was washed three times using 10 ml TBST 
buffer for 5 min at RT.  The transferred membrane was incubated in 5 ml TBST 
with sondary antibody in the dark at RT for 45-60 min.  Three times of 5 min 
washing with TBST or water was carried out to rinse membrane to remove excess 
secondary antibody.  The membrane was scanned by Li-Cor Odyssey 9260 Imager 
to obtain image.  Quantification of gel intensity was by ImageJ (NIH, USA).  
Experiments were carried out three times.  Values quoted are averages with error 
bars depicting standard deviation.  The western blot antibody information was as 
followed: for ERp57 using R283 as primary antibody which is raised in rabbits 
against the IQEEKPKKKKKAQEDL peptide (lab owned) and goat Anti-Rabbit 800 
secondary antibody as the secondary antibody (Thermo Fisher), for ERp57-V5 using 
anti-V5 antibody (Invitrogen) as primary antibody and goat anti-Mouse IgG (H+L) 
(DyLight 800) (Thermo Fisher) as secondary antibody, for Trx using Streptavidin 
Protein DyLight 800 (ThermoFisher).   
2.18 Proteinase K treatment 
SP cells or microsomes which were prepared as above were incubated on ice with 
10 µg/ml or 20 µg/ml proteinase K (Roche) for 25 min in the presence of 10 mM 
CaCl2.  The proteinase K was inactivated by the addition of phenylmethanesulfonyl 
fluoride (PMSF) (freshly made, final concentration 0.5 mM).  For SP cells, 
proteinase and PMSF was removed by washing twice with KHM buffer.  For 
microsomes, the proteinase and PMSF was removed by sucrose cushion 
ultracentrifugation as previously describes (2.14.2).   
2.19 Determination of the redox state of ER localised 
ERp57  
The redox state of ERp57 in SP cells was determined as described previously 
(Jessop and Bulleid, 2004).  SP cells were either untreated or treated with 10 mM 
diamide at RT for 10 min.  Samples were washed twice with 500 µl KHM buffer to 
remove diamide.  Oxidised SP cells were incubated at 30 oC for 60 min in KHM 
buffer with or without DTT or the purified reductive components (1 mM NADPH, 
25 µM human Trx (expressed and purified as above), 16.25 nM human TrxR (IMCO) 
or 600 nM Yeast TrxR (expressed and purified by Jana Rudolf), 1.25 mM G6P, 10 
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U/ml G6PDH).  The SP cells were pelleted by centrifugation at 14,800 × g for 1 
min and then incubated with 500 µl PBS containing 25 mM NEM to block free thiols.  
The samples were washed twice using PBS (1 ml) to remove excess NEM.  The SP 
cells were lysed on ice with lysis buffer (50 mM Tris-HCl containing 150 mM NaCl, 
2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 1% (v/v) Triton X-100) for 
10 min.  The lysate was centrifuged at 14,800 × g at 4 oC for 10 min.  The 
supernatant was removed to a new tube and boiled with 2% (w/v) SDS (VWR 
chemicals) to denature the protein.  Denatured samples were incubated at RT 
with 10 mM TCEP to break existing disulfide bonds followed by a 1 - 2 h incubation 
with 20 mM alkylating agent 4-acetamido-4’-maleimidylstilbene-2, 2’-disulfonic 
acid (AMS) (Invitrogen) in the dark to alkylate free thiols.  The samples were 
separated by SDS-PAGE and a western blot performed with R283 antibody or anti-
V5 antibody to detect different redox state of ERp57 or V5-tagged ERp57 
respectively.   
2.20 Determination of the redox state of Trx  
Purified Trx (final concentration 25 µM) was incubated in KHM buffer at 30 oC for 
60 min in the absence or presence of 100 µM NADPH, 16.25 nM human TrxR (IMCO), 
1.25 mM G6P, 1 U G6PDH (total reaction volume was 100 µl).  The reaction was 
stopped by the addition of NEM (final concentration 10 µM).  Samples were 
incubated with streptavidin agarose resin (Thermo) in immunoprecipitation (IP) 
buffer (50 mM Tris-HCl pH7.5, 1% Triton, 150 mM NaCl, 2 mM EDTA, 0.5 mM PMSF 
and 0.02% Na-azide) at 4 oC for 60 min.  The streptavidin beads were pelleted by 
centrifugation.  The beads were washed three times with IP buffer to remove 
unbounded proteins.  Trx was eluted from streptavidin beads by incubating at RT 
for 15 min with PBS buffer including 2% SDS (w/v) and 3 mM Biotin.  The samples 
were then boiled at 105 oC for 15 min and incubated with 10 mM TCEP at RT for 
10 min to break existing disulfide bonds followed by a 1.5 h incubation with 20 
mM AMS (Invitrogen) in the dark to alkylate free thiols.  The samples were 
separated by SDS-PAGE and a western blot performed using Streptavidin Protein 
DyLight 800 (ThermoFisher).  The oxidised Trx displayed a decrease in mobility 
because of the larger molecular weight of AMS than NEM. 
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2.21 Evaluation of the activity of G6PDH 
G6PDH is a cytosolic enzyme which produces NADPH using NADP and G6P.  The 
NADPH concentration can be observed by the absorbance at 340 nm.  To check 
the activity of G6PDH which was used in the reconstituted cytosolic Trx/TrxR 
system, G6PDH (10 U/ml) was incubated in KHM buffer with 1.25 mM G6P and 100 
µM NADP at 30 oC for 60 min.  Samples in the absence of either G6PH, G6P or NADP 
were negative controls.  All samples were measured absorbance at 340 nm at the 
end of incubation.   
2.22 Measurement of TrxR activity 
Thioredoxin reductase (TrxR) activity in the cell extracts was measured using an 
assay kit for mammalian Trx and TrxR (IMCO).  Different concentrations (1.87 – 
9.37 ng/ µl) of TrxR and diluted cell extract were added to the TE buffer (50 mM 
Tris-Cl, 20 mM EDTA, 1 mg/ml BSA) containing 10 µM Trx.  In certain experiments, 
the reaction mixture was incubated at RT for 15 min with a TrxR inhibitor, such 
as AF, TRi1 or TRi2 (Stafford et al., 2018).  A volume of 30 µl mixture was carefully 
transferred into CELLSTAR™ 96 Well Polystyrene Flat Bottom Cell Culture 
Microplate (Greiner Bio-One).  A volume of 20 µl reaction mixture M+N (2 mM β-
NADPH, 210 mM HEPES pH 7.6, 790 μM insulin, 20 mM EDTA) was added into every 
well.  The mixture was incubated in a PHMP Thermoshaker (Grant Bio) at 200 rpm, 
37 oC for 30 min.  At the end of incubation, the stop solution (8 M GuHCl in 0.2 M 
Tris-Cl pH 8.0, 1 mM DTNB) was added to terminate all reactions (200 µl/well) and 
release free TNB which was a yellow product and absorbed light at 412 nm.  For 
accuracy, the TrxR activity was assayed in triplicate. 
2.23 Concentration measurement of NADP and NADPH 
NADP and NADPH concentrations in the cell extract and RRL were measured using 
NADP/NADPH-Glo™ Assay (Promega).  The cell extract (50 µl) was incubated with 
an equal volume of base solution (0.2 N NaOH).  For the measurement of NADP 
concentration, a half of the cell extract (50 µl) was incubated with 25 µl HCl (0.4 
N) at 60oC for 15 min to destroy the NADPH in the cell extract.  The sample was 
incubated at RT for 10 min and then neutralized by the addition of 25 µl Trizma 
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base (0.5 M).  To measure the concentration of NADPH, a half of the solution (50 
µl) was heated at 60oC for 15 min to destroy NADP in cell extract.  The sample was 
cooled down to RT for 10 min.  An equal volume of HCl/Trizma (0.25 M Trizma 
base, 0.2 N HCl) was added into the base-treated samples.  For accuracy, the 
concentration of NADP and NADPH was normally assayed in triplicate.  A standard 
curve using variant concentration (0 - 500 nM) of NADP and NADPH was generated 
to quantitate the concentration of NADP and NADPH in the cell extract or RRL.  
After the acid and base treatment, samples were mixed with 25 µl NAD/NADH-
Glo™ detection reagent (reconstituted luciferin detection reagent 1ml, reductase 
5μl, reductase substrate 5μl, NADP cycling enzyme 5μl, and NADP cycling substrate 
5μl) (Promega) and immediately transferred into Corning® 96 Well white Solid 
Polystyrene Microplate (Life Science). A PHERAstar® FS microplate reader (BMG 
LABTECH) was used to record the luminescence of each sample.   
2.24 Concentration measurement of the GSSG and GSH 
The measurement of oxidised glutathione (GSSG) and reduced glutathione (GSH) 
concentration in cell extract and RRL was measured as followed.  For total 
concentration of GSSG and GSH assay, a volume of 20 µl of cell extract or RRL was 
added into 1 ml assay buffer (0.1M NaPO4 buffer pH 7.5 including 1mM EDTA, 
0.2mM NADPH, 0.2mM DTNB).  The reaction mixture was warmed to 30 oC followed 
by the addition of 1 unit of GSH reductase to reduce all of the GSSG to GSH.  
Reduced GSH converts the DTNB to a yellow product TNB, the absorbance at 412 
nm of TNB can indicate the concentration of GSH.  The solution was pipetted into 
CELLSTAR™ 96 Well Polystyrene Flat Bottom Cell Culture Microplate (Greiner Bio-
One).  The absorbance at 412 nm was recoded for 1 h.  For GSSG concentration 
measurement, a 100 µl of the cell extract was incubated with a 2 µl of 2-
vinylpyridine in 100 mM Tris (pH 7) at 30 oC for 1 h to alkylate GSH.  The GSSG in 
the cell extract were reduced by the GSH reductase and measured as above.   
2.25 Sample preparation for Mass Spectrometry analysis 
Samples were prepared and data was analysed by Sergio Lilla in our collaborate 
lab in the Beatson West of Scotland Cancer Centre as previously described (van 
der Reest et al., 2018).   
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2.25.1 Treatment of the microsomes 
roGFP microsomes (final concentration 5 unit/µl) were incubated with the 
reconstituted Trx/TrxR pathway using cytosolic components (1 mM NADPH, 25 µM 
human Trx (expressed and purified as above), 16.25 nM human TrxR (IMCO), 1.25 
mM G6P, 10 U/ml G6PDH) in the absence or presence of Trx for 0 or 60 min.  
Reactions were carried out in quadruplicate.  After the incubation, samples were 
prepared for MS as followed.   
2.25.2 Sample preparation for MS analysis 
Samples were lysed in a buffer containing 4% SDS, 50 mM triethylammonium 
bicarbonate pH 8.5 and 55 mM unlabelled iodoacetamide (light IAA, 12C2H4INO) to 
alkylate free cysteine thiols.  The lysates were briefly sonicated (15-30 s, three 
times/sample) in eppendorf tubes.  The samples were then centrifuged at 16,000 
g for 5 min at 4 °C.  The supernatant was transferred to clean tubes and incubated 
at RT in the dark to allow complete labelling of free cysteine thiols with 55 mM 
unlabelled iodoacetamide (light IAA, 12C2H4INO).  The protein concentration in 
each sample was determined by Bradford assay and samples were stored at −80 °C 
until further processing.   
For each experiment replicate, 30 µg of protein extracts were reduced with 70 mM 
DTT followed by dilution 1:2 using 50 mM triethylammonium bicarbonate buffer 
pH 7.0.  The newly generated free cysteine thiols were subsequently alkylated by 
stable-isotope labelled iodoacetamide (heavy IAA, 13C2D2H2INO).  Differentially 
alkylated proteins were precipitated using trichloroacetic acid (TCA).  The pellets 
were washed with 50 µl of HEPES 200 mM and digested with endoproteinase Lys-C 
(ratio 1:33 enzyme:lysate) for 1 h, followed by a trypsin, overnight (ratio 1:33 
enzyme:lysate).   
The digested peptides from each experiment, and a pool sample, were 
differentially labelled using TMT10-plex reagent (Thermo Scientific).  Each sample 
was labelled with 0.1 mg of TMT reagent dissolved in 50 μl of 100% anhydrous 
acetonitrile.  The reaction was carried out at RT for 2 h.  Fully labelled samples 
were mixed in equal amount and desalted using a 100 mg Sep Pak C18 reverse 
phase solid-phase extraction cartridges (Waters). 
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2.25.3 High pH peptide fractionation  
TMT-labelled peptides were fractionated using high pH reverse phase 
chromatography on a C18 column (150 × 2.1 mm i.d. - Kinetex EVO (5 μm, 100 Å)) 
on a HPLC system (Agilent, LC 1260 Infinity II, Agilent).  A two-step gradient was 
applied, from 1–28% B in 42 min, then from 28–46% B in 13 min to obtain a total of 
21 fractions for MS analysis. 
2.25.4 UHPLC-MS/MS analysis 
Fractionated peptides were separated by nanoscale C18 reverse-phase liquid 
chromatography using an EASY-nLC II 1200 (Thermo Scientific) coupled to an 
Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific).  Elution was 
carried out using a binary gradient with buffer A (2% acetonitrile) and B (80% 
acetonitrile), both containing 0.1% formic acid.  Samples were loaded with 6 µl of 
buffer A into a 50 cm fused silica emitter (New Objective) packed in-house with 
ReproSil-Pur C18-AQ, 1.9 μm resin (Dr Maisch GmbH).  Packed emitter was kept at 
50 °C by means of a column oven (Sonation) integrated into the nanoelectrospray 
ion source (Thermo Scientific).  Peptides were eluted at a flow rate of 300 nl/min 
using different gradients optimised for three sets of fractions: 1–7, 8–15, and 16–
21.  Initial Percentage of buffer B (%B) was kept constant for 3 minutes, then a 
two-step gradient was used, all with 113 min for step one and 37 min for step two.  
The %B were changed as follows.  For F1-7, %B was 2 at the start, 17 at step one, 
and 26 at step two.  For F8-14, %B was 4 at the start, 23 at step one, and 35 at 
step two.  For F15-21, %B was 6 at the start, 27 at step one, and 43 at step two.  
All gradients were followed by a washing step (95% B) of 10 min followed by a 
5 min re-equilibration step at the initial %B of each gradient, for a total gradient 
time of 168 min.  Eluting peptides were electrosprayed into the mass spectrometer 
using a nanoelectrospray ion source (Thermo Scientific).  An Active Background 
Ion Reduction Device (ESI Source Solutions) was used to decrease air contaminants 
signal level.  The Xcalibur software (Thermo Scientific) was used for data 
acquisition.  A full scan over mass range of 350–1400 m/z was acquired at 60,000 
resolution at 200 m/z, with a target value of 500,000 ions for a maximum injection 
time of 20 ms.  Higher energy collisional dissociation fragmentation was performed 
on the 15 most intense ions, for a maximum injection time of 100 ms, or a target 
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value of 100,000 ions.  Peptide fragments were analysed in the Orbitrap at 50,000 
resolution. 
2.25.5 MS Data Analysis 
The MS Raw data were processed with MaxQuant software version 1.6.3.3 (Cox 
and Mann, 2008) and searched with Andromeda search engine (Cox et al., 2011), 
querying (Apweiler et al., 2010).  First and main searches were performed with 
precursor mass tolerances of 20 ppm and 4.5 ppm, respectively, and MS/MS 
tolerance of 20  ppm.  The minimum peptide length was set to six amino acids and 
specificity for trypsin cleavage was required, allowing up to two missed cleavage 
sites.  MaxQuant was set to quantify on “Reporter ion MS2”, and TMT10plex was 
chose as Isobaric label.  Interference between TMT channels were corrected by 
MaxQuant using the correction factors provided by the manufacturer.  The “Filter 
by PIF” option was activated and a “Reporter ion tolerance” of 0.003 Da was used.  
Modification by light (H(3)NOC(2)) and heavy (HNOCx(2)Hx(2)) iodoacetamide on 
cysteine residues (carbamidomethylation) were specified as variable, as well as 
methionine oxidation and N-terminal acetylation modifications, no fixed 
modifications were specified.  The peptide, protein, and site false discovery rate 
(FDR) was set to 1 %.  MaxQuant outputs were analysed with Perseus software 
version 1.6.2.3 (Cox and Mann, 2008).  The MaxQuant output ModSpecPeptide.txt 
file was used for quantitation of cysteine-containing peptides oxidation, whereas 
ProteinGroup.txt file was used for protein quantitation analysis.  The peptides.txt 
and Carbamidomethyl sites tables were concatenated with the main data table as 
source of additional peptides features.  Peptides with Cys count lower than one 
were excluded from the analysis, together with Reverse and Potential 
Contaminant flagged peptides.  From the ProteinGroups.txt file, Reverse and 
Potential Contaminant flagged proteins were removed, as well as protein groups 
identified with no unique peptides.  The TMT corrected intensities of proteins and 
peptides were normalised to the median of all intensities measured in each 
replicate.  Only cysteine-containing peptides uniquely assigned to one protein 
group within each replicate experiment, and robustly quantified in three out of 
three replicate experiments, were normalised to the total protein levels and 
included in the analysis.  To determine significantly oxidised cysteine-containing 
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peptides, a Student t-test with a 5% FDR (permutation-based) was applied using 
normalised reporter ions Intensities.   
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Chapter 3 Reduction of ER proteins by the 
cytosolic reductive pathway requires facilitative 
membrane transport 
3.1 Introduction 
Green Florescent Protein (GFP) was first isolated from Aequorea vitoria after the 
extraction and purification of a bioluminescent protein, aequorin (Shimomura et 
al., 1962, Johnson et al., 1962).  In vivo, GFPs emit fluorescence due to the energy 
from a luciferase-oxyluciferin excited-state complex (Ward and Cormier, 1976) or 
a Ca2+-activated photoprotein (Prasher et al., 1992).  The GFP was successfully 
expressed in different organisms (prokaryotic and eukaryotic), such as Escherichia 
coli and Caenorhabditis elegans (Chalfie et al., 1994).  Because the expression of 
GFP did not require any jellyfish-specific enzymes and special substrates and 
cofactors were not needed for its emission of fluorescence, GFP was then broadly 
used as a marker for gene expression and protein localisation in living organisms 
(Chalfie et al., 1994, Harper et al., 1999).   
Variants of GFP were engineered to enable to monitor the redox status in living 
organisms by introducing different mutations (Meyer and Dick, 2010).  Redox 
sensitive GFP (roGFPs) became an indicator which allowed real time visualization 
of redox status in cells (Dooley et al., 2004).  The two excitation peaks of roGFP 
result from different forms of the fluorophore, the neutral form and the anion 
form, that are dependent on the redox status (Hoseki et al., 2016).   
Because roGFP was genetically coded, it can be targeted to specific organelles, 
such as the ER, by fusing it to organelle specific signal sequence.  An efficient ER 
reporter of real-time redox changes in living mammalian cells, ER-SFGFP-iE, was 
generated in our group based on a superfold roGFP variant, roGFP1-iL, by 
incorporating new cysteines to form an intracellular disulfide bond (van Lith et 
al., 2011) (Figure 3-2).  Under reducing conditions, the disulfide bonds are cleaved 
resulting in the decrease of the neutral form of roGFPs and the increase of the 
anion form of roGFPs.  Under oxidising environment, the disulfide bond is formed 
that causes the increase of the neutral form and decrease of the anion form of 
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roGFPs.  These neutral and anion forms of roGFP have different excitation peaks 
at 390 nm and 475 nm respectively.  The emission fluorescence intensity at 525 
nm then displays rapid and reversible ratio metric changes corresponding to redox 
state changes of cells in vivo.  Under reduced conditions, a decrease of 
fluorescence at 390 nm excitation wavelength was observed while the 
fluorescence increased at 470 nm excitation wavelength. The oxidation of cells 
leads to the opposite emission of fluorescence following excitation at 390 and 470 
nm (Figure 3-1).  The cells which could stably express ER-SFGFP-iE were used to 
prepare ER derived microsomes, for the experiments described in this chapter.   
 
Figure 3-1  Excitation spectra of roGFP1-iL under no treatment, after reduction (DTT) or 
oxidation (diamide).  Reduced roGFP had higher emission fluorescence intensity at 525 nm when 
it is excited at 460 nm while oxidised roGFP had higher emission fluorescence intensity at 525 nm 
when it is excited at 390 nm (van Lith et al., 2011).   
Microsomes are ER derived vesicles with a diameter of 100 – 200 nm and isolated 
from homogenates of liver and other tissues(Claude, 1943, Kriechbaumer, 2018) 
or cultured cells (Sukhodub and Burchell, 2005) by differential centrifugation.  
Microsomes are composed of rough ER, smooth ER and ribosomes.  Numerous 
enzyme activities are associated with the microsomal fraction.  The microsomes 
can still carry out protein synthesis, protein translocation and glycosylation as 
happens in intact cells (Palade and Siekevitz, 1956, Sabatini, 2014).  In this 
chapter, we prepared microsomes from a HT1080 cell line which stably 
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overexpresses roGFP to investigate how disulfide reduction occurs inside the ER 
lumen.   
 
Figure 3-2  Stable cell-line expressing ER-SFGFP-iE was evaluated by live-cell imaging and 
was responsive to gross changes in redox conditions.  A.  Depicts fluorescent images of 
untreated, diamide or DTT-treated cells.  Fluorescent ration changes are visualised using false 
colours with more reducing ratios in blue and more oxidising in red.  B.  Normalised fluorescent ratios 
of individual cells are averaged, and changes observed over time following the addition of 1 mM 
diamide followed by DTT (final concentration 10 mM).   
The cell contains numerous intracellular organelles such as the nucleus, 
mitochondria, ER and Golgi apparatus each with its own set of enzymes and 
specialised functions.  Synthesis and trafficking of secreted proteins are 
facilitated by the ER and Golgi apparatus. In the ER, the proteins undergo a series 
of modifications, like disulfide formation and reduction, glycosylation, to achieve 
its functional structure (Braakman and Hebert, 2013).  It has previously been 
shown that the cytosolic Trx/TrxR pathway is necessary for correct disulfide bond 
formation in the ER (Poet et al., 2017).  How the reducing equivalents that are 
generated in cytosol are transported across the ER membrane is still an open 
question.  It has been demonstrated previously that a system for transfer of such 
reducing equivalents across an internal membrane does exist in prokaryotes 
(Berkmen, 2012).  Various mechanisms are involved to ensure correct disulfide 
bond formation (Kadokura et al., 2003).  DsbC is responsible for the isomerisation 
of the misfolded disulfide bonds (Shevchik et al., 1994).  To maintain its 
isomersation function, DsbC is required to stay in a reduced state.  A periplasmic 
membrane protein, DsbD, can receive reducing equivalents from the cytoplasmic 
NADPH via cytoplasmic Trx and then pass the electrons to the DsbC (Rietsch et 
al., 1997, Berkmen, 2012).   
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To address the role of mammalian cytosolic Trx in the reduction of  disulfides 
within the ER lumen, mutants of Trx along with other cytosolic components were 
used to reconstitute the Trx/TrxR pathway.  This approach makes use of the 
finding that mutant thiol-dependent oxidoreductases lacking the C-terminal 
cysteine of the CXXC active site motif form long-lived mixed disulfide 
intermediates with tarobtain proteins (Figure 3-3).  Thus, substrate proteins 
remain covalently linked to the mutant oxidoreductase and become amenable to 
isolation and analysis (Figure 3-3A).  Trx1 has 5 cysteines. Two (cysteines 32 and 
35) are catalytic cysteines while another three (cysteines 62, 69 and 73) are non-
catalytic (Figure 3-3B).  To create Trx mutants, the second cysteine of the 32CXXC35 
motif was replaced by serine (C35S) and all of the non-catalytic cysteines (C62, C69 
and C73) were replaced with alanine because they may cause oxidative inactivation 
by either intra- or intermolecular disulfide bond formation.  It was proven that 
Cys73 is easily accessed in the active site surface of Trx three-dimensional 
structure (Weichsel et al., 1996).  It is possibly the active site Cys73 which forms 
disulfide bonds with glutathione in human T cell blasts (Casagrande et al., 2002).  
Subsequently, it was demonstrated that the Cys62 and Cys69 can form a non-native 
disulfide bond under oxidising conditions and the non-native disulfide bond 
resulted in the inhibition of TrxR activity (Watson et al., 2003).  Trx1 mutant 
proteins Trx C-C, Trx C-S and S-S were produced and purified for future 
experiments.  Three human Trx1 mutants (CC, CS, SS) will be used to reconstitute 
the Trx/TrxR pathway to investigate if the catalytic cysteines are playing a role 
in the electron transfer from the outside to the inside of ER derived microsomal 
membrane.   
To investigate whether the minimal Trx/TrxR pathway could influence the redox 
state in the mamalian ER, we used purified cytosolic components, NADPH, G6PDH, 
G6P and Trx and TrxR, to reconstitute the cytosolic Trx/TrxR pathway.  In this 
chapter, the reconstituted Trx/TrxR pathway and impermeable reducing agent 
TCEP were incubated with ER derived microsomes containing roGFPs to address 
the reduction pattern of ER localised proteins.  Redox changes in the microsomes 
were measured with roGFP fluoressence at different excitation wavelengths.  In 
order to investigate which membrane protein is involved in the electron-shuttling, 
we used an MS approach to analyse the reodox status of proteins in the microsomes 
before and after reconstitution with the Trx/TrxR pathway components.  In the 
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next chapter, we will evaluate the impact of the reconstituted Trx/TrxR pathway 
on the ER localised PDI family member ERp57 which plays critical role in the 
disulfide isomerisation of glycoproteins.   
 
Figure 3-3  Catalytic mechanism of Trx and mutants of Trx.  A. Catalytic mechanism of wild-type 
Trx1 (upper panel) and the principle of mutant Trx (lower panel).  The mixed disulfide intermediate 
is normally resolved by cysteine-35.  Replacement of cysteine-35 by serine (C35S) stabilizes the 
covalent intermediate.  The affinity tag enables purification of resulting enzyme–substrate 
complexes.  B.  Schematic representation of wild type (CC) and mutants (CS and SS) of Trx. Catalytic 
(C32, C35) and structural cysteines (C62, C69, C73) are indicated. His6: hexahistidine tag; SBP: 
streptavidin-binding peptide (Schwertassek et al., 2007a). 
3.2 Results 
3.2.1 The impermeable reducing agent TCEP can reduce 
microsomal roGFP 
Microsomes prepared from a HT1080 cell line which overexpresses roGFP in the 
ER, were tested to ensure that the roGFP are still redox-sensitive.  The same 
concentration of microsomes were left untreated or treated with the reducing or 
oxidising agents (Figure 3-4).  The ratios of emission fluorescence intensities at 
525 nm with excitation wavelength at 390 and 460 nm (ratio= 390nm/460nm) were 
calculated to indicate the redox state of roGFP microsomes.  When microsomes 
were treated with a reducing agent (DTT), a significant decrease of ratio 
(390nm/460nm) was observed and oxidised microsomes with diamide gave an 
obvious increase of ratio (390nm/460nm).  These results indicated that the 
prepared roGFP microsomes are sensitive to changes in redox conditions and we 
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can easily track the redox change of roGFP in the ER derived microsomes in real 
time.   
 
Figure 3-4  roGFP microsomes are sensitive to redox state changes.    roGFP microsomes redox 
state were indicated by the emission fluorescence intensity (at 525 nm) at excitation wavelength 
390nm divided by that at 460 nm (Ratio = 390nm/460nm).  Untreated microsomes ratio 
(390nm/460nm) was normalised as value 1 (indicating by olive square).  Microsome reduction by the 
reducing agent DTT (1 mM) (indicating by blue dot) led to a ratio (390nm/460nm) decrease while a 
ratio increase was caused by the oxidation by oxidising agent diamide (1 mM) (indicating by orange 
triangle).   
To investigate if the membrane impermeable reductant TCEP can reduce roGFP in 
the microsomes, three samples (experimental replicates) were prepared in PBS in 
the absence or presence of 0.1 % (V/V) TritonTM X-100 which can permeabilise the 
membrane without denaturing the proteins.  The emission fluorescence at two 
excitation wavelengths were recorded for 10 min to obtain the baseline.  At 10 
min, TCEP (final concentration 1 mM) was injected into the microplate wells.  
After the fluorescence emission saturated, Triton (final concentration 0.1%) was 
added at 40 min to a sample which was incubated in the absence of Triton.   
Before addition of TCEP, the same ratios were observed in the presence or absence 
of Triton which indicated that the presence of Triton did not affect the redox 
state of roGFP (Figure 3-5A).  At 10 min, TCEP was injected into the samples.  A 
change to the roGFP redox status was observed in all three samples indicating 
reduction.  The ratio values of roGFP in the presence of Triton (indicated by blue 
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triangle) decreased to a lower level than in the absence of Triton (indicated by 
grey square) which indicates more reduction happened in the presence of Triton 
than in the absence of Triton.  In addition, the ratio change rate was faster in the 
presence of Triton than in the absence of Triton which indicates that the reduction 
of roGFP by TCEP was not due to the microsomes permeability of TCEP.  If a 
fraction of the microsomes were permeable to TCEP then the rate of reduction of 
this fraction would be as rapid as the rate of reduction in the presence of Triton 
and then the rate would slowdown, a biphasic rate of reduction of roGFP would 
be observed.  After the redox state became stable, Triton was added to the sample 
in which the microsomes were incubated in the absence of Triton.  Immediately 
after the addition of Triton, the ratio value dropped significantly to the same ratio 
value as the microsomes were incubated with Triton from the beginning (indicated 
by red circle).  The results demonstrated that the transfer of reducing equivalents 
from TCEP across the ER membrane occurred in the absence of Triton (Figure 3-5B 
and C).  The results suggested that a membrane protein is possibly involved in the 
transducing reducing equivalents across the ER membrane, fulfilling an equivalent 
role to DsbD in the prokaryotic plasma membrane (Kadokura et al., 2003).   
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Figure 3-5  Addition of Triton resulted in further reduction of roGFP microsomes in the 
presence of TCEP.  A.  Ratio (390nm/460nm) change in the presence and absence of Triton.  
Emission fluoresence at 525 nm of three roGFP microsome samples at two different excition 
wavelengths 390 nm an 460 nm were recorded and caculated the ratio (390nm/460nm) to obtain the 
baseline (0 - 10 min).  At 10 min, these three sample were treated with the same concentration of 
TCEP (1 mM) by injection into the microplate wells.  Initially, one sample was treated with TCEP in 
the presence of 0.1% TritonTM X-100 (indicated by blue triangle) while the other two samples were 
treated with TCEP in the absence of Triton (indicated by grey squares and red circles).  At 40 min, a 
sample incubated without Triton was injected with Triton (final concenrtation 0.1%) (indicated red 
circles).  The emission of fluorescence was recorded.  The ratio (390nm/460nm) was calculated and 
then normalised with baseline value (regarded as 1).  B.  Schematic diagram of TCEP reduction of 
roGFP microsomes before the addition of Triton (0-10 min).  C.  Schematic diagram of TCEP 
reduction of roGFP microsomes after the addition of Triton (10-40 min). 
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To further investigate the membrane permeability of TCEP, immobilised TCEP 
(TCEP beads) was used to reduce roGFP microsomes.  TCEP was immobilized on 
agarose beads (TCEP beads) which ensured it cannot cross the microsomal 
membrane (Figure 3-6A).  The TCEP beads were buffered to neutrality and washed 
with PBS to fully remove any soluble TCEP.  The roGFP microsomes were either 
untreated or treated with the elution buffer from TCEP beads or TCEP beads.  
After incubation to allow the reduction progress, the TCEP beads were removed 
by centrifugation.  The microsomes were transferred into 96-microplate wells and 
the fluorescence was measured at different excitation wavelengths to obtain the 
ratio which indicated the redox state of roGFP microsomes.   
The results showed that the reduction of roGFP with TCEP beads is significant 
(p=0.00001), while the reductive effect of the wash buffer on roGFP is not 
significant (p=0.03) (Figure 3-6B).  The result suggests that TCEP beads can reduce 
the roGFP inside of microsome without crossing the microsomal membrane 
supporting the requirement for a membrane protein to facilitate the reduction of 
microsomal roGFP.   
 
Figure 3-6  Reduction of roGFP microsomes by immobilized TCEP. A.  Schematic diagram of 
reduction of roGFP in microsomes by immobilized TCEP disulfide reducing gel (TCEP beads).  TCEP 
(Tris[2-carboxyethyl] phosphine hydrochloride) was immobilized on 4% crosslinked beaded agarose 
(indicating by grey oval circle) which ensures TCEP cannot cross microsomal membrane and can 
only reduce roGFP by acting via a membrane protein (indicating by yellow oval circle).  B.  Redox 
state of roGFP in untreated microsomes (UT) or microsomes treated with TCEP beads wash buffer 
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(wash) and TCEP beads (beads).  The difference in ratio value between untreated and incubated 
with wash buffer is not significant (p=0.03) but there is a significant difference between untreated 
sample with the sample incubated with TCEP beads (p = 0.00001).   
3.2.2 Microsomal roGFP was reduced by the membrane 
impermeable reducing agent TCEP via facilitated transport. 
To address how the reducing agent TCEP can reduce the roGFP in microsomes, 
roGFP microsomes were treated with varied concentrations of TCEP in the absence 
or presence of 0.1% Triton™ X-100.  The fluorescence intensities at different 
excitation wavelengths were recorded before and after the addition of TCEP.  The 
ratios (390nm/460nm) were calculated and the rate of ratio change (k) was 
calculated by fitting the data to an exponential decay function (y = -A(e-k (t-t0)-
1)+C), where t0 = the time of addition of TCEP, c = initial fluorescence ratio and 
A = difference in fluorescence ratio between t0 and t.   
The ratios (390nm/460nm) of roGFP microsomes treated with different 
concentrations of TCEP (0.2, 0.4, 0.6, 0.8, 1.0, 1.5 and 2 mM) were normalised to 
the ratio (390nm/460nm) of untreated roGFP microsomes (Figure 3-7A).  It was 
noticed that the rate of ratio change increased with the increased concentration 
of TCEP (0-1 mM).  However, when the microsomes incubated with concentrations 
of TCEP higher than 1 mM (1.5 and 2 mM), the rate of ratio change (k) reached 
saturation (Figure 3-7A).  The k value increased as the concentration of TCEP 
increased.  The rate of ratio changes in the absence of Triton appeared to exhibit 
a linear correlation with TCEP concentration when the final concentration of TCEP 
was lower than 1mM.  However, the rate of change became saturated after 
treatment with higher TCEP concentration (1.5 mM and 2mM) (Figure 3-7B).  The 
rate saturation indicates that the TCEP is transported across the membrane by a 
facilitated membrane transport process (Figure 3-7C). 
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Figure 3-7  Reduction of roGFP microsomes by TCEP in the absence of Triton.  A.  roGFP 
microsomes were suspended in PBS.  The fluorescence at different excitation wavelengths were 
recorded for 10 min to obtain a baseline.  Different concentrations of TCEP (final concentrations 0, 
0.2, 0.4, 0.6, 0.8, 1.0, 1.5 and 2 mM) were injected into each well.  Emission fluorescence was 
continually recorded until the ratio reached saturation.  Each sample at different concentrations of 
TCEP was performed in experimental triplicates.  B.  The rate of ratio change (indicated by k) 
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(390nm/460nm) was calculated and plotted vs TCEP concentration.  C.  Schematic diagram of TCEP 
reduction of roGFP in microsomes in the absence of Triton.  In the absence of Triton, the microsome 
membrane was intact.  The TCEP cannot cross the membrane by diffusion to reduce roGFPs in the 
lumen.  This reduction process was facilitated by an unidentified membrane protein (indicated by 
yellow oval shape). 
As a control, another group of microsomes were treated with different 
concentrations of TCEP (final concentrations 0, 0.2, 0.6, 1.0, 1.5 and 2 mM) in the 
presence of Triton™ X-100 which can permeabilise microsomes membrane allowing 
the reduction of roGFP by diffusion.  In the presence of Triton, the rate of change 
(k) was calculated and analysed as above (Figure 3-8 A and B).  Compared with 
roGFP microsomes in the absence of Triton, more significant reductions of redox 
state of roGFP microsomes were observed.  Even that treated with the same 
concentration of TCEP, samples in the presence of Triton had a lower ratio 
indicating a more rapid reduction of roGFP.  The ratio (390nm/460nm) of roGFP 
microsomes with 2 mM TCEP decrased to 0.72 in the absence of Triton while the 
ratio (390nm/460nm) decresed to 0.62 in the presence of Triton (Figure 3-8A).  
The rate of change (k) in the presence of Triton had a linear relationship to the 
concentration of TCEP and it was not saturable (Figure 3-8B) which is consistent 
with a diffusion-mediated process (Figure 3-8B).  The results above indicate that 
after treatment with Triton, the membrane was solubilised and TCEP can directly 
reduce the roGFP by diffusion (Figure 3-8 C).   
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Figure 3-8  Reduction of roGFP microsomes by TCEP in the presence of 0.1% Triton™ X-100. 
A.  roGFP microsomes were suspended in PBS in the presence of 0.1% Triton™ X-100 to 
permeabilise the microsome membrane without denaturing proteins. The experiment was carried out 
as above.  B.  The rate of ratio change (indicated by k) was calculated and analysed using Origin.  
C.  Schematic diagram of TCEP reduction of roGFP in microsomes in the presence of Triton.  In the 
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presence of Triton, the microsome membrane was permeabilised and the proteins in microsomes 
were exposed to TCEP.  The TCEP can reduce solubilised roGFP by diffusion.   
Our result above indicate that membrane proteins were involved in the reduction 
of roGFP in microsomes by the membrane impermeable TCEP.  Integral membrane 
proteins may include cytosolic domains (indicated by yellow oval and brown 
square) or it only has ER lumen domain  (indicated by red triangle) (Figure 3-9 A).  
To see whether a membrane protein was involved in the facilitated transport of 
TCEP, proteinase K, a serine protease, was used to cleave the regions of 
membrane proteins exposed to the outside of the microsomes (Figure 3-9 A).   
Microsomes were untreated or incubated with proteinase K (final concentration 
10 µg/ml and 20 µg/ml) in the presence of CaCl2 (final concenrtation 10 mM) for 
25 min.  The proteinase K was then inactivited by a 5 min incubation with 0.5 mM 
PMSF.  Microsomes were suspended in PBS in a 96-well microplate reader to 
measure the roGFP fluoresence.  After obtaining a steady baseline, TCEP (final 
concentration 1 mM) was injected into each well.  The fluoresence was 
continuously recorded until the signal became stable.  The ratio was calculated 
and normalised using the ratio of roGFP in untreated microsomes (Figure 3-9B).  
After the addition of TCEP, the ratios of roGFP in microsomes treated with 
proteinase K decreased from 1 to 0.61 which is similar with the reduction in 
untreated microsomes (from 1 to 0.66), suggesting that the proteinase K 
treatment did not influence the reduction of roGFP in microsomes.  This result 
indicates that the reduction of micrsomal roGFP by TCEP is not sensitive to 
proteinase K (Figure 3-9A).   
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Figure 3-9  Reduction of roGFP in microsomes with and without Proteinase K treatment.  A.  
Schematic diagram of proteinase K treatment of roGFP microsomes.  Proteinase K treatment 
resulted in cleavage of microsomal proteins exposed to the outside of the membrane (yellow oval 
indicating transmembrane proteins; red triangle indicating membrane protein localised inside of the 
microsomes and brown square indicating membrane protein which were exposed to outside of 
membrane).  B.  Reduction of roGFP microsomes untreated or treated with proteinase K (two 
concentration 10 µg/ml and 20 µg/ml).   
3.2.3 Reconstitution of the Trx/TrxR pathway 
It has been demonstrated that cytosolic TrxR is required for correct disulfide 
formation in the ER (Poet et al., 2017).  The Trx/TrxR pathway was essential for 
mammalian cells to transfer reducing equivalents from the cytosol to the ER.  Here 
we addressed whether other cytosolic components were required for the transfer 
of reducing equivalents.  A cytosolic Trx/TrxR pathway was reconstituted using 
purified components (G6P, G6PDH, NADPH, Trx and TrxR) to evaluate the minimal 
components required to facilitate reduction of microsomal roGFP.  It is known that 
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the reduction of Trx is catalysed by TrxR using the reducing equivalents from 
NADPH (Holmgren and Bjornstedt, 1995, Arnér, 2009).  To ensure the supply of 
NADPH in our reconstituted Trx/TrxR system, the addition of G6P and G6PDH can 
be used to recycle the oxidised NADPH (NADP+) (Tian et al., 1998, Stanton, 2012) 
after donating the reducing equivalents to the Trx.  Because of the presence of 
G6P and G6PDH which can continuously recycle NADPH, either commercial NADPH 
and NADP+ can be used in our reconstituted Trx/TrxR system. 
The cytosolic enzyme, G6PDH, can catalyses the conversion of G6P to PGL 
resulting in the reduction of NADP to NADPH that can be measured at 340 nm 
(Figure 3-10A) (Smolinski et al., 2019, Freeman and Willner, 2009).  NADP, G6P 
and G6PDH were incubated together or the reaction was carried out in the absence 
of one component.  During the incubation, the absorbance of NADPH at 340 nm 
was measured.  It was noticed that no absorbance change at 340 nm was seen in 
samples in the absence of either NADP, G6P or G6PDH (Figure 3-10B).  When all 
three components (NADP, G6P and G6PDH) were present, NADPH absorbance was 
observed.  This result indicated that the G6PDH was active.   
 
Figure 3-10  G6PDH and G6P assay.   A.  Schematic of G6PDH activity measurement.  G6PDH is 
a cytosolic enzyme which catalyses the conversion of G6P to PGL resulting in the reduction of NADP 
to NADPH [2].  In order to test G6PDH activity, the experiment was designed to take advantage of 
the maximum absorbance NADPH at 340 nm.  B.  Absorbance of NADPH at 340 nm.  NADP (100 
µM), G6P (1.25 mM) and G6PDH (1 U/100 µl) were incubated in a complete reaction or reaction in 
the absence of one component (NADP, G6P or the enzyme G6PDH) at 30 oC.  During incubation, 
the absorbance of NADPH at 340 nm was measured.  The experiments were carried out in 
experimental triplicates.   
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In order to reconstitute the cytosolic Trx/TrxR pathway in vitro, human Trx (hTrx) 
mutants were expressed and purified (Figure 3-11).  Small-scale protein expression 
was verified following induction of Trx expression with IPTG (Figure 3-12A).  More 
protein at around 20 kDa was observed on the gel in the sample after IPTG 
induction indicating that hTrx C-C were successfully expressed (Figure 3-12A lane 
1 before induction by IPTG, and lanes 2-3 after addition of IPTG).  One of the 
colonies was used to carry out large scale of protein expression.   
 
 
Figure 3-11  Workflow of protein induction and purification.   
For large scale expression a 500 ml bacterial culture was initiated following 1/100 
dilution of an overnight culture.  After 3-4 hour culture, IPTG was added to induce 
protein expression.  A portion of bacteria culture was kept to check the protein 
expression (Figure 3-12B).  After addition of IPTG, a denser band at 20 kDa was 
observed (Figure 3-12B lanes 2 and 4) compared to the sample before induction 
by IPTG, indicating that the protein was being expressed after induction.   
After induction, the bacteria were pelleted and lysed using a French press.  The 
supernatant was collected after centrifugation and filtered through a 0.45 µm 
filter.  The solution was loaded on a nickel agarose affinity chromatography 
column.  Because of a poly-His-tag fused to its C-terminus, recombinant proteins 
hTrx CC were bound to the column and then eluted with imidazole buffer.  Based 
on the UV absorption at 280 nm of elution buffer (Figure 3-12C), fractions were 
collected for analysis by SDS-PAGE under reducing condition (Figure 3-12D).  The 
gel showed that hTrx CC was soluble (Figure 3-12D, lane 1) and hTrxCC was eluted 
by imidazole (Figure 3-12D, lanes 6 and 7).  Some contaminating proteins were 
also eluted at this stage and appeared as some weak bands on Coomassie-stained 
gel.  Hence, further purification was required.   
Subsequently we used gel filtration to further purify hTrx and remove the 
contaminating proteins.  The fractions from His-tag chromatography containing 
hTrx CC were gathered in one tube and concentrated to 1 ml.  The sample was 
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loaded on an equilibrated gel filtration column.  The proteins were separated 
based on the molecular size.  Based on the UV absorption at 280 nm of elution 
buffer (Figure 3-12E), gel filtration fractions were analysed by SDS-PAGE under 
reducing conditions (Figure 3-12F).  Most of the contaminants were removed at 
this stage.  After gel filtration, fractions containing purified hTrx CC (Figure 3-12F 
lanes 3-5) were combined, concentrated, aliquoted and then stored at -80 oC for 
future assays.   
 
A B 
C D 
E F 
hTrx CC hTrx CC 
EL 
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Figure 3-12  Protein expression and purification of hTrx CC. A.  Small scale protein expression 
of two transformed colonies.  Two transformed colonies were picked and cultured overnight with 
antibiotic (100 µg/ml ampicillin).  Bacteria were inoculated (1:100) into fresh 5 ml LB with antibiotic.  
After 3 hours incubation, protein expression was induced by 4 hours incubation with IPTG (final 
concentration 2 mM).  Bacteria before and after induction were analysed by SDS-PAGE under 
reducing conditions.  The sample was visualized by Coomassie stain.  A negative before addition of 
IPTG was regarded as control (lane 1).  Both two colonies expressed hTrx CC (lanes 2 and 3).  B.  
Large scale of protein expression of hTrx CC.  Bacteria before (lanes 1 and 3) and after induction 
(lanes 2 and 4) were analysed by SDS-PAGE and visualized by Coomassie stain.  C.  His-tag 
chromatogram monitored at UV 280 nm of hTrx CC protein.  EL, the start of elution with imidazole 
(range from 20 to 200 mM).  D.  SDS-PAGE analysis of various fractions of his-tag chromatography.  
S indicated supernatant (lane 1) and P indicated pellet (lane 2) after centrifuge of cell lysis.  F 
indicated flow throw of nickel column (lane 3).  His-tag C Fractions indicated the fractions from his-
tag chromatography (lanes 4-9).  E.  Gel filtration chromatogram of hTrx CC protein.  The solid line 
was recorded at UV absorbance of 280 nm.  The single peak indicated target protein hTrx CC.  F.  
SDS-PAGE analysis of various fractions of gel filtration chromatography.  Based on the gel filtration 
chromatogram, fractions 14-21 were analysed by SDS-PAGE under reducing conditions.  The 
majority of purified hTx CC was included in fractions 16-18 (lanes 3-5).   
hTrx mutants (hTrx CS and SS) were also expressed and purified using the same 
protocol as above (figures not shown in thesis). 
To test the quality of purified hTrx CC before the reconstitution of cytosolic 
Trx/TrxR pathway, the activity of purified Trx and TrxR (IMCO) were measured 
using an insulin reduction assay  (Figure 3-13A) (Holmgren, 1979).  This method is 
based on the reduction of insulin disulfides by reduced thioredoxin with 
thioredoxin reductase and NADPH as ultimate electron donor (Holmgren and 
Bjornstedt, 1995).  At the end, DTNB can be reduced by reduced insulin and 
produce TNB, a yellow product that can be measured at 412 nm.  Various 
concentrations of TrxR were used to make a standard curve (Figure 3-13B).  
Purified hTrx CC was used in these reactions.  The TrxR activity increased linearly 
with the increasing concentrations of TrxR which indicated that the purified hTrx 
and TrxR are active and can be used to reconstitute the Trx/TrxR pathway. 
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Figure 3-13  TrxR activity assay using purified Trx.  A.  Scheme of Trx and TrxR activity assay 
based on insulin assay (kTRX-01, IMCO).  This method was based on the reduction of insulin 
disulfides by reduced thioredoxin (Trx) with thioredoxin reductase (TrxR) and NADPH as ultimate 
electron donor [5].  At the end, DTNB was reduced by reduced insulin to release TNB, a yellow 
product which can be measured at 412 nm.  B.  Standard curve of TrxR using insulin assays.  Purified 
hTrx CC (50 μM) was used in this assay.  NADPH concentration is 640 µg/ml.   
 
3.2.4 A reconstituted Trx/TrxR pathway can reduce roGFP in 
microsomes 
It had been demonstrated that roGFP in microsomes indicates the redox status of 
microsomes.  We initially addressed whether a cytosolic reductive pathway 
composed of purified components (G6P, G6PDH, NADPH, Trx and TrxR) could 
reduce microsomal roGFP.   
NADPH emits fluorescence at 460±50 nm when excited at 300 nm to 460 nm 
wavelengths (Figure 3-14) (Patterson et al., 2000, Chance et al., 1979).  Because 
the redox state of roGFP microsomes was indicated by the ratio 390/460nm the 
A 
B 
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presence of NADPH would give background fluorescence.  Therefore, the 
concentration of NADPH added was optimised to allow ratiometric roGFP analysis 
in the presence of the reconstituted pathway. 
   
Figure 3-14  NADPH excitation and emission spectra.  The excitation spectrum of NADPH was 
recorded from 300 nm to 460 nm wavelengths while detecting emission at 465 nm and its emission 
spectrum was recorded between 350 nm to 600 nm following excitation at 340 nm.  (Patterson et al., 
2000) 
Equal quantities of microsomes were suspended in PBS in the presence of different 
concentrations of NADPH (0, 10, 50 and 100 µM).  The emission fluorescence of 
roGFP in microsomes was obtained following excitation at 390 nm and 460 nm.  
The signal was observed for 10 min to obtain the baseline.  At 10 min, diamide 
(final concentration 1 mM) was injected into each sample to oxidise the 
microsomes.  DTT (final concentration 10 mM) was then injected into each sample 
to reduce the microsomes.  The ratio (390 nm/460 nm) was calculated and 
normalised using the baseline ratio of roGFP microsomes in the absence of NADPH 
(Figure 3-15).  From the line chart, the ratio was stable before addition of 
diamide.  Larger ratio value of baseline was noticed with the increased NADPH 
concentration.  After the injection of diamide, roGFP microsomes were oxidised 
and its ratio initially increased but then decreased in samples treated with 50 and 
100 µM NADPH.  Around 25 min, all ratio values were same.  This effect at higher 
concentrations of NADPH is probably due to the oxidation of NADPH.  After the 
injection of DTT (final concentration 10 mM), the ratio value decreased in all 
samples due to the reduction of roGFP.  This result demonstrated that NADPH 
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gives a high background fluorescence at the higher concentrations which leads to 
an inaccurate measurement of the redox state of roGFP.  Hence, a concentration 
of 10 or 50 µM NADPH was used to follow the reduction of roGFP microsomes by 
the reconstituted Trx/TrxR pathway. 
 
Figure 3-15  Optimisation of NADPH concentration during measurement redox state of roGFP 
microsomes.  The same amount of microsomes was suspended in PBS in the presence of different 
concentrations of NADPH (0, 10, 50 and 100 µM).  The emission fluorescence of roGFP in 
microsomes was obtained at excitation spectrum 390 nm and 460 nm.  The signal was observed for 
10 min to obtain a baseline.  At 10 min, diamide (final concentration 1 mM) was injected into each 
sample to oxidise the microsomes.  After the ratio reached saturation, DTT (final concentration 1 
mM) was then injected into each sample to reduce the microsomes.  The ratio (390 nm/460 nm) was 
calculated and normalised to the baseline ratio of roGFP before the addition of diamide.   
To investigate if the minimal cytosolic components of cytosolic Trx/TrxR pathway 
can change the redox state of microsomal roGFP and whether this process is Trx-
dependent, microsomes were incubated with the reconstituted Trx/TrxR pathway 
(Trx, TrxR, NADPH, G6P and G6PDH) using the wild type of Trx (CC) and active 
site mutants, Trx (CS) and Trx (SS) (Figure 3-16).  Because Trx was assumed to be 
the protein which reacts with the membrane protein to transfer reducing 
equivalents to the inside of microsomes, roGFP microsomes were incubated in the 
absence of Trx to determine if the same reducing effect occurred.  Each 
experiment was performed in experimental triplicate.  During the incubation, the 
emmision fluoresence of roGFP was recorded.  At the end of the experiment, the 
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Figure 3-16  Sample preparation of roGFP microsomes.  Two samples of roGFP microsomes 
were incubated at 30 oC with reconstituted Trx/TrxR pathway in the presence or absence of Trx using 
purified cytosol components (Trx, TrxR, NADPH, G6P and G6PDH).  During the incubation, the 
emission of fluorescence of roGFP was recorded.  The data was analysed to obtain a ratio value at 
80 min. 
 ratio was calculated from each sample.  The ratio value was normalised using the 
ratio value of roGFP microsomes treated in the absence of Trx (Figure 3-17, 
compare C(CC) and C-Trx).  The result indicated that roGFP with the sample 
treated with the reconstituted Trx/TrxR pathway became more reduced than the 
sample treated with reconstituted Trx/TrxR pathway in the absence of Trx.   
To confirm that the reducing equivalents generated outside of microsomes were 
passed via the Trx active site to the ER lumen, two enzymatically inactive Trx 
mutants, Trx (CS) and Trx (SS), were used to reconstitute the cytosolic TrxR 
pathway instead of wild type Trx (Figure 3-17).  The ratio value at 80 min in the 
absence of Trx (C-Trx) was used to normalise the other three samples.  The ratio 
value of the sample incubated with the reconstituted Trx/TrxR pathway using wild 
type Trx (CC) was 0.93 indicating the reduction of roGFP in microsomes.  The ratio 
values from incubated with the reconstituted Trx/TrxR pathway using Trx mutants 
(CS and SS) were 1.01 and 1.00, indicating no reduction of roGFP occured.  This 
result demonstrated that Trx was essential for transporting reducing equivalents 
from the outside of ER membrane to the inside.   
Chapter 3  74 
 
Figure 3-17  Reduction effect of the reconstituted Trx/TrxR pathway on roGFP microsomes.  
roGFP microsomes were incubated with reconstituted Trx/TrxR pathway using purified components 
(1.25 mM G6P, 1 U/100 µl G6PDH, 10 or 50 µM NADPH, 25 µM Trx and 16.25 nM TrxR) in the 
presence or absence of Trx.  Each assay was performed in triplicate and repeated three times.  
During the incubation, the emission fluorescence of roGFP were recorded.  At the end of the 
experiment, ratio was calculated and normalised with the ratio value of roGFP microsomes treated 
in the absence of Trx (C-Trx).  C indicating complete reconstituted Trx/TrxR pathway.  C(CC) 
indicated that the Trx with catalytic cysteine (CXXC) was used in the reconstitution of Trx/TrxR 
pathway.  CS (CXXS) and SS (SXXS) indicated the active motif mutants.   
3.2.5 Potential membrane proteins in microsomes are involved in 
ER reductive pathway 
The experiments above showed that the reconstituted Trx/TrxR pathway using 
cytosolic components was able to partially reduce roGFP which was inside 
microsomes and the process was dependent on the catalytic cysteine of Trx.  We 
considered if other membrane proteins and ER luminal proteins could be directly 
or indirectly reduced by the reconstituted Trx/TrxR pathway.   
To investigate proteins influenced by the reconstituted Trx/TrxR pathway, redox 
proteomics were carried out (Figure 3-18A).  roGFP microsomes were incubated 
with the reconstituted Trx/TrxR pathway in the absence or in the presence of Trx 
for 60 min.  After incubation, the free thiols of microsomal proteins were blocked 
by light-iodoacetamide (IAAL) under denaturing condition.  Proteins were reduced 
by DTT and the free thiols which were released by reduction were then labelled 
by heavy-iodoacetamide (IAAH).  Each reaction was carried out in quadruplicate.  
Sample preparation data analysis for MS was carried out by our collaboration lab 
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(Sergio Lilla, Cancer Research UK Beatson Institute).  The samples were prepared 
for liquid chromatography with tandem mass spectrometry (LC/MS/MS) by trypsin 
digestion followed by tandem mass tagging to enable quantification of the changes 
to the ratios of heavy to light peptides for each sample.  The resulting data was 
analysed using Perseus software and presented as a volcano plot indicating the 
statistically significant changes to the heavy light ratios comparing the incubations 
+/- Trx1 (Figure 3-18B).   
With the MS data analysis, the proteins whose redox state changed during 
treament with the Trx/TrxR pathway were identified (Table 3-1).  The volcano 
plot results showed that the redox state of the majority of ER lumenal proteins 
(indicated by blue circles) became more reduced in the sample which was treated 
with the reconstitute Trx/TrxR pathway compared with that treated in the 
absence of Trx (Figure 3-18B).  These results confirmed the important role of the 
Trx pathway in the reduction of ER proteins.   
We analysed the location of proteins whose redox state changed because of the 
treatment with the Trx/TrxR pathway based on the information from UniProt 
(Figure 3-18C).  They are localised to plasma membrane (PM), ER, nucleus, 
cytoplasm, mitochondria, lysosome, intermediate compartment, secreted 
pathway, and extracellular matrix (ECM).  The proteins localised to the nucleus, 
cytosol or mitochondria which has been identified their redox status change 
because of the treatment with the Trx/TrxR pathway were possibly co-purified 
with the microsomes.  The majority of proteins localised to the ER were reduced 
due to the incubation of the Trx/TrxR suggesting that the reducing power can be 
passed into the ER lumen by the cytosolic Trx/TrxR pathway.  Notably, cysteine 
131 of ERO1L, an endoplasmic reticulum oxidoreductase that is involved in the 
disulfide formation, was reduced by the Trx/TrxR pathway (Appenzeller-Herzog 
et al., 2008).  In addition, the secreted proteins which need to form their disulfide 
bonds in the ER are also identified, indicating that their disulfide formation is also 
influenced by treatment with the Trx/TrxR pathway.  The change of redox status 
change of several ER membrane proteins was also recognised, which suggested 
that they are maybe involved in the electron shuttling.   
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Figure 3-18  Mass Spectrometry (MS) analysis of microsome sample after incubation with 
reconstituted Trx/TrxR pathway in the absence or presence of Trx.  A.  Workflow of sample 
preparation and data analysis.  Microsomes were incubated with the reconstituted Trx/TrxR pathway 
in the absence or presence of Trx for 60 min.  The microsomes were then lysed in the presence of 
light iodoacetamide (IAAL).  The samples were subsequently reduced by DTT and released free thiols 
were labelled by heavy iodoacetamide (IAAH).  Following proteolytic digestion, the peptides are 
tandem mass tagged and fractionated prior to LC/MS/MS analysis.  The data was analysed by 
MaxQuant and Perseus software.  B.  Volcano plot of redox state change of proteins.  The blue 
circles indicate proteins which were in the ER while the orange circles indicate proteins which were 
localised to the cytosol.  The redox state of proteins indicated by grey circles did not change 
significantly after incubation.  C.  Cartoon illustrating the final cellular location of proteins whose redox 
status changed significantly upon incubation of microsomes with the reconstituted Trx/TrxR pathway 
components.  Proteins that enter the secretory pathway are in blue whereas those that do not enter 
the ER are in orange.   
  
Chapter 3  77 
Table 3-1  List of proteins showing a significant change to their oxidised thiols along with 
information on their subcellular location, position and identity of the modified cysteine(s).   
Location of cys 
modified 
Gene name protein 
location 
type Cysteine modified More 
red/ox 
cytosol GAPDH cytoplasm soluble 152;156 Red 
CCS cytoplasm soluble 227 Red 
WDFY3 cytoplasm soluble 952 Ox 
RPL37A cytoplasm soluble 39;42 Ox 
PBXIP1 nucleus soluble 559;565 Ox 
endomembrane 
system 
COL6A1 ECM soluble 745 Red 
COL6A3 ECM soluble 1823;1824 Red 
EFEMP1 ECM soluble 40;47 Red 
LAMB3 ECM soluble 451;453;511;534;536 Red 
LAMC1 ECM soluble 416;418;474;751;804;807;954; 
956 
Ox 
LAMC2 ECM soluble 28;30;53;56 Red 
MMP9 ECM soluble 256 Red 
CALR ER soluble 105 Red 
ERO1L ER  soluble 131 Red 
PLOD1 ER  soluble 267;270 Red 
POFUT1 ER  soluble 283 Red 
TMX2 ER single-
pass 
59 Red 
GPAA1 ER multi-
pass 
266 Red 
VKORC1L1 ER multi-
pass 
50 Red 
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LMAN1 ER/Golgi single-
pass 
230 Red 
LOXL2 ER/secreted soluble 395 Red 
PRDX6 lysosomal soluble 47 Ox 
LAMP1 lysosomal single-
pass 
338 Ox 
CTSA lysosomal soluble 239 Red 
IGF2R lysosomal soluble 1227 Red 
CTSB lysosomal soluble 211 Red 
KIDINS220 endosome  multi-
pass 
705 Red 
CD59 PM GPI-
anchored 
70 Red 
CPD PM single-
pass 
309 Red 
MFI2 PM GPI-
anchored 
199 Red 
MGAT5 PM single-
pass 
338 Ox 
NOTCH2 PM single-
pass 
1342;1346 Red 
PLXNA1 PM single-
pass 
358 Red 
AGRN PM/secreted soluble 650 Red 
CYR61 secreted soluble 337;314;317 Red 
ENDOD1 secreted soluble 34 Red 
FN1 secreted soluble 87;97;135;141;179;231;508 Red 
IGFBP7 secreted soluble 156 Ox 
PLAT secreted soluble 419 Red 
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PLAU secreted soluble 45 Red 
PSAP secreted soluble 42 Red 
SPARC secreted soluble 130 Red 
STC1 secreted soluble 170 Red 
VEGFC secreted soluble 328 Red 
mitochondrion NDUFA8 mitochondrion soluble 66 Red 
COA6 mitochondrion soluble 44 Red 
Unknown NUMB membrane unknown 130;132 Ox 
DPY19L1 Unknown multi-
pass 
647 Ox 
Key: ECM; extracellular matrix, PM; plasma membrane, Ox; oxidised, Red; reduced. 
3.3 Conclusion and discussion 
GFP has been re-engineered to monitor redox status in living cells (Meyer and 
Dick, 2010).  In my project, microsomes were prepared from a HT1080 cell line 
which stably overexpresses an ER localised roGFP (cell line was created by my 
colleague Marcel van Lith).  It was proven that ER localised roGFP was a good 
indicator to monitor the real-time change of redox status of ER-derived 
microsomes.  roGFP microsomes are a good tool to investigate the of impact of 
membrane impermeable reducing agent TCEP and reconstituted Trx/TrxR 
pathway on redox status inside microsomes.   
Firstly, the membrane impermeable reducing agent TCEP was used to reduce 
microsomal roGFP to investigate how the reducing power outside the microsomal 
membrane was transported into the lumen.  By using TCEP titrations in the 
presence or absence of Triton it was demonstrated that the reducing agent TCEP 
cannot cross microsomal membrane to directly reduce the microsomal roGFP.  
Membrane proteins were possibly facilitating the reduction of roGFP like the 
membrane protein, DsbD in E. Coli (Stewart et al., 1999).  However, proteinase K 
treatment did not prevent the reduction of microsomal roGFP, which indicated 
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that the membrane protein that facilitated transportation of reducing power 
might not contain a cytosolic domain, or the reduction of the membrane protein 
by TCEP was not affected by proteinase K treatment.   
It has been demonstrated previously in our group that cytosolic thioredoxin 
reductase 1 was required for correct disulfide formation in the ER (Poet et al., 
2017).  It was also showed that cytosolic NADPH was the ultimate electron donor 
for reduction in the ER.  The role of other components needed to reduce non-
native disulfides in the ER and which the reducing equivalents generated in cytosol 
are transferred into the ER, remain to be addressed.  Here, we used known 
minimal cytosolic components in the Trx/TrxR pathway (G6P, G6PDH, NADPH, Trx 
and TrxR) to reconstitute the cytosolic reductive pathway.  The microsomes were 
incubated with reconstituted Trx/TrxR pathway components in the presence or 
absence of Trx.  roGFP was reduced after incubation with complete reconstituted 
Trx/TrxR pathway components whereas no reduction occurred in the absence of 
Trx.  In addition, the reconstituted Trx/TrxR pathway using the Trx mutants, Trx 
CS and SS, was not able to reduce microsomal roGFP.  The results demonstrate 
that the reduction of microsomal roGFP was dependent on the catalytic cysteines 
in either Trx motif (CXXC).  We assumed that the reducing power which was 
generated by the reconstituted Trx/TrxR pathway was finally transported by the 
disulfide exchange between Trx and a membrane protein which contains redox-
active cysteine residues as part of their active sites (Holmgren, 1989).  Reduced 
Trx could reduce disulfide bonds within the membrane protein and then the roGFP 
was directly or non-directly reduced by this membrane protein.  Based on this 
assumption, a Trx-trapping technique was considered to be used to potential trap 
this membrane protein in the future (Schwertassek et al., 2007b) .  The catalytic 
cysteine can form a transient intermediate with its substrate protein by disulfide 
which is ususally resolved by Cys35.  The Trx mutant, Trx(CS), can not resolve the 
transient intermediate allowing us to trap and indentify the ER membrane proteins 
(Schwertassek et al., 2007b).  It is possible to trap the membrane protein that is 
involved in the disulfide shuttling from the outside to the inside.   
A proteomic experiment was carried out to identify proteins whose redox status 
was changed after incubation with the reconstituted Trx/TrxR pathway with or 
without Trx.  The redox status of several peptides changed during the incubation 
with the complete reconstituted Trx/TrxR pathway.  The analysis of protein 
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location showed that the majority of the corresponding proteins were located in 
the ER lumen.  The results demonstrated that several thiols within endogenous 
proteins that were synthesised in the ER, including thiols that form structural and 
regulatory disulfides, can be reduced by the thioredoxin reduction system.  
Notably, ERO1L which mediates disulfide bond formation via PDI (Appenzeller-
Herzog et al., 2010), was reduced during the incubation with the complete 
reconstituted Trx/TrxR pathway.  In vivo, the ERO1 can reoxidise the PDI after 
they passed their disulfide to their substrate proteins.  Furthermore, the 
regulatory Cys131 of ERO1 was identified by our proteomic experiment.  It was 
previously shown that the Cys131 in ERO1 can compete with the free thiols in 
substrate proteins to form disulfide bond with the catalytic Cys94, which is an 
feedback loop that play critical role in the reodx control in the ER (Appenzeller-
Herzog et al., 2008, Baker et al., 2008).  Due to the incubation with the Trx/TrxR 
system, more reduced PDI became substrates for ERO1 resulting in the release of 
the free thiol at Cys131.  In addition, the reduction of microsomal proteins 
suggested that the reducing equivalents were transduced into the microsomal 
lumen.  Because Trx in our recontituted Trx/TrxR pathway are ER membrane 
impermeable, it indicated the requirement for a membrane protein involved in 
the electron transport.  The reduction of several microsomal membrane proteins 
due to the incubation with the Trx/TrxR complete system were also identified by 
the proteomic experiment, such as thioredoxin-related transmembrane protein 2 
(TMX2), glycosylphosphatidylinositol anchor attachment 1 protein (GPAA1), 
vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1L1), human 
lectin mannose-binding 1 (LMAN1).  Whether they are the membrane proteins that 
are responsible for the transportation of reducing equivalents will be investigated 
in our future work.   
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Chapter 4 Trx/TrxR pathway can reduce ER 
localised ERp57 via a membrane protein 
4.1 Introduction 
Numerous enzymes are localised in ER to ensure the protein folding process.  PDI 
are a family of enzymes which facilitate reduction, oxidation and isomerisation of 
disulfide bonds (Figure 4-1).  It was demonstrated that a member of the PDI called 
ERdj5, which had previously been shown to have a role in ERAD (Ushioda et al., 
2008), plays a crucial role in the reduction of non-native disulfides formed during 
productive folding (Oka et al., 2013).  In addition, previous research suggests that 
another PDI, ERp57, has a specific role in the isomerisation of non-native disulfide 
bonds in specific glycoprotein substrates (Jessop et al., 2007).   
 
Figure 4-1  Disulfide formation and reduction.    The insertion of disulfide bonds catalysed by PDI.  
Insertion of disulfide bonds could result in native disulfides, which can be found in the correctly folded 
and functional protein structure, and non-native disulfides which are not present in the native protein.  
It was demonstrated that ERp57 and ERdj5 play crucial role in reduction of non-native disulfide 
(Jessop et al., 2007, Oka et al., 2013).  However, our understanding of reduction of non-native 
disulfides is still limited.   
The ER protein ERp57 is one member of the PDI family (Oliver et al., 1999) with 
the alternate names ER-60, ERp60, ERp61, GRP58, P58, HIP-70, Q-2 or Pdia3 (Coe 
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and Michalak, 2010, Zapun et al., 1998).  It is a 58-kDa thiol oxidoreductase which 
contains two thioredoxin-like active site motifs (CGHC) (Figure 4-2 A) (Tian et al., 
2006, Bourdi et al., 1995, Coe and Michalak, 2010).  ERp57 exhibits a variety of 
different functions.  ERp57 was demonstrated to be part of the glycoprotein-
specific quality control machinery in the ER lumen (Oliver et al., 1997) and it 
specifically interactes with newly synthesised glycoproteins to influence protein 
folding during calnexin/calreticulin cycle (Oliver et al., 1999).  It also was shown 
that ERp57 plays a crucial role in isomerisation of non-native disulfide in a distinct 
set of secreted proteins (Jessop et al., 2007).  Following the reduction of substrate 
protein, a PDI reductase like ERp57 become oxidised.  To maintain the activity of 
ERp57 as a reductase, a reductive pathway is required to reduce the oxidised 
ERp57 in the ER.   
It was shown that the redox state of ERp57 was not influenced by over-expression 
of Ero1-La suggesting specific pathways control oxidative protein folding in the ER 
(Mezghrani et al., 2001).  After disulfide exchange with substrate protein, how 
ERp57 becomes reduced is to be addressed here.  Our group found that a robust 
cytosolic Trx/TrxR pathway and cytosolic NADPH were essential for correct 
disulfide formation (Poet et al., 2017).  To investigate if redox state of the ER can 
be maintained by cytosolic Trx/TrxR pathway, ERp57, was chosen to be a 
substrate to indicate the impact of the cytosolic Trx/TrxR pathway on its redox 
state.  We optimised the assay to determine the redox status of endogenous ERp57 
in a HT1080 cell line and a HT1080 cell line which stably overexpresses ERp57-V5 
tagged protein.  The effect of the reconstituted Trx/TrxR pathway on the redox 
status of ERp57 was determined.   
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Figure 4-2  A linear representation of ERp57 and three-dimensional model of ERp57.  The 
protein contains an N-terminal amino acid signal sequence and a C-terminal QDEL ER retention 
signal.  In both the linear and three-dimensional model, the catalytic a and a’ domains are shown in 
light grey while the substrate binding b and b’ domains are shown in dark grey (Coe and Michalak, 
2010).  The yellow amino acids indicate the catalytic residues CGHC and the blue amino acids 
indicate residues involved in calnexin binding.  In the linear model, the short linker between the b 
and b’ domains is marked in orange and the basic C terminal is marked in purple.  Three-dimensional 
model of the a b b’ a’ domains based on NMR studies of the a and a’ domain of PDI (Tian et al., 
2006) and the b and b’ domains of ERp57 (Kozlov et al., 2006).   
4.2 Results 
4.2.1 Determining the redox state of ERp57 
An important aspect of the project will be to determine the PDI family member 
responsible for catalysing the reduction of non-native disulfides within client 
proteins.  To evaluate the process of reduction we will need to determine the 
redox status of the PDI family members which are most likely to be involved in 
this reductive step.  It has previously been demonstrated that ERp57 is required 
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to catalyse the isomerisation of non-native disulfides both for correct folding and 
for reduction prior to degradation (Bulleid, 2009, Jessop et al., 2007). 
To establish an assay for determining the redox status we sought to reproduce 
work carried out previously (Jessop and Bulleid, 2004, Oka et al., 2015).  In live 
cells, ERp57 exists as a mixture of two redox states: oxidised and reduced.  After 
treatment with NEM, the free thiols in reduced ERp57 can be alkylated with the 
membrane permeable alkylating reagent NEM, while the oxidised thiols within 
ERp57 will not be.  The samples were denatured by boiling with 2% SDS and were 
reduced by TCEP to break the existing disulfide bond in oxidised ERp57.  Newly 
reduced ERp57 was then alkylated with AMS which has a larger molecular weight 
than NEM.  The samples modified with AMS have a slower mobility than the protein 
modified with NEM.  Hence, the redox state of ERp57 in intact or SP cells can be 
identified by the different mobility on the gel (Figure 4-3A). 
 
Figure 4-3  Determining the redox state of ERp57.  A.  Schematic diagram of the protocol for 
determining the redox state of ERp57.  In intact or SP cells, there are two forms of ERp57, reduced 
form (green oval) and oxidised form (orange oval).  The free thiols in reduced ERp57 will be blocked 
by alkylating agent NEM (molecular weight: 125.13) (brown triangle).  After reduction by the reducing 
agent TCEP, existing disulfides in oxidised ERp57 were broken followed by the alkylation by another 
alkylating agent AMS (molecular weight: 466.4) (blue square) which has larger molecular weight than 
NEM.  Different redox states of ERp57 will identified by the electrophoresis mobility shift on gel 
because of the different molecular weight between NEM and AMS.  B.  Schematic diagram of 
determination of ERp57 redox state in SP cells.  SP cells were prepared from confluent flask of 
HT1080 cells.  SP cells were untreated or treated with diamide or DTT in KHM buffer.  Redox state 
A B 
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of ERp57 was then determined by differential alkylation which can be visualised on SDS-PAGE gel 
by the different mobility.  Blue squares indicate alkylating agent AMS; brown triangles indicate 
smaller alkylating agent NEM. 
To optimise the protocol for detection of ERp57, two antibodies (R282 and 283) 
and different blocking agents (milk and BSA) were tested in the western blot.  
HT1080 cells were lysed and the resulting lysate was denatured and separated by 
SDS-PAGE.  The proteins were transferred from the gel to a nitrocellulose blotting 
membrane followed by blocking with different blocking agents, 3% BSA and milk.  
The membranes were incubated with different primary antibodies (R282 and 283).  
After incubation with rabbit 800 secondary antibody, the membranes were 
scanned by Li-Cor Odyssey 9260 Imager to obtain image (Figure 4-4A).  The result 
shows that less background bands were observed using 3% milk (Figure 4-4A lanes 
1, 2 and 5, 6) rather than using 3% BSA (Figure 4-4A lanes 3, 4 and 7,8 ) as blocking 
agent.  More compact and clear bands revealed when using R283 (Figure 4-4A lanes 
5 and 6).  Blocking agent 3% milk and primary antibody, rabbit 283, would be used 
in later experiments. 
To address the redox state of ERp57 in SP cells, the SP cells were untreated (UT), 
treated with DTT (DTT) or diamide (Dia) at room temperature.  The samples were 
then treated with 25 mM NEM to block free thiols followed by 2 times KHM wash 
to remove excess NEM.  Redox state of ERp57 was determined as above (Figure 
4-3A).  Samples were then separated by SDS-PAGE and visualised by western blot.  
Two bands and several background bands were observed in all three samples no 
matter if the sample were untreated, oxidised or reduced (Figure 4-4B lanes 1-3).  
To optimise the protocol, PBS was used instead of KHM buffer to remove excess 
NEM.  Clearer bands were noticed.  In untreated SP cells, two bands were 
observed: an upper band and a lower band (Figure 4-4B lane 4).  The lower band 
migrated with the band in sample reduced by DTT (Figure 4-4B lane 5) indicating 
reduced form of ERp57.  The upper band migrated at the same position with as 
the band in oxidised sample (Figure 4-4B lane 6) indicating oxidised form of ERp57.  
This result suggested that PBS buffer was better than KHM buffer in washing 
sample to remove excess NEM. 
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Figure 4-4  Optimisation of determination of ERp57 redox state. A.  Optimisation of blocking 
agent (3 % BSA and milk) and primary antibody (R282 and R283) in western blot.  HT1080 cell lysis 
were separated by SDS-PAGE.  Proteins were then transferred to blotting membrane and cut into 
four pieces.  The membranes were separately blocked using two different blocking agents (3 % BSA 
and milk) followed by incubation with primary antibody (R282 or R283).  After incubated with 
secondary antibody, the membrane was scanned by Li-Cor Odyssey 9260 Imager to obtain the 
image.  B.  Comparison of KHM buffer wash and PBS wash.  SP cells were prepared from confluent 
HT1080 cell flask.  The SP cells were untreated (UT) and treated with DTT and diamide (Dia) at room 
temperature.  After treatment, the sample were treated with 25 mM NEM in PBS to block free thiols.  
The excess NEM was removed by KHM or PBS washing.  Reducing agent TCEP was used to break 
existing disulfide bonds in oxidised ERp57.  The free thiols were then incubated with a larger 
alkylating agent AMS.  The sample was separated by SDS-PAGE and western blot (3% milk, R383 
primary antibody) was carried out to visualise the proteins. Ox indicating oxidised ERp57 and red 
indicating reduced form of ERp57.  C.  HT1080 cell line which can stably overexpress ERp57 
including a V5 tag (ERp57-V5) which can be easily identified by anti-V5 antibody was used in the 
determination instead of untransfected HT1080 cell line. 
A B 
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Another option for determining the redox state of ERp57 was using HT1080 cell 
line which can stably overexpress a V5-tagged ERp57.  ERp57-V5 can be easily 
identified by anti-V5 antibody.  This cell line was created by my colleague Marie 
Ann Pringle.  The determination of ERp57 was carried out as above.  Anti-V5 
antibody was used as the primary antibody in the western blot and then was 
incubated with Mouse 800 secondary antibody.  Stronger bands and less 
background bands were observed (Figure 4-4C).  It was noted that the reduced 
form ERp57 (lower band) (Figure 4-4C lane 3) can be distinguished from the 
oxidised form of ERp57 (higher band) (Figure 4-4C lane 2).  There were two forms 
of ERp57 in untreated HT1080 ERp57-V5 SP cells which was consistent with HT1080 
SP cell.  The result demonstrated that the ERp57-taggged HT1080 cell line was a 
good cell line to study redox state change of ERp57.   
4.2.2 The Trx/TrxR pathway can reduce oxidised ERp57 
It has been demonstrated that ERp57 was required for the disulfide isomerisation 
of non-native disulfides both for correct folding and for reduction prior to 
degradation.  We recently demonstrated that the reconstituted Trx/TrxR pathway 
was able to reduce roGFP in microsomes (chapter 3).  We considered if the 
reconstituted Trx/TrxR pathway could change the redox state of ERp57. 
In order to investigate if the reducing power is from cytosol, the redox status of 
ERp57 in the SP cells is determined in RRL, cell extract which was prepared from 
HT1080 cell line, the cell extract treated with PD-10 column that has been 
removed the cytosolic small molecules, and KHM buffer which has been used in SP 
cell preparation.   
SP cells were prepared from confluent HT1080 cell flask which is not transfected.  
The SP cells were untreated (UT) and treated with DTT (DTT) or diamide (Dia) at 
room temperature as controls.  Because it was demonstrated that the addition of 
G6P can promote correct disulfide bond formation, the other samples were 
incubated at 30oC for 60 min in the absence or presence of G6P in KHM buffer or 
RRL in order to investigate if the addition of G6P can influence the redox status 
of ERp57 in SP cells.  The sample were then treated with 25 mM NEM in PBS to 
block free thiols.  The excess NEM was removed by two washes with PBS.  The 
reducing agent TCEP was used to break existing disulfide bonds in oxidised ERp57.   
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The free thiols were then alkylated by a larger alkylating agent AMS.  The sample 
was separated by SDS-PAGE and western blot was carried out to visualise the 
proteins as above.  One upper band (ox) was observed in the oxidised sample 
(Figure 4-5A lane 1) while one lower (red) was noticed in the reduced SP cells 
(Figure 4-5A lane 2).  Two bands showed in UT SP cells which indicated that there 
were two redox sates of ERp57: oxidised and reduced form (Figure 4-5A lane 3).  
Similar bands were observed in SP cells in the absence or presence of G6P (Figure 
4-5A lanes 4 and 5).  This result demonstrated that the incubation in KHM buffer 
did not change ERp57 redox state and the cytosolic component, G6P, cannot 
reduce ERp57 on its own.  A compact lower band (indicating reduced form of 
ERp57) was observed in the sample which was incubated in RRL in the presence or 
absence of G6P (Figure 4-5A lanes 6 and 7).  It demonstrated that there were 
reducing equivalents in RRL resulting the reduction of ERp57.   
Since cell extract was prepared from the cell line which was also used to 
generated SP cells, the cell extract and the cell extract that was filtered through 
the PD-10 column to remove the small cytosolic molecules, were incubated with 
SP cells in order to determine if the reducing power originated in the cytosol.  To 
make it easier to visualise the redox change after the incubation in cell extract, 
the SP cells were fully oxidised by 10 mM diamide in KHM buffer and the excess 
diamide was removed by KHM buffer washing before incubation in cell extract.  
One upper band (indicating oxidised ERp57) was observed in SP cells which were 
incubated in KHM buffer alone (Figure 4-5B lane 1).  This indicated that the 
incubation in KHM buffer does not change the redox state of ERp57 which was 
consistent with the result we obtained previously.  When the SP cells were 
incubated in cell extract (CE), one strong lower band (red) and a faint upper (ox) 
appeared indicating that cell extract reduced the oxidised ERp57 during the 
incubation (Figure 4-5B lanes 2 and 3).  No reduced band occurred if the SP cells 
were incubated in the cell extract that was filtered through a PD-10 desalting 
column (GE Healthcare) (Figure 4-5B lane 4).  This absence of reduction was 
possibly caused by the PD-10 desalting column removing small molecular 
components in the cytosol, such as G6P, NADPH and glutathione. 
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Figure 4-5  Incubation of SP cells in KHM buffer didn’t change redox state of ERp57. A.  SP 
cells were prepared from confluent untransfected HT1080 cell flask.  The SP cells were untreated 
(UT) and treated with DTT (DTT) or diamide (Dia) at room temperature.  The other samples were 
incubated at 30 oC for 60 min in the absence or presence of G6P in KHM buffer or RRL. After 
treatment, the sample were incubated with 25 mM NEM in PBS to block free thiols.  The excess NEM 
was removed by 2 times PBS wash.  Reducing agent TCEP was used to break existing disulfide 
bonds in oxidised ERp57.  The free thiols were then reacted with a larger alkylating agent AMS.  The 
sample was separated by SDS-PAGE and western blot was carried out to visualise the proteins.  Ox 
indicating oxidised ERp57 and red indicating reduced form of ERp57.  B.  Cell extract from HT1080 
cell line (HT1080 CE) and HT1080 cell line which expressed roGFP can reduce oxidised ERp57 
(roGFP CE) while the cell extract which was filtered through a PD-10 column to remove small 
molecular components cannot reduce oxidised ERp57.  SP cells were prepared from confluent 
HT1080 cell flask.  All SP cells were first oxidised by 10 mM diamide. KHM buffer washing was used 
to remove excess diamide. The SP cells were incubated in KHM buffer, roGFP CE or HT1080 CE 
with or without filtration. The redox state was then determined by differential alkylation as above.  
Based on the experiments result above, KHM buffer was chosen to be the buffer 
to reconstitute cytosolic Trx/TrxR pathway using purified components (1 mM 
NADPH, 25 µM human Trx (expressed and purified as above), 16.25 nM human TrxR 
(IMCO) or 600 nM Yeast TrxR (expressed and purified by Jana Rudolf), 1.25 mM 
G6P, 1 U G6PDH) to see if a reconsituted Trx/TrxR pathway can reduce ERp57.   
SP cells were generated from HT1080 cell line and HT1080 ERp57-V5 cell line 
respectively.  SP cells were first fully oxidised by diamide.  Oxidised cells were 
then treated with DTT, complete Trx/TrxR pathway in the presence or absence of 
Trx, glutathione, or Trx alone.  The redox status of ERp57 was determined by 
differential alkylation and a western blot was carried out to visulise proteins.   
A B 
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In the untreated samples, ERp57 appeared as two bands after AMS treatment 
where the upper band indicated oxidised ERp57 and the lower band indicated 
reduced ERp57 (Figure 4-6 A lane 7, B and C lane 6).  A single upper band showed 
that the ERp57 was fully oxidised after diamide treatment (Figure 4-6 A lane 5, B 
and C lane 1).  Two redox forms of ERp57 were observed in SP cells which had 
been incubated with complete Trx/TrxR system (Figure 4-6 A lane 1, B and C lane 
3) indicating that reduction of oxidised ERp57 happened following incubation with 
the reconstituted Trx/TrxR pathway.  In one sample the human TrxR (Ch) was 
replaced with yeast TrxR (Figure 4-6 B lane 4) and the reduction of ERp57 also 
occurred.  However, no reduced band occurred in the sample which was treated 
with the reconstituted Trx/TxR system in the absence of Trx (Figure 4-6 A lane 2, 
B lane 5 and C lane 5).  No ERp57 was reduced in sample which was treated with 
Trx alone (Figure 4-6 C lane 4).  In addition, incubation with glutathione lead to 
reduction of ERp57 in SP cells (Figure 4-6 A lane 3 and 4).  These results 
demonstrated that the reconstituted Trx/TrxR pathway outside of ER can reduce 
ERp57 inside the ER membrane and this reduction process was dependent on Trx.  
In addition, the addition of GSH can reduce the oxidized ERp57 and the reduction 
impact is more powerful than the Trx/TrxR pathway.   
The results above demonstrate the importance of Trx in the reduction of ERp57.  
To investigate how Trx can reduce ERp57 in the ER, we determined the redox state 
of the Trx after incubation with the complete reconstituted Trx/TrxR pathway.  
The method for determination of Trx redox state was similar to the determination 
of ERp57 redox state i.e. by differential alkylation using NEM and AMS.  Purified 
Trx was incubated in KHM buffer including or not including cytosolic components 
(NADPH, G6P, G6PDH and TrxR).  After incubation, free thiols in Trx were blocked 
by NEM.  Reducing agent was used to break existing disulfides and then AMS was 
used to alkylate the free thiols.  Because of the different mobility on the gel, the 
reduced form of Trx (alkylated by NEM) ran faster on the gel while the oxidised 
form of Trx (alkylated by AMS) was slower.  Two redox forms were observed when 
Trx was only incubated in KHM buffer (Figure 4-6D lane 1).  The upper band 
indicated that there was oxidised Trx.  Only one lower band was observed when 
Trx was incubated with other cytosolic components in TrxR pathway.  This result 
indicated that the reduction of ERp57 in the ER requires fully reduced Trx.  
Because Trx was membrane impermeable, proteins localised to the ER membrane 
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might be involved in electron-shuttling from outside to inside of membrane after 
disulfide bond with the reduced Trx to further influence ER proteins like ERp57.   
 
Figure 4-6  Reduction effect of reconstituted Trx/TrxR pathway on ERp57 redox state.  A.  SP 
cells were prepared from HT1080 wild type (WT) cell line.  Sample were untreated (UT) (lane 7).  SP 
cells in all other samples were first oxidised by incubation with 10 mM diamide.  One portion of SP 
cells were kept as oxidised control (Dia) (lane 5) while one sample was then reduced by DTT as a 
reduced control (DTT) (lane 6).  The sample were treated with the reconstituted Trx/TrxR pathway 
(C) (lane 1), reconstituted Trx/TrxR pathway in the absence of Trx (C-T) (lane 2), reconstituted 
Trx/TrxR pathway plus glutathione (C+GSH) (lane 3), or only GSH (lane 4).  The determination of 
redox state was determined as above.  Western blot was carried out using an anti-ERp57 (R283) as 
primary antibody.  B.  The sample were prepared as described above.  Ch indicated the reconstituted 
Trx/TrxR pathway using human TrxR (lane 3), Cy indicated the reconstituted Trx/TrxR pathway using 
yeast TrxR (lane 4), and C-T indicated the complete system in the absence of Trx (lane 5).  C.  SP 
cell were generated from HT1080 cell line expressing ERp57-V5.  Samples were prepared as above.  
A B 
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HT1080  ERp57-V5 tagged  D 
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Trx indicated that the SP cells were only treated with purified Trx.  Western blot was carried out using 
an anti-V5 antibody as primary antibody.  D.  Redox state of Trx in the absence or presence of 
reconstituted Trx/TrxR pathway in KHM buffer.  The Trx was incubated in the absence (Trx) or 
presence (C) of other components of reconstituted Trx/TrxR pathway for 60 min.  The NEM was then 
added to block free thiols in Trx.  The Trx was then isolated using streptavidin agarose.  PBS buffer 
including 2% SDS and 3 mM biotin was used to elute the Trx from streptavidin agarose.  The Trx 
proteins were then reduced and not or alkylated by AMS.  Samples were then separated by SDS-
PAGE and visualised by western blot (antibody: Streptavidin Protein DyLight 800).   
4.2.3 Trx/TrxR pathway using Trx mutants (CS, SS) failed to reduce 
oxidised ERp57 
Results above suggested that the Trx/TrxR pathway can reduce ER localised ERp57 
and this process was dependent on Trx.  To address the role of Trx in the reduction 
process of ERp57 redox state, two Trx mutants (Trx C-S and Trx S-S) were used in 
the reconstituted Trx/TrxR pathway instead of wild Trx C-C.   
SP cells were generated from HT1080 ERp57-V5 cell line and fully oxidised by 
diamide (Figure 4-7A).  Oxidised SP cells were then treated with DTT, complete 
Trx/TrxR pathway using Trx wild type (CC) and two mutants (CS and SS).  The 
redox status of ERp57 were determined by differential alkylation and a western 
blot using anti-V5 antibody was carried out to visuliazed proteins.   
In untreated SP cells, two redox forms of ERp57 were observed (Figure 4-7B lane 
6).  Only the oxidised form of ERp57 was observed after the SP cells treated with 
diamide (lane 1).  This showed that ERp57 was fully oxidised.  A reduced band was 
observed when the SP cells were incubated with reconstituted Trx/TrxR pathway 
using wild type Trx (C-C) (lane 3).  However, the incubation with reconstituted 
Trx/TrxR pathway using Trx mutants (C-S and S-S) failed to reduce oxidised ERp57 
(lane 4 and 5).  This result demonstrated that the catalytic cysteines of Trx are 
required for the reduction of ERp57.   
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Figure 4-7  Catalytic cysteine was essential for reduction of ERp57.  Reconstituted Trx/TrxR 
pathway using wild type Trx can reduce oxidised ERp57.  Untreated (UT), diamide (Dia), dithiothreitol 
(DTT), reconstituted Trx/TrxR system using wild type Trx (C-C), reconstitute Trx/TrxR system using 
Trx mutants (C-S; S-S).  Ox means oxidised form of ERp57; red indicating reduced form of ERp57.   
4.2.4 A membrane protein is required for the reduction of ERp57 
during incubation with the Trx/TrxR pathway  
The previous results demonstrated that the cytosolic Trx/TrxR pathway (NADPH, 
G6P, G6PDH, Trx and TrxR) can reduce oxidised ERp57 which localised in the ER.  
It means that the reducing power generated by Trx/TrxR pathway which was 
outside of ER can be passed into ER lumen and then influenced ERp57 redox state.  
Catalytic cysteine of Trx might exchange disulfide to a membrane protein and 
then reduce ERp57 inside the ER membrane.  How can the reducing power be 
transported into the ER? Are there any putative disulfide transporters in the ER 
membrane involved in this process? (Figure 4-8A). 
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Figure 4-8  Influence of proteinase K treatment of SP cells on redox status of ERp57 in 
incubation with reconstituted Trx/TrxR pathway.  A.  It has been demonstrated that the cytosolic 
Trx/TrxR pathway (NADPH, G6P, G6PDH, Trx and TrxR) can reduce oxidised ERp57 localised to 
the ER.  How is the reducing power transported into the ER?  Are there any putative disulfide 
transporters in the ER membrane involved in this process? B.  Schematic diagram of determination 
of redox state of ERp57 in SP cells treated by proteinase K (Pro K).  SP cells were prepared from 
confluent cells which can stably overexpressing ERp57 including a V5 tag in ER.  Cytosol was 
removed and intact ER was treated with proteinase K to digest membrane proteins.  The SP cells 
were incubated with reconstituted Trx/TrxR pathway.  The redox state of ERp57 was visualised by 
differential alkylation after SDS-PAGE gel and western blot.  Ox means oxidised form of ERp57; red 
indicating reduced form of ERp57.   
To investigate if membrane proteins are involved in the reduction process, a 
proteinase which can cleavage polypeptides was used to treated SP cells (Figure 
4-8B).  The experiment was carried out as previously with microsomes.  The 
difference was that SP cells were treated with different concentrations (10 or 20 
µg/ml) of proteinase K followed by inactivation by PMSF before oxidation of 
diamide.  The SP cells were then incubated with the Trx/TrxR pathway. The redox 
status of ERp57 were then determined by differential alkylation.  In untreated SP 
cells, ERp57 exists in two forms oxidised and reduced (Figure 4-9 lane 6).  After 
A 
B 
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treated with the complete Trx/TrxR system, a reduced band was observed (lane 
3) compared with the fully oxidised sample (lane 1).  However, the incubation 
with the reconstituted Trx/TrxR pathway failed to reduce the oxidised ERp57 in 
samples which the SP cells were treated with proteinase K (lane 4 and 5).  This 
result indicates that membrane proteins which have a protease-sensitive cytosolic 
domain were involved in the reduction of ERp57 via the Trx/TrxR pathway.   
 
Figure 4-9  Proteinase K treatment could inhibit reduction of oxidised ERp57 by reconstituted 
Trx/TrxR pathway.  SP cells were prepared from confluent cells which can stably overexpressing 
ERp57 including a V5 tag in ER.  Cytosol was removed and intact ER was treated with Proteinase K 
to digest membrane protein.  The oxidised SP cells were incubated in KHM buffer including DTT or 
the reconstituted Trx/TrxR pathway.  The redox state of ERp57 was visualised by differential 
alkylation after SDS-PAGE gel and western blot.  Untreated (UT); diamide (Dia); dithiothreitol (DTT); 
reconstituted Trx/TrxR system (C) using purified cytosolic components, NADPH, G6P, G6PDH, Trx 
and TrxR; Pro K means the SP cells were treated with proteinase K (10 µg/ml; 20 µg/ml ).  Ox means 
oxidised form of ERp57; red indicating reduced form of ERp57.   
4.2.5 ERp57 was reduced by TCEP via a process that was not 
influenced by proteinase K treatment 
In chapter 3, roGFP microsomes experiments showed that reducing agent TCEP 
reduced roGFP microsomes via membrane transport.  Here, we used ERp57 as 
another reporter to investigate if reducing agent TCEP lead to reduction in the ER 
via membrane transport. 
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SP cells were generated from a HT1080 ERp57-V5 tagged cell line.  Two groups of 
samples were untreated or treated with proteinase K.  After inactivation by PMSF, 
the SP cells were untreated (UT), treated with diamide (Dia), DTT or TCEP.  The 
redox status of ERp57 was determined by differential alkylation and a western 
blot was carried out with anti-V5 antibody (Figure 4-10).  As before, there were 
two redox forms of ERp57 in the sample which was not treated (Figure 4-10 A and 
B lane 1): the reduced form (red) and oxidised form (ox) of ERp57.  After 
oxidation, only one oxidised form was observed in the diamide treated sample 
indicating that the ERp57 was fully oxidised (Figure 4-10 A and B lane 2). In the 
reduced sample (DTT), only the reduced form of ERp57 was observed (Figure 4-10 
A and B lane 3).  In addition, ERp57 was reduced by the membrane impermeable 
reductant TCEP (Figure 4-10A lane 4).  However,  no difference in the ability of 
TCEP to reduce ERp57 was observed following proteinase K treatment of SP cells 
(Figure 4-10B lane 4).  This result suggested that the reduction of any membrane 
protein involved by TCEP is not compromised by digestion of the cytosolic region.   
 
Figure 4-10  Proteinase K treament of SP cells does not prevent reduction of ERp57 by TCEP.   
SP cells were generated from HT1080 ERp57-V5 tagged cell line.  Two group of samples were 
untreated (A) or treated (B) with proteinase K.  After inactivation of the proteinase by PMSF, the SP 
cells were untreated (UT), treated with diamide, DTT or TCEP. Redox status of ERp57 was 
determined by differential alkylation and western blot was carried out with anti-V5 antibody. 
A B 
Chapter 4  98 
4.3 Conclusion and Discussion 
Previous work on the reduction of non-native disulfides in proteins entering the 
secretory pathway demonstrated a connection between the electron donor NADPH 
produced in the cytosol and the client protein within the ER (Poet et al., 2017).  
However, the intermediate steps in this pathway remain unknown.  Based on the 
different locations in cells, the knowledge gap is divided into three questions:  1. 
Are there additional components needed in the cytosolic reduction pathway?  2. 
What is the putative disulfide transporter in the ER membrane?  3. Which 
components are involved in the conversion of non-native to native disulfides in 
the ER? 
G6P, G6PDH, NADPH, Trx and TrxR were known as the minimal components in 
cytosolic Trx/TrxR pathway (Poet et al., 2017).  We used purified components to 
reconstitute the cytosolic Trx/TrxR pathway.  Inside the ER, we assumed that a 
member of the PDI family was involved in the reductive pathway in the lumen.  
The function of PDIs is driven by redox state.  In the reduced state, it is able to 
bind and reduce substrate proteins while in the oxidised state, the substrate can 
be oxidised and released (Tsai et al., 2001).  Hence, after disulfide exchange with 
client protein, it is necessary to reduce PDI so it can act as a reductase.  One of 
PDI family members, ERp57, was shown to have a specific role in the isomerisation 
of non-native disulfide bonds in specific glycoprotein substrates (Jessop et al., 
2007).  ERp57 was chosen as an indicator of redox status to determine the impact 
of the Trx/TrxR pathway on the redox state of an ER luminal PDI.  Determination 
of redox state of ERp57 in HT1080 WT or HT1080 which was transfected ERp57-V5 
tagged protein was optimised based on a previously described approach (Oka et 
al., 2015).   
Here we demonstrated that reconstituted Trx/TrxR using purified components 
(NADPH, G6P, G6PDH, Trx and TrxR) could reduce oxidised ERp57. This process is 
dependent on the catalytic cysteines of Trx.  The Trx/TrxR pathway reconstituted 
by using Trx mutants was not able to reduce oxidised ERp57.  This suggested that 
the reducing power generated outside of ER membrane was transferred into ER 
lumen depending on the disulfide bond exchange reaction between Trx and 
potential membrane protein.  Our result also showed that the oxidised ERp57 can 
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be reduced with the incubation with GSH which is consistent with previous study 
(Jessop and Bulleid, 2004).  It was demonstrated that GSH can directly reduce 
mammalian oxidoreductase in the ER to keep them in a reduce status in order to 
maintain their activity in the disulfide reduction and isomerisation.  This indicates 
that there are possibly several mechanisms in mammalian cells that are 
responsible for the disulfide formation or isomerisation.   
To investigate if membrane proteins are involved in reduction of oxidised ERp57, 
proteinase K was used to treat SP cells to digest the cytosolic domain of ER 
membrane proteins.  The reduction of ERp57, which had been fully oxidised was 
prevented by the proteinase treatment.  It showed that membrane proteins were 
involved in the reduction of ERp57.  The cytosolic domain of membrane proteins 
were involved in disulfide exchange with reduced Trx and further passed the 
reducing power into ER lumen and directly or indirectly reduced ERp57.  Recently, 
it was reported that an ER localised transmembrane protein lipase maturation 
factor 1 (LMF1) influenced the redox homeostasis in ER and could ensure the 
disulfide bond formation (Roberts et al., 2018).  In LMF1 KO cell line, ER became 
more oxidised.  Next, it is worth considering the possibility of LMF1 in the 
reductive pathway which connect the cytosol and ER.  The key question in the 
future is how to identify the membrane protein involved in the reductive pathway.   
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Chapter 5 Developing a post-translational folding 
assay to evaluate the ability of purified 
components to rearrange disulfides 
5.1 Introduction 
In mammalian cells, a secreted protein needs to enter a nuclear contiguous 
intracellular organelle, the ER, to allow different modifications, such as signal 
peptide cleavage, N-Linked glycosylation, disulfide bond formation and proline 
hydroxylation to achieve its native and functional structure (Braakman and 
Bulleid, 2011).  After modification, the protein has to pass the quality control in 
the ER and then the correctly folded proteins will be transported to its target 
location.  Otherwise, the misfolded protein will be transported into the cytosol 
and degraded by the ER-associated protein degradation (ERAD) system.  The whole 
journey is started with the recognition of a signal sequence, which is generally 
located in the N terminus of the protein sequence, by signal recognition particle 
(SRP) (High, 1995).  The complex of ribosomes, nascent chain and SRP then bounds 
to the SRP receptor which is localised in ER membrane.  The ribosome/nascent 
chain complex is directed to the Sec61 translocon and the newly synthesising 
nascent chain is translocated across the ER membrane and exposed to the ER 
lumen.  Once the polypeptide chain is exposed to the various ER chaperones and 
folding enzymes in the ER lumen, folding begins.  The rate of cotransl(oc)ational 
folding is limited by the rate of translation (generally 4-5 residues per seconds) 
(Braakman et al., 1991, Horwitz et al., 1969).  Most formation of the secondary 
structure more rapid than translation.  That is the reason that formation of the 
secondary structure happens on the nascent polypeptide chain.  Modification may 
take place during or after the termination of translation and full translocation 
(Braakman and Bulleid, 2011).   
Disulfide bonds are common linkages in secreted proteins and protein localised to 
the cell membrane.  They are formed between free thiols of two cysteine residues 
and play crucial roles to support the structure, stability, and function of proteins 
(Fass, 2012).  Disulfide bond formation is catalysed by the thiol disulfide exchange 
reaction with ER-localised PDI family members (Benham, 2012).  Disulfide bonds 
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can form not only cotranslationally but also posttranslationally (Braakman and 
Hebert, 2013).  The insertion of a disulfide can result in covalent linkages found 
in the native structure as well as those that are not, so called non-native 
disulfides.  Such non-native disulfides which are formed between the incorrect 
cysteine residues need to be resolved for the polypeptide to form its native and 
functional conformation.  The resolution of non-native disulfides is absolutely 
required for cells to be able to fold secreted proteins correctly and to remove 
misfolded proteins to alleviate cell stress.  The question that how the non-native 
disulfide bonds are reduced, remains to be addressed.  Based on the work carried 
out previously, we have an unknown connection between the ultimate electron 
donor (NADPH) in the cytosol and the final acceptor in the ER.  NADPH is the 
ultimate electron donor for the resolution of non-native disulfides in the ER and 
the cytosolic TrxR pathway ensures the correct formation of native disulfide bonds 
(Poet et al., 2017).   
To investigate if the known cytosolic components (G6P, G6PDH, NADPH, Trx and 
TrxR) are sufficient to reconstitute the reductive pathway for isomerisation of 
non-native disulfide bonds, we developed a post-translational folding assay.  To 
develop the assay, we took advantage of the properties of a commercial 
translational system RRL with the addition of SP cells acting as an ER source.  
Translation of a model protein was carried out in a RRL translation system in the 
presence of 35S-labelled Met and SP cells where the plasma membrane has been 
selectively permeabilised to release the cytosol but leaving the intracellular 
organelles, such as ER and Golgi apparatus intact.  Reagents (eg. G6P) can be 
added to the translation system during or after translation followed by 
immunoisolation of the translation product.  The reduction of non-native disulfide 
can be distinguished by different mobilities of reduced and disulfide bonded 
proteins following separation of the product by SDS-PAGE in the absence of added 
reducing agent.  Different substrate proteins such as β1-integrin (Poet et al., 
2017), low-density lipoprotein receptor (LDLr) (Bulleid, 2009), tissue-type 
plasminogen activator (tPA) and Adam 10 disintegrin domain were compared to 
develop the post-translational folding assay.  We demonstrated that the smallest 
substrate protein, Adam 10 disintegrin domain, is the most sensitive indicator for 
posttranslational isomerisation of non-native disulfide bonds.  We also showed by 
using the post-translational folding assay, that the minimal cytosolic component 
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required for the reduction of non-native disulfide bonds in the ER is the Trx/TrxR 
pathway.   
5.2 Results 
5.2.1 Development of the post-translational folding assay  
To determine whether we could restore the cytosolic reductive pathway to reduce 
disulfides, we first established a post-translational folding assay in the absence of 
added SP-cells.   
Translations were carried out as described previously (Poet et al., 2017).  We took 
advantage of a commercial translation system RRL without any reducing reagents 
containing all the cellular components essential for protein synthesis in vitro, such 
as tRNA, ribosomes, initiation factors, elongation factors and termination factors 
, to synthesis human β1-integrin (Pelham and Jackson, 1976).  The RNA template 
and 35S-Met were added into RRL to allow radiolabelled protein synthesis (Figure 
5-1).  When the RNA template was translated without any addition, a mixture of 
proteins with different disulfide bonds (native and non-native disulfide bonds) was 
synthesised.  After translation, G6P was added into the mixture to allow further 
incubation for different times.  If G6P was able to reduce disulfide bonds, then 
we will get homogeneous reduced protein.  The sample was then separated by 
SDS-PAGE.  The gel was fixed, dried and exposed to phosphorimager plate 
overnight.  The films were scanned by FLA-7000 bioimager to obtain result images.   
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Figure 5-1  Schematic of the post-translational folding assay.  Translation was carried out in 
RRL in the presence of 35S-labelled met/cys in the absence of added SP-cells.  Various disulfide 
bonds (native and non-native disulfide) maybe formed during translation in the absence of G6P.  
After translation is finished, G6P was added into the reaction system.  If the G6P has ability to activate 
the reductive pathway, disulfides will be reduced.   
Previous research showed that the addition of G6P could re-establish the reducing 
environment in the cytosol by driving glucose-6-phosphate dehydrogenase 
(G6PDH) to produce more NADPH (Poet et al., 2017).  We repeated the experiment 
showing that only the reduced form of β1-integrin was synthesised when 
translation is carried out in the presence of G6P (Figure 5-2 lane 2).  In other 
samples, G6P was added into RRL and post-translationally incubated for various 
times.  NEM was added into the reaction at different time points to block free 
thiols.  Here, the oxidised β1-integrin was gradually reduced becoming fully 
reduced after 40 min (Figure 5-2 lane 5-8).  
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Figure 5-2  Time course of post-translational folding assay in cytosol.  Translation of β1-integrin 
was carried out in RRL in the presence of 35S-labelled Met and the absence of semi-permeabilized 
(SP) cells with (lane 2) or without G6P (1 mM).  After translation, the samples were incubated in the 
presence (lane 2) or absence of G6P (lane 3) (1 mM).  Following translation in the presence of G6P, 
samples were incubated for different times (10 - 90 min) after the addition of G6P.  The alkylating 
agent NEM (5 mM) was used block free thiols to avoid disulfide bond change after the reaction ended.  
The sample was then separated by SDS-PAGE under non-reducing conditions.  The gel was fixed, 
dried and exposed to phosphorimager plate overnight.  The films were scanned using the FLA-7000 
phosphorimager to obtain images.  Note, the sample (lane 1) was translated in the absence of G6P, 
but it was run under reducing condition as a reduced control.  Ox indicating oxidised form of proteins 
including different types of disulfide bond; red indicating that the proteins were fully reduced.   
It has been demonstrated that the cytosolic reductive pathway drives the 
resolution of non-native disulfides formed within the ER and the inhibition of TrxR 
could prevent correct disulfide formation (Poet et al., 2017).  To investigate if the 
TrxR is involved in the post-translational resolution of non-native disulfides into 
native disulfide, we planned to use the inhibitors of TrxR in the post-translational 
folding assay.  The ability of AF and TRi1 (Stafford et al., 2018) to inhibit TrxR in 
our cell extract was tested before their application in the post-translational 
folding assay.   
The classical way to determine the activity of the thioredoxin system is by using 
an insulin reduction assay (Holmgren, 1979).  This method is based on the 
reduction of insulin disulfides by reduced thioredoxin with thioredoxin reductase 
and NADPH as ultimate electron donor (Holmgren and Bjornstedt, 1995).  At the 
end of the reaction, DTNB can be reduced by the reduced insulin and produce 
TNB, a yellow product that can be measured at 412 nm.  The absorbance at 412 
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nm indicated TrxR activity in the cell extract.  Various concentrations of TrxR 
were used to make a standard curve which could indicate that the assay is working 
well (in chapter 3).  In addition, the cell extract prepared from Hela cell line as 
described previously was tested for TrxR activity (Figure 5-3A).  TrxR activity in 
the cell extract which was treated with PD-10 column to remove the small 
molecules like G6P was also tested.  Without addition of Trx, no TrxR activity was 
observed (negative control).  TrxR activity was not influenced by the DMSO solvent 
which was used to dissolve AF and TRi1 (Stafford et al., 2018).  When the cell 
extract was treated with inhibitors (AF and TRi1), the TrxR activity was inhibited 
significantly.  These results suggested that either AF or TRi1 could be used as a 
TrxR inhibitor in post-translational folding assay.   
To determine if thioredoxin reductase (TrxR1) was involved in the post-
translational reduction pathway, the translation system was untreated or treated 
with AF which can irreversibly inhibit the activity of TrxR1.  The post-translational 
folding assay was carried out as described above.  TrxR inhibitor AF was used to 
treat the reaction system before translation (Figure 5-3 lane 3) or after translation 
(Figure 5-3 lane 9).  It was noticed that a diffuse band was presented when 
translation was carried out in the presence of G6P in RRL which was treated with 
AF (Figure 5-3 lane 1).  This indicated that the AF treatment prevented the 
reduction of disulfide bonds during translation.  No reduction was observed in 
sample which were post-translationally incubated in absence of G6P (Figure 5-3 
lane 4), but reduction was observed in samples which were post-translationally 
incubated with G6P (Figure 5-3 lanes 5 - 8).  This suggested the post-translational 
addition of G6P can promote the reduction of disulfide bonds.  However, this 
reduction was stopped with AF (Figure 5-3 lane 9).  These results demonstrated 
that addition of G6P and cytosolic thioredoxin reductase are required for the 
reduction of disulfide bonds in the cytosol after translation.   
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Figure 5-3  G6P and cytosolic thioredoxin reductase is required for the reduction of disulfides 
in the cytosol.  A.  Inhibition impact of AF and TRi1 on TrxR in Hela cell extract before or after PD-
10 column treatment.  To make sure the TrxR concentration was same in each lysate, the Hela cell 
extract was diluted so that the lysates had the same protein concentration.  B.  Translation of β1-
integrin was carried out in RRL in the presence of 35S - Met in the absence of SP cells without G6P 
(1 mM) (lane 1) or with (lane 2) in the absence (lane 2) or presence of AF (lane 3).  After translation, 
the samples untreated or treated with TrxR inhibitor AF were incubated in the absence (lane 4) or 
presence of G6P (1 mM) for different times (10 - 90 min).  The alkylating agent NEM (5 mM) was 
used block free thiols to avoid disulfide bond change after reaction ended.  The sample was then 
separated by SDS-PAGE under non-reducing conditions.  The gel was fixed, dried and exposed 
overnight.  The films were scanned by FLA-7000 bioimager to obtain result images.  The oxidised 
species was present when translated or post-translational incubated without G6P (lane 1 and 4).  
The presence of AF during translation and when added post-translation prevented the reduction of 
disulfide bonds (lane 3 and 9).  Ox indicating oxidised form of proteins including different types of 
disulfide bond; red indicating that the proteins were fully reduced.   
5.2.2 Development of post-translational folding assay in the ER  
To investigate the reduction progress of non-native to native disulfides in the ER, 
SP cells were added to the RRL translation system (Wilson et al., 1995).  Here, the 
SP cells acted as a source of ER which allowed the newly synthesised proteins to 
be translocated into the ER and undergo processes such as signal sequence 
cleavage, disulfide bond formation, and glycosylation.   
The post-translational folding assay in the ER was developed based on the post-
translational folding assay in cytosol (Figure 5-4A).  The SP cells were added to 
the translational system to allow the translocation and protein folding to occur in 
A 
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the ER.  After translation, proteins with different kinds of disulfide bonds were 
synthesised in ER at the same time.  G6P was then added to the translational 
system.  If G6P was able to restore the reductive pathway then non-native 
disulfide bonds would be converted to native disulfide bonds.  At the end of 
incubation, the alkylating agent NEM was added to prevent disulfide exchange.  
Two bands were observed in the sample which was translated in the presence of 
G6P (Figure 5-4B lane 1).  The upper band indicated glycosylated β1-integrin (gly- 
β1) and the lower band was untranslocated β1-integrin (untrans).  The sample 
which was translated in the absence of G6P separated as a smear on the gel 
indicating a mixture of glycosylated and untranslocated β1-integrin with various 
disulfide bonds (Figure 5-4B lane 2).  When translation was carried out without 
G6P and then post-translationally incubated with G6P, a similar banding pattern 
was observed (Figure 5-4B lane 3).  We were unable to directly identify the post-
translational isomerisation of non-native to native disulfide bonds by the mobility 
shift on SDS-PAGE.  It was necessary to optimise the protocol to distinguish 
different proteins containing non-native or native disulfide bonds by the SDS-
PAGE.   
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Figure 5-4  Schematic diagram of post translational folding assay in ER.  A.  Translation was 
carried out in RRL in the presence of radiolabeled 35S Met.  SP cells were added to RRL translation 
system as a source of ER.  After translation, NEM was added to some samples to block disulfide 
exchange.  In the other samples, the SP cells were post-translationally incubated with G6P.  B.  The 
translation was carried out with (lane 1) or without G6P (lane 2) (final concentration 1 mM) in the 
presence of SP cells.  After translation in the absence of G6P, the reaction system was incubated in 
the presence of G6P (lane 3).  The samples were separated by SDS-PAGE under non-reducing 
condition.   
a) Optimisation of post-translational folding assay 
Immunoprecipitation was used to optimise the post-translational folding assay in 
the ER (Figure 5-5).  The post-translational folding assay was carried out as 
previously, SP cells were isolated from the translation mix by centrifugation and 
then lysed to release the ER components.  The cell lysate was incubated with 
protein G beads for 30 mins to preclear proteins which could bind non-specifically 
to the protein G beads.  After centrifugation, the supernatant was removed to a 
new tube and incubated overnight with β1-integrin antibody (JB1A or 9EG7) 
(Lenter et al., 1993, Tiwari et al., 2011) in the presence of newly added protein 
G beads.  The beads were isolated and washed three times to remove non-
A 
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specifically bound proteins.  The proteins were eluted from the beads by boiling 
with SDS-loading buffer at 105 oC.  The proteins were separated by SDS-PAGE 
under non-reducing condition.   
 
Figure 5-5  Workflow for the optimised post-translational folding assay in ER.  Translation of 
β1-integrin was carried out in the presence of SP-cells in the RRL.  After translation, the products 
were incubated in the absence or presence of 1mM G6P.  An antibody that recognises all forms of 
β1-integrin (JB1A) or a conformational-specific antibody (9EG7) was used to isolate the protein 
before SDS-PAGE.  Products were separated by SDS-PAGE under non-reducing conditions or non-
reducing gel as indicated. The gel was fixed, dried and exposed to phosphorimager plate overnight.  
The films were scanned by FLA-7000 bioimager to obtain result images.   
When G6P was included during translation, a more intense band was observed in 
the immunoprecipitates with the conformational antibody 9EG7, which can only 
recognise β1-integrin with native disulfide, than when translation was carried out 
in the absence of G6P (Figure 5-6B, compares lane 1 and 2).  This suggested that 
more proteins with native disulfide bonds were synthesised during translation with 
G6P.  In contrast when translations were carried out with G6P in the presence of 
AF, a quite weak band was observed (Figure 5-6 B, lane 3).  These results suggest 
that the addition of G6P during translation resulted in the formation of native 
disulfides but not if TrxR was inhibited by AF.  An increase in signal was obtained 
following incubation post-translationally with G6P from 10 min indicating the post-
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translational reduction of non-native disulfides (Figure 5-6B, lane 5 - 8).  Similar 
distinct bands were also appeared after post-translational incubation in the 
presence of G6P even when the cells were treated with the TrxR inhibitor 
auranofin before this incubation (Figure 5-6, B, lane 9).  This indicated that the 
inhibition of TrxR1 did not prevent the reduction of native-disulfides after 
translation.  A band indicating protein with native disulfide bonds was observed 
in sample which were translated and post-translationally incubated in the absence 
of G6P indicating that, in this case, post-translational non-native disulfide 
reduction is independent of G6P addition (Figure 5A and B, lane 4).  The results 
suggest that the post-translational reduction of non-native to native disulfides was 
independent of the involvement of Trx pathway driven by G6P in the RRL.  It was 
difficult to determine if the addition of G6P after translation can result in the 
isomerisation of non-native to native disulfide bonds when using β1-integrin as 
substrate in this post-translational folding assay.  
  
Figure 5-6  Post-translational non-native disulfide reduction in ER is independent of G6P in 
RRL.  Translation of β1-integrin was carried out in the presence of HT1080 SP-cells.  G6P (1 mM) 
was included either during translation or post-translationally in the absence or presence of 1mM G6P 
as indicated. Auranofin, inhibitor of TrxR, was used before or after translation as indicated to 
determine if the TrxR pathway was involved in the post-translational folding process.  A.  An antibody 
that recognises all forms of β1-integrin (JB1A) was used to isolate the protein before SDS-PAGE.  B.  
A conformational-specific antibody (9EG7) was used to demonstrate the formation of native 
disulfides following the post-translational addition of G6P.  Products were separated by SDS-PAGE 
under non-reducing conditions. The mobility of the glycosylated (gly-β1) protein is as indicated. 
A B 
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Besides β1-integrin, two other substrates such as the tissue-type plasminogen 
activator (tPA) (Bulleid et al., 1992) and low-density lipoprotein receptor (LDLr) 
(Oka et al., 2013) were tested to determine if they would be suitable to use in 
this post-translational folding assay (Figure 5-7).  The translation of the tissue-
type plasminogen activator (tPA) and low-density lipoprotein receptor (LDLr) was 
carried out with (lane 2) or without G6P (lane 3) (final concentration 1 mM) in the 
presence of SP cells as previously described.  In one sample, the RRL was 
pretreated with TrxR inhibitor AF (lane 4).  After translation in the absence of 
G6P, the reaction system was incubated in the absence (lane 5) or presence (lane 
6) of the same concentration of G6P.  Before the addition of G6P, the system was 
incubated with auranofin (lane 7).  Unfortunately, it was difficult to tell if the 
disulfide bonds change during the post translational addition of G6P.  The 
incubation with and without G6P after translation did not exhibit any differences 
in the banding pattern (lane 5-6).   
 
Figure 5-7  Test of substrate proteins for post-translational folding assay.  The translation of 
the tissue-type plasminogen activator (tPA) and low-density lipoprotein receptor (LDLr) was carried 
out with (lane 2) or without G6P (lane 3) (final concentration 1 mM) in the presence of SP cells as 
previously described.  In one sample, the RRL was pretreated with TrxR inhibitor AF (lane 4).  After 
translation in the absence of G6P, the reaction system was incubated in the absence (lane 5) or 
presence (lane 6) of the same concentration of G6P.  Before the addition of G6P, the system was 
incubated with auranofin (lane 7).  One sample (lane 1) was separated under reducing condition. 
And the other samples (lane 2 - 7) were separated by SDS-PAGE under non-reducing condition. 
tPA 
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b) Post-translational folding assay using substrate protein Adam 10 
disintergin domain 
To generate a suitable substrate to study the post-translational rearrangement of 
non-native disulfides in the ER, Adam 10 disintegrin domain was chosen because 
of its dense disulfide pattern, which has a high possibility of forming non-native 
disulfides (Figure 5-8C).  A V5 epitope and a string of methionine residues (Met*5) 
was included at the C terminus to aid immunoprecipitation and boost the signal 
of the radiolabelled translation product (Figure 5-8A).  As the substrate does not 
have a stop codon, the disintegrin domain is not released from the ribosome.  The 
fact that the nascent chain remains attached to the ribosome means that 63 amino 
acids (plus 20 aa signal sequence) are exposed to the lumen of the ER as 63 amino 
acids are required to bridge the gap from the polypeptide translocation site 
through the ribosome tunnel and Sec61 translocon (Figure 5-8B) (Robinson et al., 
2017).  
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Figure 5-8  Schematic representation of Adam 10 disintegrin domain.  A.  Schematic 
representation of Adam 10 disintegrin domain and the organisation of key elements including the 
signal peptide, Neo-epitope tag (NE), Adam 10 disintegrin domain, V5 epitope (V5), methionine 
residues (Met5) (Robinson et al., 2020).  B.  Schematic representation of the stalled Adam disintegrin 
domain entering the ER.  After the signal peptide (20 aa) is cleaved, 63 amino acids are exposed to 
ER lumen allowing disulfide formation and folding while 63 aa span the ribosome and Sec61.  C.  
The native disulfides in stalled Adam 10 integrin. Orange lines indicate native disulfides in exposed 
nascent chain; Grey broken lines indicate native disulfides which cannot form because of the 
unexposed cysteines in the ribosome/ Sec61 tunnel.   
PCR was used to amplify Adam 10 disintegrin domain to provide a transcript that 
encodes 146 aa including a signal peptide, Neo-epitope tag (NE), Adam 10 
disintegrin domain, V5 epitope (V5), and methionine residues (Met5) (Figure 5-9A).  
The forward primer was used to add a T7 promoter onto the template while the 
reverse primer lacks a stop codon (Figure 5-9C).  The transcript was constructed 
without a stop codon which makes it stall on the ribosome.   
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Figure 5-9  Full DNA sequence, primer information and amino acid information of Adam 10 
disintegrin.  A.  DNA sequence of the full-length Adam 10 disintegrin template.  B.  Primers used to 
generate the DNA fragments.  F: forward primer, adding a T7 promoter; R: Reverse primer, adding 
the 5x Met to generate translation intermediates protein 146 amino acids in length.  C.  Amino acid 
sequence of full-length Adam 10 disintegrin template.  Blue: Beta-2-M signal sequence; red: Neo-
epitope tag;  Green: Disintegrin domain from ADAM10;  Orange: V5 tag and 5x Met.  (From Philip 
Robinson).   
A co-translational assay was carried out to determine if we could distinguish 
changes to the disulfide bonding pattern of the Adam 10 disintegrin domain in the 
presence or absence of G6P.  The RNA was also translated in the presence of DTT 
in RRL containing HT1080 SP cells which acted as an ER source to provide fully 
reduced protein.  After the reaction, samples were immunoprecipitated using 
anti-V5 antibody and then analysed by SDS-PAGE.  When the transcript was 
translated in the presence of DTT, two compact bands were noticed on the gel 
(Figure 5-10 A and B lane 1).  The upper band (indicated by *) is reduced preprotein 
that was not translocated into the ER and the lower band (indicated by arrow) is 
the signal peptide cleaved protein.  A faster migrating diffuse band was observed 
when translation was carried out in the absence of G6P suggesting the substrate 
formed different kinds of disulfides including native and non-native disulfides 
during the translation (Figure 5-10 lane 2).  Several distinct bands were observed 
in the presence of G6P (Figure 5-10 lane 3).  These results demonstrated that the 
addition of G6P is required for correct disulfide formation which is consistent with 
previous conclusions (Poet et al., 2017).   
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Figure 5-10  Co-translational and post-translational folding assay using Adam 10 disintegrin 
domain as a model protein.  A.  Adam 10 disintegrin domain was translated in the presence of DTT 
(lane 1) or absence of DTT and in the absence (lane 2) or presence of G6P (lane 3).  B. Post-
translational incubation of Adam 10 translation products in the absence (lane 2) or presence of G6P 
(lane 3).  Autoradiographs of radiolabelled, immunoisolated translation product generated from 
stalled intermediate of Adam 10.  Gels were run under non-reducing conditions.  An example of 
preprotein (untranslocated) (*) and signal peptide cleavage (arrow) are highlighted in the samples.  
Disulfide bond rearrangement (DR).   
To investigate if Adam 10 disintegrin domain is suitable as a model protein for 
disulfide rearrangement in the post-translational folding assay, the RNA template 
was translated in RRL with HT1080 SP cells in the absence of G6P.  After the 
translation, the products were incubated in the absence and presence of G6P and 
then the products were immunoprecipitated using anti-V5 antibody and then 
analysed by SDS-PAGE.  After translation, a diffuse band was observed when post-
translationally incubated without the addition of G6P (Figure 5-10 lane 2) 
indicating that the products were Adam 10 disintegrin with different kinds of 
disulfides.  However, after the addition of G6P at the end of translation, several 
distinct bands appeared (Figure 5-10 lane 3) suggesting that the addition of G6P 
facilitated the rearrangement of disulfides.  The change in banding pattern before 
and after the addition of G6P was more noticeable than β1-integrin.  Hence, we 
decided to use Adam 10 disintegrin domain as a model substrate for our post-
translational folding assay.   
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5.2.3 The cytosolic Trx/TrxR pathway is required for post-
translational disulfide rearrangement 
We wondered if the Trx/TrxR pathway is also required for the post-translational 
disulfide rearrangements we observed after addition of G6P.  To address this 
question, the TrxR inhibitor AF was used in the post-translational folding assay to 
see if the disulfide rearrangement after translation was prevented (Figure 5-11B).   
A co-translational assay was carried out as a control (Figure 5-11C, lanes 1-3).  The 
RNA was translated in the presence of DTT or in the absence or presence of G6P 
in RRL containing SP cells.  After translation, samples were immunoprecipitated 
using anti-V5 antibody and then analysed by SDS-PAGE.  Similar results (Figure 
5-11, lane 1 - 3) were obtained to those seen previously (Figure 5-10).   
A post-translational folding assay was carried out using TrxR inhibitor AF.  As 
described above, the translation was performed in the absence of G6P in SP cells 
and after translation the products were incubated in the absence or presence of 
G6P.  No disulfide reaarangement occurred in the absence of added G6P (Figure 
5-11C, lane 4) as seen previously while several distinct bands were observed after 
incubation with G6P (Figure 5-11C, lane 5).  However, in the presence of the TrxR 
inhibitor AF, the post-translational incubation with G6P did not lead disulfide 
rearrangement (Figure 5-11C, lane 7).  Diffuse bands were observed when the  
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Figure 5-11  The cytosolic Trx/TrxR pathway is essential for post-translational disulfide 
rearrangement (DR).  A.  Schematic diagram of post translational folding assay using Adam 10 
disintegrin domain as substrate.  Translation was carried out in RRL in the presence of SP-cells.  
G6P was included either during translation or post-translationally.  V5-antibody was used for 
immunoprecipitation and to remove background labelling. Products were separated by SDS-PAGE.  
B.  Trx/TrxR reductive pathway in the cytosol.  AF is an inhibitor of TrxR.  Figure adapted from (Poet 
et al., 2017).  C.  Co- and post- translational folding assay of G6P in the presence or absence of 
TrxR inhibitor AF.  Note * indicating preprotein which was not translocated into ER;  arrow indicating 
signal peptide cleaved protein;  DR indicating disulfide rearrangement.   
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translation products were post-translationally incubated in the absence or 
presence of G6P (Figure 5-11C, lane 6, 7).  This result indicated that post-
translational disulfide rearrangement in the ER was dependent on G6P and 
required the Trx/TrxR pathway to transfer reducing equivalent from the outside 
of ER into the ER lumen.   
5.2.4 Reconstitution of the Trx/TrxR pathway using minimal 
cytosolic components leads to post-translationally disulfide 
bonds rearrangement 
Experiments with TrxR inhibitor AF above showed that the cytosolic TrxR pathway 
is required for post-translational disulfide rearrangement in the ER.  We already 
know the minimal components for cytosolic TrxR pathway (Trx, TrxR, NADPH, G6P 
and G6PDH) (Poet et al., 2017).  It has been demonstrated that the reconstituting 
the Trx/TrxR pathway using these components can influence redox status of one 
PDI family member, ERp57, as well as the redox state of roGFP in the ER derived 
microsomes.  Here we used the post-translational folding assay using Adam 10 
disintegrin domain to investigate if the Trx/TrxR pathway cytosolic components 
were sufficient for the reduction of disulfide bonds after translation.   
As described above, the RNA was translated in the absence of G6P in a RRL with 
SP cells.  A co-translational assay was carried out as above as control (Figure 5-12B 
lane 1-3).  For the post-translational folding assay, SP cells were washed in KHM 
buffer to remove RRL translation system and then were incubated in KHM buffer 
in the absence and presence of the Trx/TrxR pathway using purified cytosolic 
components (Trx, TrxR, NADPH, G6P and G6PDH).  In one sample, SP cells were 
incubated in KHM buffer with TrxR, NADPH, G6P and G6PDH, in the absence of 
Trx.  A diffuse banding pattern was observed prior to addition of the Trx/TrxR 
pathway as translation was carried out in the absence of G6P (Figure 5-12B, lane 
4) while several distinct bands were observed after incubation with the Trx/TrxR 
pathway (Figure 5-12B, lane 5) which indicated that the Trx/TrxR pathway could 
lead to disulfide rearrangements.  A diffuse banding pattern remained when the 
translation products were incubated with TrxR, NADPH, G6P and G6PDH (Figure 
5-12B, lane 5, 6).  This indicated that known minimal cytosolic components in the 
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cytosolic reductive pathway was sufficient for the rearrangement of disulfide 
post-translationally and that this process was dependent on the presence of Trx.   
 
Figure 5-12  Reconstituted Trx/TrxR pathway lead to post-translational disulfide 
rearrangement.  A.  Workflow of post translational folding assay.  Translation of Adam 10 disintegrin 
domain was carried out in RRL in the presence of radiolabeled 35S Met.  SP cells were added into 
RRL translation system acting as ER source.  After translation, NEM was added to some samples to 
block the free thiols.  In the other samples, the SP cells were pelted and washed with KHM buffer to 
remove RRL and then incubated in KHM buffer including or not including the Trx/TrxR system (C) 
using purified cytosolic components (Trx, TrxR, NADPH, G6P and G6PDH).  One sample was 
incubated with reconstituted Trx/TrxR pathway in the absence of Trx (C-Trx).  B.  Translations were 
carried out in RRL as described above.  Translations in the presence of DTT or in the absence of 
DTT and presence of G6P were stopped by addition of NEM (B, lanes 1-3).  After translation, SP 
cells were pelleted and washed by KHM buffer to remove RRL and then incubated in KHM buffer 
(lane 4), in the presence of the Trx/TrxR system (C) (lane 5), or with TrxR, NADPH, G6P and G6PDH 
but without Trx (C-Trx) (lane 6).  Note * indicating preprotein which was not translocated into the ER;  
arrow indicating signal peptide cleaved protein;  DR indicating disulfide rearrangement.   
A 
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5.2.5 Post-translational folding assay with TCEP 
We previously demonstrated that the membrane impermeable reducing agent 
TCEP can reduce roGFP which localised in ER derived microsomes via membrane 
transport.  We also showed that TCEP can reduce the PDI enzyme, ERp57.  In both 
experiments, the reducing agent had a stronger reduction effect than the 
Trx/TrxR pathway.  We also determined whether TCEP can rearrange disulfide 
bond after translation.   
To investigate the effect of the reducing agent TCEP on post-translational 
disulfide exchange, a post-translational folding assay was carried out.  As 
described above, the RNA template was translated in the absence of G6P in RRL 
with SP cells.  In some samples, the SP cells were directly incubated in the absence 
(Figure 5-13 lane 1) or in the presence of G6P (final concentration 5 mM) (Figure 
5-13 lane 2) or TCEP (final concentration 1 mM) (Figure 5-13 lane 3).  To remove 
the effect from RRL, the SP cells were pelleted and washed with KHM buffer to 
remove the RRL or the other components in translation system.  The SP cells were 
then resuspended in KHM buffer or cell extract in the absence or presence of TCEP 
(final concentration 1 mM) (Figure 5-13 lane 4-7).  All the reactions were ended 
by the addition of alkylating agent.  The Adam 10 disintegrin was immunoisolated 
using an anti-V5 antibody.  The proteins were then separated by SDS-PAGE.   
A mixture of proteins with different forms of disulfide bonds appeared when the 
SP cells were incubated in RRL (Figure 5-13 lane 1) indicating no reduction 
happened, which was consistent with previous results above.  The addition of G6P 
into RRL promoted disulfide rearrangement in RRL which was showed by clear 
bands on the gel (Figure 5-13 lane 2).  The same pattern of protein bands was 
observed after the addition of TCEP (Figure 5-13 lane 3).  The disulfide 
rearrangement occurred in the sample which was only incubated in KHM buffer 
with TCEP.  Compared with the sample incubated in KHM buffer, it suggested that 
the TCEP can lead to the reduction of disulfide bonds on its own and this reduction 
was independent of other components in cytosol.  Some rearrangement of 
disulfides occurred when the SP cells were incubated in a cell extract which was 
prepared from HT1080 cell line (Figure 5-13 lane 6).  The addition of TCEP into 
cell extract leads to disulfide rearrangement (Figure 5-13 lane 7).  The results 
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demonstrated that a membrane impermeable reducing agent can lead to disulfide 
bonds on its own and the reduction process was not dependent on any other 
cytosolic components.   
 
Figure 5-13  TCEP can lead to the disulfide rearrangement post-translationally.  Translations 
were carried out in RRL as described above.  After translation, the products were incubated in the 
absence (lane 1) or presence of G6P (5 mM) (lane 2) or TCEP (1 mM) (lane 3).  In the other samples, 
the SP cells were centrifuged and washed by KHM buffer to remove RRL.  The SP cells were 
resuspended in KHM buffer or a cell extract (CE) in the absence or presence of TCEP.  The reactions 
were terminated by the addition of NEM to block free thiols.  Products were separated by SDS-PAGE 
gel.  Note * indicating preprotein which was not translocated into ER; arrow indicating signal peptide 
cleaved protein; DR indicating disulfide rearrangement. 
5.2.6 Membrane protein, LMF1 and SEPN1, are not required for 
native disulfide bond formation of β1-integrin 
It was shown previously (Peterfy et al., 2007) that LMF1, an ER localised 
membrane protein, is required for the protein folding and secretion of Lipoprotein 
lipase (LPL).  Recently, it was demonstrated by proteomic and biochemical 
experiments that LMF1 interacts with ER localised PDI family members, like 
ERp72, ERp44 and ERdj5 as well as cytosolic protein Trx (Roberts et al., 2018) 
(Roberts et al., 2018) .  All the proteins have been proven to play an important 
role in disulfide formation process.  Another ER resident protein Selenoprotein N 
(SEPN1) is one of the selenocysteine-containing protein family.  It is involved in 
maintaining of ER redox and calcium homeostasis (Marino et al., 2015).  The 
function of LMF1 and SEPN1 is still not clearly known.  We decided to test if they 
(5 mM) 
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are involved in the isomerisation of non-native disulfide bonds and if they could 
connect the reductive pathway in cytosol and the reduction of disulfide bonds in 
the ER.  We obtained HEK 293 wild type and LMF1 KO cell lines (gift from Saskia B 
Neher) (Roberts et al., 2018) and Hela wild cell line and SEPN1 KO cell lines (gift 
from Ester Zito) (Varone et al., 2019).   
A co-translational assay was first carried out to investigate if the LMF1 and SEPN1 
was involved in the disulfide formation process.  Translations were carried out in 
the absence or presence of G6P in RRL translation system including SP cells that 
were prepared from different cell lines (HEK 293 wild type and LMF1 KO cell line; 
Hela wild cell line and SEPN1 KO cell line).  The NEM was added to the reaction to 
block free thiols and then the SP cells were isolated by centrifugation and washed 
once with KHM buffer to remove RRL.  One portion of sample was boiled with SDS-
loading buffer and directly run on the SDS-PAGE as total translation product (TT).  
The remaining part was immunoisolated with a conformation-specific antibody 
and then separated on SDS-PAGE.   
Two clear bands were observed when the translation products were separated 
under reducing conditions (Figure 5-14 lanes 1 and 2).  The lower band was 
untranslocated (untrans) β1-integrin and the upper band was glycosylated β1-
integrin which was running slower than untranslocated β1-integrin because of its 
glycosylation.  When we used HEK 293 wild and LMF1 KO SP cells as ER source in 
translation system, a smear band was observed in the absence of G6P (Figure 5-14 
A and B, lane 3), but two bands appeared when the translation was carried out in 
the presence of G6P (Figure 5-14 A and B, lane 4).  This suggested that the native 
disulfide bonds formation requires the addition of G6P which was also 
demonstrated by the IP samples.  More β1-integrin with native disulfide bonds 
were observed in the samples that were translated in the presence of G6P (Figure 
5-14 A and B lane 6).  No difference was observed between the translations that 
were carried out with HEK 293 WT and LMF1 KO cell line (Figure 5-14 A and B).  
This result suggested that LMF1 was not essential for native disulfide bonds 
formation of β1-integrin.  Two bands were observed in samples which were 
translated with Hela WT or Hela SEPN1 KO SP cells in the absence of G6P (Figure 
5-14 C and D lane 3) which indicated that native disulfide bond formation of β1-
integrin in the presence of Hela SP cells were not depend on addition of G6P.  This 
was also demonstrated by the IP results (Figure 5-14 C and D lane 5).  The same 
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amount of β1-integrin was isolated by conformation specific antibody 9EG7 in both 
Hela wild and SEPN1 KO cell line.  And in both total translation and IP samples, no 
difference was observed between WT and SEPN1 KO cell line (Figure 5-14 C and 
D).  These results suggested that the formation of native disulfide bonds in β1-
integrin did not require the membrane proteins LMF1 or SEPN1 and this indicated 
the possibility of other membrane protein in the reductive pathway which ensures 
native disulfide bond formation.   
 
Figure 5-14  Membrane proteins, LMF1 and SEPN1, are not required for native disulfide bond 
formation within β1-integrin.  SP cells were prepared from different cell lines (HEK 293 wild type 
and LMF1 KO cell line; Hela wild cell line and SEPN1 KO cell line).  The β1-integrin was translated 
in the absence or presence of G6P (final concentration 1 mM) in RRL containing SP cells.  During 
the translation, the products were radiolabelled by 35S Met.  The reactions were ended by the addition 
of alkylating NEM.  The SP cells were isolated by centrifugation and washed once by KHM buffer to 
remove RRL.  The SP cells was then resuspended in 40 µl KHM buffer.  Two portions of 5 µl SP 
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cells were kept as total translation product (TT).  The remaining part of samples were 
immunoprecipitated using conformational specific antibody 9EG7.  All samples were separated by 
SDS-PAGE.  One portion of total translation product was run on the gel under reducing condition 
(lanes 1 and 2).  The rest of samples were under non-reducing condition. 
5.3 Conclusion and Discussion 
Previous work on the reduction of non-native disulfides in proteins entering the 
secretory pathway demonstrated a connection between the electron donor NADPH 
produced in the cytosol and client proteins within the ER (Poet et al., 2017).  
However, the intermediate steps in this pathway remain unknown.  The post-
translational folding assay which we have developed will be used to evaluate the 
ability of cytosolic components to resolve non-native disulfides in the ER lumen 
and will ultimately be used to identify the membrane protein involved. 
We first developed the post-translational folding assay in RRL.  The translation 
was carried out as described previously (Poet et al., 2017).  We took advantage of 
a commercial translation system RRL containing all the cellular components 
essential for protein synthesis in vitro, such as tRNA, ribosomes, initiation factors, 
elongation factors and termination factors, to synthesis human β1-integrin protein 
(Pelham and Jackson, 1976).  The RNA template and 35S-Met were added into RRL 
to allow radiolabelled proteins synthesis.  When the RNA template was translated 
without any addition, a mixture of proteins including different disulfide bonds 
(native and non-native disulfide bonds) was synthesised.  After translation, a 
cytosolic component eg. G6P can be added into the mixture to allow further 
incubation for different times.  If the component can reduce disulfide bonds, then 
a homogeneous reduced protein will be observed on the SDS-PAGE gel.  By using 
this system, we demonstrated that the post-translational addition of G6P in the 
cytosol leads to the reduction of disulfide bonds.  The post-translational folding 
assay which was carried out with TrxR inhibitor AF demonstrated that the cytosolic 
reduction of protein disulfide bonds after translation needed the TrxR pathway in 
the cytosol.   
The post-translational folding assay in the ER was carried out as above with SP 
cells acting as ER source.  The SP cells were prepared from cultured confluent 
cells by the treatment with digitonin which selectively permeabilised the plasma 
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membrane to allow the removal of cytosolic components, but the ER membrane 
maintains its integrity because of its low cholesterol content (Wilson et al., 1995).  
Initially, the post-translational folding assay was not successful when it was 
performed in RRL with SP cells using β1-integrin as the substrate protein.  After 
translation, the reduction of non-native disulfides in β1-integrin was independent 
of the component G6P added to the reaction system. This maybe caused by the 
particularity of RRL.  
RRL Translation System has been used for characterising protein products from 
RNA transcripts and investigating transcriptional and translational control for over 
four decades, primarily due to the ability to reproducibly obtain large amounts of 
RRL that is highly efficient in protein translation (Jackson and Hunt, 1983, Walter 
and Blobel, 1983).  Reticulocytes are made from immature red blood cells at the 
penultimate stage of differentiation.  At this stage the red blood cells have lost 
their nucleus, but their protein synthesis (primarily of hemoglobin) continues 
robustly using pre-existing cellular components necessary for protein synthesis 
(tRNA, ribosomes, amino acids, initiation, elongation and termination factors) 
(Lodish and Desalu, 1973).  After the reticulocytes are lysed, RRL is optimised 
further for mRNA translation supplemented with tRNA, creatine phosphate, 
creatine phosphokinase, DTT, potassium acetate, magnesium chloride or hemin 
(Pelham and Jackson, 1976).  In addition, RRL may contain a variety of post-
translational processing activities (Walter and Blobel, 1983, Krieg and Melton, 
1984).  The addition of canine pancreatic microsomal membranes to a standard 
translation reaction means core glycosylation can be examined.  Hence, a more 
defined system to study the role of cytosolic components in the resolution of non-
native disulfides within the ER maybe worth establishing.  A cytosol extract from 
Hela cells or HT1080 cells containing all the cytosolic components probably could 
provide an alternative of RRL (Mikami et al., 2006).   
As in vitro studies work best with smaller simpler proteins (Braakman and Bulleid, 
2011), other substrate proteins, LDLr, tPA and Adam 10 disintegrin domain were 
considered as model substrate proteins to develop the post-translational folding 
assay in ER.  We successfully developed the post-translational folding assay in the 
ER with Adam 10 disintegrin domain as the substrate protein.  
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We demonstrated the post-translational disulfide rearrangement needs the 
addition of G6P after translation and the process could be inhibited by TrxR 
inhibitor in RRL.  It was previously demonstrated that the addition of G6P drove 
the generation of NADPH providing an electron donor for cytosolic TrxR1, which 
in turn reduces Trx1.  A robust TrxR1 pathway was required to prevent the 
formation of non-native disulfides and allow correct disulfides to form within 
proteins entering the ER (Poet et al., 2017).  Similarly, the addition of G6P in RRL 
after translation could encourage the disulfide rearrangement.  This is maybe 
caused by the generation of NADPH which could provide electrons for the 
rearrangement in ER after depletion by translation reactions.  Instead of adding 
G6P to RRL after translation, the SP cells were isolated from RRL and resuspended 
in a Hela cell extract.  The disulfide rearrangement also occurred and this process 
was independent of addition of G6P in Hela cell extract.  This indicated that the 
redox status of cytosol in Hela cell line was different from the HT1080 cell line 
and there were enough reducing equivalents in Hela cell extract which could 
provide enough reducing power for the disulfide reduction.   
After the success of post-translational folding assay of G6P, we used this assay to 
evaluate the ability of reconstituted Trx/TrxR pathway using cytosolic 
components (Trx/TrxR/NADPH/G6PDH/G6P) to reduce disulfide bonds after 
translation. The result demonstrated that the reconstituted Trx/TrxR reductive 
pathway using purified components (NADPH, G6P, G6PDH, Trx and TrxR) can lead 
to the disulfide rearrangement of Adam 10 disintegrin domain in the ER after 
translation and the absence of Trx can prevent disulfide rearrangement. Because 
we isolated the SP cells from translational system and excess RRL was removed by 
KHM buffer wash.  This excluded the possibility of the effects of other cytosolic 
components in the isomerisation of non-native disulfide bonds.  The disulfide 
rearrangement still happened when the SP cells were only incubated with 
reconstituted Trx/TrxR pathway in KHM buffer.  It proved that no additional 
components are needed in cytosolic reductive pathway.  The post-translational 
folding assay also proved the equal effect of TCEP on the isomerisation of non-
native disulfide bonds.  
Current results of β1-intergin translations using LMF1 and SEPN1 KO SP cells 
showed that the ER membrane proteins, LMF1 and SEPN1, were not required for 
native disulfide bond formation during translation.  In the future, it would be 
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worth carrying out the post-translational folding assay using Adam 10 disintegrin 
domain as substrate to investigate if these two ER membrane proteins are 
necessary for the post-translational disulfide bonds rearrangement.   
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Chapter 6 Discussion 
6.1 General discussion 
6.1.1 The minimal components in the cytosolic Trx/TrxR pathway 
are sufficient for the ER reductive pathway 
The Trx/TrxR system exists extensively in prokaryotes and eukaryotes and their 
structure and function have been well characterised (Holmgren et al., 1975, 
Sandalova et al., 2001, Collet and Messens, 2010).  Mammalian Trx has 
approximately 25% sequence identity to Trx in E. coli (Eklund et al., 1991).  In the 
Trx/TrxR system, the electrons from NADPH can flow to the substrate protein in 
an oxidised form via the catalytic cysteines of the Trx active site motif.   
The Trx/TrxR system plays diverse and critical roles in mammalian cells.  The 
Trx/TrxR system can regulate transcription by regulating the nuclear and 
cytoplasmic redox-sensitive transcription factors (Schenk et al., 1994, Hirota et 
al., 1999).  Trx can also regulate apoptosis by binding with apoptosis signal-
regulating kinase 1 (ASK1) (Saitoh et al., 1998).  In E.coli, the electrons for 
reduction of non-native disulfide ultimately came from cytoplasmic NADPH via 
Trx/TrxR system (Rietsch et al., 1997).  Hence, the mammalian Trx/TrxR were 
assumed to contribute to the reduction of incorrect disulfide in the ER (Bulleid 
and van Lith, 2014).  A previous study emphasised the critical role of the 
mammalian cytosolic TrxR pathway in the correct disulfide formation in the ER 
(Poet et al., 2017).  It was unknown whether additional cytosolic components are 
required for the reduction of non-native disulfide occurring in the ER.   
To further investigate the effect of the cytosolic Trx/TrxR pathway, we 
successfully reconstituted the cytosolic Trx/TrxR pathway using minimal 
components (G6P, G6PDH, NADPH, Trx, and TrxR) (Figure 6-1).  The concentration 
of each component is controlled as close as possible to the cell extract to 
reconstitute a Trx/TrxR pathway like that in vivo.  Using a reconstituted Trx/TrxR 
system can eliminate the influence of numerous compounds in the cytosol on the 
redox change in the ER or microsomes to focus on the effect of Trx/TrxR pathway.  
We demonstrated that no additional cytosolic components are required for the 
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transduction of the reducing equivalents from the cytosolic Trx/TrxR system to 
the ER and the process is dependent on the catalytic cysteines in the Trx motif.  
We determined that the Trx was fully reduced in the presence of the reconstituted 
Trx/TrxR system.  In terms of thermodynamic stability, the oxidised form of Trx 
is far more stable than its reduced form (Roos et al., 2007).  The large difference 
in stability provides the driving force for the reduction of the substrate protein by 
Trx (Roos et al., 2007).  This suggested that electrons are directly shuttled to the 
substrate protein in the ER from Trx which is itself reduced by TrxR.   
Cytosolic Trx/TrxR pathway is not the only cytosolic reductive pathway 
contributing to the reduction of non-native disulfide bonds in the ER (Chakravarthi 
et al., 2006).  To reduce the non-native disulfide in the ER, PDI needs to stay in a 
reduced form to donate electrons to the substrate proteins.  In chapter 4, we 
noticed that incubation with GSH, that is required for redox homeostasis in the ER 
(Appenzeller-Herzog et al., 2010), can fully reduce oxidised ERp57 in the SP cells.  
This result is consistent with a previous study by Jessop (Jessop and Bulleid, 2004).  
They showed that cytosolic GSH is required for the ER reductive pathway by 
maintaining the ERp57 in a reduced state.  However, there is no direct evidence 
of the effect of GSH on disulfide rearrangement after translation.  It is worth 
investigating post-translational reduction of substrate proteins by GSH using our 
post-translational folding assay.   
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Figure 6-1  Schematic of the flow of the reducing equivalents from the outside of the ER to 
the ER lumen.  Reducing equivalents can come from different sources, the reconstituted Trx/TrxR 
pathway, GSH and membrane impermeable reducing agent TCEP.  Unknown membrane proteins 
(MP, indicated by squares) are involved in the transduction of reducing equivalents to the ER.  It has 
been demonstrated the cytosolic Trx/TrxR pathway and TCEP can reduce ERp57, roGFP, and lead 
to the disulfide rearrangement in the ER, which is dependent of the interaction between Trx and a 
membrane protein.  We also showed that the GSH can reduce ERp57.  The questions remaining to 
address are:  (1)  Which membrane protein is involved in the transduction of reducing equivalents?  
(2)  How does the ERp57 accept electrons from membrane proteins?  (3)  Can other PDI family 
members accept electrons from the cytosolic Trx/TrxR pathway?  (4)  How are non-native disulfides 
reduced?   
6.1.2 A membrane protein is involved in the ER reductive pathway 
Cytosolic Trx/TrxR pathway exists in all living cells including prokaryotics and 
eukaryotics (Holmgren and Bjornstedt, 1995, Arner et al., 1999).  It plays a central 
role in redox balance (Cardenas-Rodriguez and Tokatlidis, 2017) and signal 
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transduction (Monteiro et al., 2017) at the cellular level.  In bacteria, it was 
demonstrated that the electrons can flow from the cytosolic Trx/TrxR system to 
periplasmic DsbC via a membrane protein DsbD and then finally to the substrate 
proteins (Cho and Beckwith, 2009, Chung et al., 2000, Rietsch et al., 1997).  A 
previous study showed the link between the cytosolic Trx/TrxR pathway and the 
correct disulfide formation in the ER in mammalian cells (Poet et al., 2017).  
However, we do not know if there is a membrane protein in the ER which functions 
like DsbD that can shuttle the electrons.   
We demonstrated the cytosolic Trx/TrxR pathway can reduce diverse proteins in 
the ER derived microsomes, ERp57 in the ER, and can reduce the non-native 
disulfides in the SP cells. These results further confirm that reducing equivalents 
generated by the cytosolic pathway can cross the ER membrane.  Later, we took 
advantage of proteinase K and SP cells to prove that the digestion of the ER 
membrane protein prevents the reduction of fully oxidised ERp57 suggesting the 
existence of a membrane protein facilitating the electron shuttling.  In addition, 
the reconstituted Trx/TrxR pathway using Trx catalytic cysteine mutants 
indicated that the membrane protein can be reduced by receiving the electrons 
from the reduced form of Trx (Holmgren and Bjornstedt, 1995, Holmgren, 1995).  
Our study confirms the existence of a membrane protein like prokaryotic DsbD in 
the ER membrane which can shuttle electrons and highlights the potential 
catalytic mechanism.  In the future, we will focus on investigating the membrane 
protein which is the substrate of reduced Trx.   
We initially used a membrane reducing agent TCEP to replace the reconstituted 
Trx/TrxR pathway.  It demonstrated that TCEP can also reduce ERp57, non-native 
disulfides and roGFP via a membrane protein.  However, when the microsomes or 
SP cells were treated with the proteinase K, the reducing equivalents can still 
cross the microsome or SP cells, which is different from the Trx/TrxR pathway.  
This suggested the membrane protein which is required for the TCEP reductive 
pathway is not protease sensitive.  A different catalytic mechanism is required for 
the TCEP and its membrane substrate protein.   
Apart from cytosolic Trx/TrxR pathway, GSH is suspected as another reducing 
equivalents source for the ER reductive pathway (Jessop and Bulleid, 2004, Bulleid 
and van Lith, 2014).  Herein using the ERp57 as the redox indicator, we showed 
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that the electron from GSH can cross the ER membrane, supporting the hypothesis.  
A previous study by Alise Ponsero showed in S. cerevisiae that GSH is imported 
into the ER lumen through the Sec61 channel by facilitated diffusion and the 
transport process is regulated by BiP (Ponsero et al., 2017).  Whether Sec61 is 
required for the GSH dependent ER reductive pathway in mammalian cells remains 
to be addressed.  It is worthwhile to evaluate this possibility using our roGFP 
microsomes, ERp57-V5 in SP cells and post-translationally folding assay.   
6.1.3 The redox balance in the ER is tightly maintained by the 
oxidative and reductive pathway  
In chapter 4, the results indicated that the Trx/TrxR pathway can reduce fully 
oxidised ERp57, a PDI family member.  However, a redox change of PDI is not 
observed in the microsomal lumen after incubation with the reconstituted 
Trx/TrxR pathway in chapter 3.  These results suggested that the redox status of 
PDI is in balance.   
It known that the PDI can catalyse the oxidisation, reduction, and isomerisation 
of disulfide bonds (Darby et al., 1998, Ellgaard and Ruddock, 2005).  The oxidation 
function required the oxidised form of PDI while the reduction and isomerisation 
functions need PDI in the reduced form (Bulleid and Ellgaard, 2011).  The balance 
between the reduced form and oxidised form needs to be tightly regulated to 
ensure the normal functions of PDI.  The oxidised formed of PDI is maintained by 
several pathways, like ERO1 (Cabibbo et al., 2000, Pagani et al., 2000), VKOR1 
(Schulman et al., 2010), and so on.  We consider that if the microsomal PDI was 
reduced by reducing equivalents from reconstituted Trx/TrxR pathway, the 
electrons were accepted by ERO1 and VKOR1 meaning there would be no change 
is the redox status of PDI.  This is supported by the MS result showing that ERO1 
and VKOR are reduced in microsomes treated with complete Trx/TrxR pathway (in 
chapter 4).   
The limitation of our MS experiment is that it begins with microsomes in which the 
redox state is in balance which causes difficulty in observing the change of redox 
state of ER localised proteins in the presence and in the absence of Trx.  In chapter 
4, we determined that ERp57 is partially reduced and oxidised in untreated 
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HT1080 SP cells.  It is hard to observe the reduction effect of Trx/TrxR pathway 
on the ERp57 in untreated SP cells.  But if we first fully oxidised the SP cells, the 
redox state of ERp57 was restored (partially reduced and oxidised) after the 
incubation with complete Trx/TrxR pathway while the ERp57 was still in a fully 
oxidised state in the absence of Trx.  We can consider using fully oxidised 
microsomes in the future to amplify the effect of reconstituted Trx/TrxR on the 
microsome membrane protein and microsomal lumen proteins.  This approach 
would improve the possibility to identify the membrane proteins and ER localised 
proteins involved in the ER reductive pathway.   
6.1.4 The ER reductive pathway 
RRL is a commonly used mammalian cell free translation system (Pelham and 
Jackson, 1976).  The commercial RRL has been universally used in protein folding 
and modifications (Carlson et al., 2012).  Recently, the RRL with SP cells was 
applied to investigate in vitro disulfide formation in the ER (Poet et al., 2017).  
Based on this mammalian translation system, we developed a post-translational 
folding assay using a stalled substrate protein (Robinson et al., 2020) which can 
evaluate the reductive ability of cytosolic components on the newly synthesised 
polypeptide chain after translation.  We demonstrated that the reconstituted 
Trx/TrxR pathway can reduce non-native disulfides and leads to disulfide 
rearrangement in the nascent chain.  In addition, through a proteomic analysis in 
chapter 3, a lot of secreted proteins became more reduced compared to the 
sample in the absence of Trx.   
PDI can catalyse the reduction of disulfides.  We chose one PDI family member, 
ERp57 which is essential for the folding of glycosylated protein (Jessop et al., 
2007), as an indicator.  The result showed the fully oxidised ERp57 in SP cells can 
be reduced by the complete Trx/TrxR pathway suggesting the ER-localised PDI can 
receive electrons from the Trx/TrxR pathway.  Whether other PDI family members 
can receive electrons from the Trx/TrxR pathway is worth testing, for example 
ERdj5 that already shows its importance in removing non-native disulfides (Oka et 
al., 2013, Ushioda et al., 2008).   
We demonstrated the link between cytosolic Trx/TrxR pathway and the redox 
state of diverse substrate proteins in the ER lumen and the connection between 
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cytosolic Trx/TrxR pathway and ERp57 (Figure 6-1).  How ERp57 accepts electrons 
from the membrane protein, whether additional components are required in this 
process, whether other PDI is involved in the reductive pathway, and how the 
nascent chain is reduced are still puzzles to address.  These can be our research 
focus in the future.   
6.2 Future experiments 
6.2.1 Membrane protein involved in Trx/TrxR-dependent reductive 
pathway 
Components of the cytosolic Trx/TrxR pathway that are required for the ER 
reductive pathway have been clarified.  We also demonstrated that a membrane 
protein is necessary for the reduction in the ER.  However, we have not identified 
the membrane protein.   
a) Trapping membrane proteins using Trx mutants 
Based on our study, the ER membrane protein which is involved in the ER reductive 
pathway is assumed accepting electrons from reduced Trx (Figure 6-2) (Holmgren, 
1995).  If we consider the membrane protein is the substrate protein of Trx, 
different methods can be used to trap Trx substrates complexes (Collet and 
Messens, 2010).  As described previously in chapter 3, the Cys35 in Trx active motif 
is required to dissociate the transient intermediate during the disulfide exchange 
with substrate proteins (Schwertassek et al., 2007a).  Mutation of Cys35 (replace 
by serine) can stop the dissociation process allowing Trx and substrate protein to 
stay in the transient intermediate.  We already purify the different Trx mutants 
(CC, CS, and SS) in chapter 3.  It will provide us an opportunity to trap the 
membrane protein.   
To identify the ER membrane protein, we will use the ER derived microsomes as 
the material rather than intact cells which have diverse intracellular organelles.  
These microsomes will be incubated with reconstituted Trx/TrxR pathway using 
the Trx mutants (CC, CS, and SS), so that the reconstituted system can keep the 
Trx mutants in reduced state.  The incubation will be ended with the incubation 
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with NEM blocking the free thiols followed by the lysing of the microsomes.  The 
Trx can be immunoisolated by streptavidin beads due to the streptavidin tag.  The 
samples will be separated by SDS-PAGE and visualized by the antibody, 
Streptavidin Protein DyLight 800, we will expect that diverse bands occur in the 
sample incubated with Trx CC and CS and more intense bands will be observed in 
CS sample due to the Cys35 mutation.  Only a single band should be observed in 
the sample treated with TrxSS, because both catalytic Cys are mutated.  The 
protein bands occurring in the CS sample but not the SS sample will be analysed 
by the MS to identify the membrane protein.   
 
Figure 6-2  Potential catalytic mechanism of membrane protein by the reduced form of Trx.  
The membrane protein potentially received electrons by nuleophilic attack from Cys32 in the reduced 
Trx (Trx-(SH)2) forming a transient intermediate.  Another electron was then donated from Cys35.  In 
the end the Trx become oxidised and the membrane protein becomes reduced.  (Holmgren, 1995) 
b) Homologous analysis with prokaryotic membrane protein DsbD 
In prokaryotes, the reductive pathway has been clearly clarified (Berkmen, 2012).  
The cytosolic membrane protein DsbD (Missiakas et al., 1995, Katzen and 
Beckwith, 2000) can keep protein disulfide isomerase DsbC (Rietsch et al., 1996) 
in reduced status using reducing equivalents providing by the cytosolic Trx/TrxR 
system.  We have demonstrated that in mammalian cells the cytosolic Trx/TrxR 
system can also provide the reducing equivalents to the ER and the process is Trx-
dependent.  We assume that the ER membrane protein involved in the reductive 
pathway may have a certain similarity with DsbD.  Maybe we can try to find ER 
membrane protein in mammalian cells which have a homologous sequence with 
DsbD using bioinformatics.   
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c) Proteomic analyse by MS 
In chapter 3, we showed our reconstituted Trx/TrxR pathway can reduce ER-
localised protein.  In addition, some membrane proteins were also identified by 
the MS.  However, the ERp57 redox state did not show large differences.  We 
assumed that in the untreated microsomes the redox state of membrane proteins 
and redox state of ER-localised proteins are still in balance.  We can consider 
optimising the MS protocol to investigate which proteins are involved in the 
Trx/TrxR dependent ER reductive pathway.  Like the determination of redox state 
of ERp57, oxidation with diamide can be applied in the protocol.  However, it is 
hard to thoroughly remove diamide from microsomes by centrifugation.   
To obtain oxidised microsomes, we can treat the confluent HT1080 cells which 
can stably overexpress roGFP before preparation of microsomes.  The redox status 
of roGFP microsomes will be evaluated by the ratio (390nm/460nm).  The same 
portion of microsomes will be incubated with reconstituted Trx/TrxR pathway in 
the absence and presence of Trx.  The redox state of proteins will be evaluated 
by MS as described previously in chapter 2.  We expect that more membrane 
protein and ER-localised proteins will be observed than that in untreated in 
microsomes. 
6.2.2 Membrane protein involved in GSH-dependent pathway  
GSH is produced in the cytosol but GSH is also required in other intracellular 
organelles, like the mitochondria (Meredith and Reed, 1982) and the ER (Hwang 
et al., 1992).  A lot of evidence has shown that GSH can be transport crossing the 
ER membranes (Molteni et al., 2004, Chakravarthi et al., 2006).  Our experimental 
result in chapter 4 also supports that GSH can across the ER membrane and lead 
to the reduction of PDI.  However, there is limited information about how the GSH 
crosses the ER membrane.  Recently a study found a new function of Sec61 
channel, facilitating GSH diffusion to the ER and the study also showed that in S. 
cerevisiae the transportation of GSH crossing the ER membrane is regulated by 
the ERO1 and BiP (Ponsero et al., 2017).  We think it is worth investigating if the 
Sec61 is involved in the GSH-dependent ER reductive pathway.   
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To confirm the importance of Sec61 in GSH transportation, we can consider using 
mycolactone, an exotoxin which can block the Sec61 channel (Baron et al., 2016, 
McKenna et al., 2017), in our post-translational folding assay and ERp57-V5 redox 
state determination.   
The translations are carried out in the absence of G6P and remove the excess RRL 
with KHM washing.  The SP cells will be untreated or treated with mycolactone 
followed by the post-translation incubation with or without GSH.  The products 
will be separated by SDS-PAGE.  If the reduction is observed in the SP cells 
untreated with mycolactone but no reduction observed in the sample treated with 
mycolactone, the result will suggest that the Sec61 are involved in the GSH 
dependent reductive pathway.  If reduction occurs in both the untreated and 
treated sample with mycolactone, perhaps there are other membrane proteins 
involved in the GSH transportation.  
Determination of the redox state of ERp57-V5 can be used in the evaluation of the 
role of Sec61.  The SP cells are generated from the HT1080 ERp57-V5 cell line, 
after full oxidation, the SP cells are treated with or without mycolactone.  Then 
the SP cells will be incubated with GSH.  The redox state of ERp57 will be 
visualised by differential alkylation.  If no reduction occurs in the SP cells treated 
with mycolactone, it will demonstrate that the GSH is transported across the ER 
membrane by Sec61 channel.   
6.2.3 Evaluation the role of the membrane protein in the ER 
reductive pathway 
In chapter 3 we already screened several ER membrane proteins, TMX2, GPAA1, 
VKORC1L1, and LMAN1, whose redox state can be influenced by the complete 
Trx/TrxR system.  In addition, if we succeed to identify more membrane protein 
using Trx trapping and proteomic analyse, it is necessary to have an assay to 
evaluate if the proteins are involved in the ER reductive pathway.  In chapter 5, 
we developed a post-translational folding assay using a stalled substrate.  We can 
take advantage of this assay.   
Based on the identified protein, we can create KO cell line using CRISPR-Cas9 
(Sander and Joung, 2014).  SP cells can be prepared from the wild type and KO 
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cell line.  The translation of Adam 10 will be carried out in the absence of G6P in 
RRL with two different kinds of SP cells.  The SP cells will be isolated by 
centrifugation and washed with KHM buffer to remove excess RRL.  Sample will be 
incubated with the reconstituted Trx/TrxR system in the absence and presence of 
Trx.  The NEM would be used to stop the reaction.  The protein will be 
immunoisolated and separated by SDS-PAGE.  Different band patterns will be 
observed in samples which are translated with the wild type.  If diffused bands 
occur in the samples which are translated with the KO cell line.  The result would 
suggest the KO protein is required in the ER reductive pathway.   
6.2.4 The influence of Trx/TrxR on the redox status of other PDI 
family members 
In chapter 4 we demonstrated that cytosolic Trx/TrxR pathway can reduce ERp57.  
It is worth investigating whether other PDIs are involved in the Trx/TrxR 
dependent ER reductive pathway.  A previous study proved that ERdj5 is also 
involved in the reduction of non-native disulfide (Oka et al., 2013, Ushioda et al., 
2008).   
To investigate if the ERdj5 is involved in the Trx/TrxR dependent ER reductive 
pathway, an ERdj5-V5 tagged cell line can be used to generate SP cells.  After 
fully oxidised by diamide, the SP cells will be incubated with reconstituted 
Trx/TrxR pathway in the absence and presence of Trx.  The redox state will be 
determined by differential alkylation and visualised by the western blot.  If the 
ERdj5 is reduced due to the incubation with the complete Trx/TrxR system, the 
result will suggest that the ERdj5 is also involved in the Trx/TrxR dependent 
reductive pathway.  In a similar way, the role of other PDI in the ER reductive 
pathway can be demonstrated using this assay.  If there is a good quality antibody 
which can recognise the PDI, we can directly determine the redox state in wild 
type cell line rather than V5-tagged cell line.   
In my thesis, we have demonstrated that the cytosolic reductive pathway is 
required for the reduction of ER-localised proteins and the reduction of non-native 
disulfide using a reconstituted Trx/TrxR pathway.  We suggested that a membrane 
protein is required for the ER reductive pathway and indicated the possible 
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mechanism of electron shuttling via an ER membrane protein using Trx mutants.  
In summary the work presented in my thesis provides further information on the 
ER reductive pathway enabling future work to focus on identifying membrane 
proteins involved in electron transfer and to expand the number of PDI family 
members involved in the reduction of the non-native disulfides.   
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ABSTRACT
Folding of proteins entering the mammalian secretory pathway
requires the insertion of the correct disulfides. Disulfide formation
involves both an oxidative pathway for their insertion and a reductive
pathway to remove incorrectly formed disulfides. Reduction of these
disulfides is crucial for correct folding and degradation of misfolded
proteins. Previously, we showed that the reductive pathway is driven
by NADPH generated in the cytosol. Here, by reconstituting the
pathway using purified proteins and ER microsomal membranes,
we demonstrate that the thioredoxin reductase system provides the
minimal cytosolic components required for reducing proteins within
the ER lumen. In particular, saturation of the pathway and its protease
sensitivity demonstrates the requirement for a membrane protein to
shuttle electrons from the cytosol to the ER. These results provide
compelling evidence for the crucial role of the cytosol in regulating ER
redox homeostasis, ensuring correct protein folding and facilitating
the degradation of misfolded ER proteins.
KEY WORDS: Disulfide formation, Endoplasmic reticulum, Protein
folding, Thioredoxin pathway
INTRODUCTION
Proteins entering the secretory pathway undergo several
modifications that are unique to the ER, including glycosylation
and disulfide formation (Braakman and Bulleid, 2011). The
consequence of these modifications is often increased stability of
the protein fold in preparation for secretion into the extracellular
milieu. Failure to fulfil the correct modification can lead to protein
misfolding and disease (Wang and Kaufman, 2016). Correct protein
disulfide formation requires resident ER proteins to catalyse both
disulfide formation and reduction (Ellgaard et al., 2018). Disulfide
formation is catalysed primarily by Ero1, which oxidises members
of the protein disulfide isomerase (PDI) family by coupling the
reduction of oxygen to the introduction of a disulfide (Sevier et al.,
2007). PDI then exchanges its disulfide with substrate proteins
during and following their translocation into the ER lumen (Chen
et al., 1995). During this process, disulfides might form that are not
present in the final native structure (Jansens et al., 2002). Such non-
native disulfides need to be removed to allow correct folding or to
facilitate protein degradation (Ushioda et al., 2008). Hence, there is
a requirement for both an oxidative and reductive pathway in the ER
to ensure that correct native disulfides are formed or for proteins to
be targeted for degradation (Bulleid and Ellgaard, 2011). In addition
to the reduction of structural disulfides, there is also a requirement
for a reductive pathway to recycle enzymes such as methionine
sulfoxide reductase (Cao et al., 2018), vitamin K epoxide reductase
(Rishavy et al., 2011), peroxiredoxin IV (Tavender et al., 2010) and
formyl glycine generating enzyme (Dierks et al., 2005), which
contain active site thiols that become oxidised during catalysis.
Despite our understanding of the various pathways to introduce
disulfides, our knowledge of the reductive pathway is limited.
Members of the PDI family such as ERdj5 are likely to catalyse the
initial stage in the reduction of non-native disulfides (Jessop et al.,
2007; Oka et al., 2013; Ushioda et al., 2008). ERdj5 has a relatively
low reduction potential, making it an efficient reductase (Hagiwara
et al., 2011). ERdj5 is recruited to substrate proteins via its
interaction with BiP (Cunnea et al., 2003; Hagiwara et al., 2011;
Oliver et al., 1997). Following the reduction of substrates, the PDI
reductases become oxidised so there is a requirement for their
enzymatic reduction to maintain activity. Within the cytosol, the
main disulfide reductase, thioredoxin-1 (Trx1), is maintained in a
reduced state by the action of cytosolic thioredoxin reductase 1
(TrxR1) with potential contributions from both the glutathione
reductase (GR) and glutaredoxin (Grx) pathways (Lillig and
Holmgren, 2007). Both the Trx1 and glutathione (GSH) pathways
require NADPH as ultimate electron donor to maintain their
reductase activity within the cytosol. However, there are no known
equivalent pathways present within the ER for the reduction of
disulfides in the thioredoxin domains within the PDI family. We
recently showed that the regeneration of NADPHwithin the cytosol is
required to ensure correct disulfide formation in the ER lumen (Poet
et al., 2017), raising the possibility that the cytosolic reductive
pathways are responsible for ensuring correct disulfide formation in
the ER lumen. How the reducing equivalents generated in the cytosol
are transferred to the ER lumen remains unknown, but a system for
the transfer of such equivalents does exist in prokaryotes. There,
disulfide formation and reduction within the periplasmic space is
catalysed by DsbA and DsbC, which are structurally homologous to
Trx1 (Kadokura et al., 2003). Disulfide formation is coupled to the
electron transport chain via a membrane protein called DsbB,
allowing de novo disulfide formation in the disulfide exchange
protein DsbA. To remove incorrectly oxidised periplasmic thiols, the
cytosolic thioredoxin reductase pathway via thioredoxin reduces
the membrane protein DsbD, which transfers electrons across the
membrane to reduce DsbC that then catalyses disulfide reduction.
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A role forGSH in the reduction of protein thiols has been suggested
based on its role as a redox buffer (Chakravarthi et al., 2006). This role
is thought to be required to maintain redox balance after large
fluctuations in either reducing or oxidising conditions (Appenzeller-
Herzog et al., 2010; Jessop and Bulleid, 2004; Molteni et al., 2004).
A recent report identifying Sec61 as a GSH transporter provides a
possible route for its transfer into the ER (Ponsero et al., 2017).
However, the GSH requirement for the formation of the correct
disulfides in proteins is less clear. Depletion of ER GSH either by
inhibition of GSH synthase or by targeting GSH-degrading enzymes
does not prevent correct disulfide formation in proteins containing
complex disulfides, such as tissue-type plasminogen activator or the
low-density lipoprotein receptor (Chakravarthi and Bulleid, 2004;
Tsunoda et al., 2014). The relative roles of the thioredoxin and GSH
pathways inmaintaining ER redox poise and in reducing oxidised thiols
remain undefined (Bulleid and Ellgaard, 2011; Ellgaard et al., 2018).
To evaluate the requirement for the reduction of disulfides within
the ER, we reconstituted the pathway using purified cytosolic
components and microsomal vesicles or semi-permeabilised (SP)
cells as a source of ER. Using a redox-sensitive green fluorescent
protein (roGFP) as a readout (van Lith et al., 2011), we established
the minimum requirements for disulfide reduction and demonstrated
that the transfer of reducing equivalents across the ER membrane
requires a membrane protein. In addition, we showed that the
resolution of non-native to native disulfides can be driven solely by
the thioredoxin pathway. Our results highlight the similarity
between the pathways for reduction of disulfides in the bacterial
periplasm and the mammalian ER.
RESULTS
The reduction of ER-localised disulfides requires an ER
membrane component
To follow the reduction of disulfide bonds within the ER lumen, we
created a HT1080 stable cell line expressing a version of roGFP that
can act as a reporter of disulfide formation within the ER of
mammalian cells. To improve the folding and stability of roGFP, we
included the superfolder mutations as described previously (Hoseki
et al., 2016), but using an ER targeted roGFP1-iE rather than
roGFP1-iL. The resulting cell line demonstrated bright ER-localised
fluorescence that was responsive to changes in both oxidation and
reduction, making it an ideal reporter for changes in ER redox state
(Fig. 1A,B). In addition, there was an absence of light-induced
fluorescence changes, an effect that compromised the use of the
roGFP1-iL variant (van Lith et al., 2011). The variant of roGFP was
designated ER-SFGFP-iE. We isolated microsomal vesicles from
the ER-SFGFP1-iE cell line and were able to follow changes to ER
redox status over time using a plate reader (Fig. 1C). We established
that the microsomes were sensitive to both reduction with
dithiothreitol (DTT) and oxidation with diamide, indicating that
the reporter was neither fully oxidised nor reduced following
isolation. Reduction with membrane-permeable DTT was rapid,
reaching completion within 10 min. When the membrane-
impermeable reducing agent tris-(2-carboxyethyl)phosphine
(TCEP) was added to microsomes containing ER-SFGFP-iE,
reduction still occurred but much slower than if the microsomes
were solubilised prior to TCEP addition (Fig. 1D, blue versus
black). Reduction in intact microsomes did not reach completion
unless detergent was added to solubilise the ER membrane (see
from 35 min in Fig. 1D). To ensure the TCEP was not directly
reducing ER-SFGFP-iE, we carried out a similar experiment but
used TCEP immobilised on agarose beads. ER-SFGFP-iE was
reduced significantly (P=0.00001) by immobilised TCEP agarose
beads but not by buffer pre-incubated with TCEP beads (P=0.03)
(Fig. 1E). These results strongly suggest the indirect reduction of
ER-SFGFP-iE by TCEP when the microsomal membrane is intact.
The lack of full reduction of ER-SFGFP-iE by TCEP suggests
that the reaction had reached saturation. To evaluate this possibility
further we determined the rate of reduction with a range of TCEP
concentrations (Fig. 1F,G). The results show that the rate of
reduction does indeed reach saturation at concentrations of TCEP
over 1 mM, suggesting a facilitated process. To show that TCEP can
reduce ER-SFGFP-iE directly and fully we determined the rate of
reduction with a range of TCEP concentrations after solubilising the
ER membrane (Fig. 1H,I). Under these conditions the rate did not
reach saturation, suggesting a diffusion-limited process. These
results with the membrane-impermeable reducing agent suggest the
indirect reduction of an ER-localised disulfide mediated via an ER
membrane component.
The thioredoxin reduction pathway is sufficient to reduce
ER-localised proteins via a membrane protein
To evaluate the cytosolic components required to ensure reduction of
ER-localised disulfides,we attempted to reconstitute the pathwaywith
purified components.We reasoned that a source of NADPHwould be
required as well as TrxR1 and Trx1. To ensure efficient recycling of
NADPH, we included glucose 6 phosphate (G6P) as well as G6P
dehydrogenase. To demonstrate that the system could maintain Trx1
in its reduced state, we determined the redox status of purified
Trx1 before and after incubation with the recycling system. Redox
status was evaluated following modification with 4-acetamido-4′-
malemidylstilbene-2,2′-disulfonic acid (AMS), which increases the
protein mass and thus slows its electrophoretic mobility. Prior to
incubation, Trx1 was present as a mixture of both reduced and
oxidised protein (Fig. 2A, lane 1). After incubation with TrxR1 and
the NADPH recycling system, Trx1 was fully reduced (Fig. 2A,
lane 2). When our microsomes containing ER-SFGFP-iE were
incubated with the TrxR1 reduction system, roGFP became more
reduced, an effect that was dependent on the inclusion of Trx1 as no
reduction occurred in the presence of TrxR1 and the NADPH
recycling system alone (Fig. 2B, C-Trx). No reduction of roGFP was
observed when active site mutants of Trx1 (CXXS or SXXS) were
used in place of wild-type protein (CXXC). These results demonstrate
that the minimal requirement for reduction of ER-localised roGFP is
the thioredoxin reduction system and that disulfide exchange is
mediated through the Trx1 CXXC active site motif. As the reduction
was Trx1 dependent and Trx1 is membrane impermeable, it is highly
likely that an ER membrane component is required to transfer the
reducing equivalents from Trx1 to roGFP.
The experiments with roGFP provide us with a useful way to
follow reduction of a specific disulfide within the ER lumen by
components added outside the vesicles; however, this protein is not
normally present in the ER. Hence, we evaluated the redox status of
ERp57, a member of the PDI family, to determine whether the
thioredoxin reduction system could also reduce an endogenous ER
protein that has previously been shown to be required for the correct
folding of glycoproteins (Jessop et al., 2007).
We used the approach described for AMS (Jessop and Bulleid,
2004) to probe the redox status of ERp57 in SP cells isolated from a
cell line stably transfected with V5-tagged ERp57 (Jessop et al.,
2007). Samples were either untreated or treated with the oxidising
agent diamide, with the reducing agent DTT or with the membrane-
impermeable TCEP (Fig. 3Ai,ii). Treatment with N-ethylmaleimide
(NEM) blocks any free thiols and subsequent reduction, and
alkylation with AMS reduces the mobility of the protein. Proteins
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that contain disulfides in the original SP cells, therefore, show
reduced mobility on SDS-PAGE. Following this procedure, ERp57
in untreated SP cells migrated as two species representing the
oxidised and reduced forms, by comparison with the diamide- or
DTT-treated samples (Fig. 3Ai, lanes 1-3). After incubation with
TCEP most of the ER-localised ERp57 was reduced, although not
completely (Fig. 3Ai, lane 4), a result that mirrors the incomplete
reduction of roGFP and demonstrates that TCEP can substitute for a
cytosolic reduction system.
To evaluate the ability of the thioredoxin pathway to reduce
ER-localised ERp57, we first fully oxidised SP cells with diamide,
removed diamide by re-isolating the SP cells and incubated them
with the complete TrxR1 reduction system, just recombinant Trx1
or the reduction system without Trx1 (Fig. 3Bi,ii). Partial reduction
Fig. 1. See next page for legend.
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of fully oxidised ERp57 occurred in the presence of the complete
system (Fig. 3Bi, lane 3) but did not occur with just Trx1 alone
(Fig. 3Bi, lane 4) indicating a requirement for the recycling system.
The reduction of ERp57 was dependent on Trx1 (Fig. 3Bi, lane 5) as
was the case with roGFP. In addition, the active site mutants of Trx1
lacking one or both cysteines within the CXXCmotif were unable to
reduce ERp57 (Fig. 3Ci,ii; lanes 4 and 5). These results demonstrate
that ER-localised ERp57 can be reduced following oxidation by the
cytosolic reduction pathway and that this reduction is dependent on
thioredoxin.
To further characterise the membrane component required for
reduction, we carried out a proteinase K digestion of our SP cells
prior to assay for ERp57 reduction (Fig. 3Di,ii). We surmised that if
a membrane protein was involved then the transfer of reducing
equivalents across the membrane might be sensitive to proteolysis.
Proteinase K digestion prevented the reduction of oxidised ERp57
by the reconstituted reduction system (Fig. 3Di, lane 4), suggesting
the requirement for a membrane protein whose cytosolic domain is
sensitive to digestion. We also determined whether the reduction of
ERp57 by TCEP was sensitive to proteinase K treatment of the SP
cells (Fig. 3Ei,ii). TCEP was still able to reduce oxidised ERp57
(Fig. 3Ei, lane 4), suggesting that either the membrane protein
involved can be reduced efficiently by TCEP without its protease-
sensitive cytosolic domain or that TCEP acts via a component
separate from the thioredoxin-dependent pathway.
The thioredoxin reduction pathway is sufficient to reduce
non-native disulfides in nascent chains exposed to the
ER lumen
We previously demonstrated that non-native disulfides formed
during the synthesis of β1 integrin require a cytosolic reductive
pathway to ensure their isomerisation to the correct disulfides (Poet
et al., 2017). To evaluate the ability of our reconstituted pathway to
isomerise non-native disulfides, we generated stalled translocation
intermediates of a protein that forms non-native disulfides following
in vitro translation in the presence of SP cells (Robinson et al.,
2020). By isolating SP cells containing these intermediates, wewere
then able to follow the rearrangement of disulfides post-
translationally in the presence or absence of a TrxR1 reduction
system (Fig. 4A). We generated a stalled translocation intermediate
of the disintegrin domain of ADAM10 by translating an RNA
transcript lacking a stop codon. The length of the synthesised chain
is sufficient to allow exposure of several cysteine residues in the ER
lumen (Fig. 4B) that have the potential to form disulfides.
Translations were performed using a rabbit reticulocyte lysate
supplemented with SP cells to study folding in the ER (Wilson et al.,
1995). All samples were treated with NEM on completion to
irreversibly modify thiols and freeze the disulfide status of the
samples for downstream processing. When translations were carried
out in the presence of a reducing agent (DTT) and the samples
separated under non-reducing conditions, two products of
approximately 18 and 20 kDa were synthesised (Fig. 4C, lane 1).
These products correspond to the translocated, signal sequence
cleaved chain and untranslocated preprotein (Robinson et al., 2020).
When the translations were carried out in the absence of added G6P
and a post-translational incubation carried out in the absence of
G6P, a diffuse pattern emerged with the translation products
forming both intra- and interchain disulfides (Fig. 4C, lane 2).When
G6P was added post-translationally and samples incubated for
60 min, more distinct products were formed indicative of discrete
disulfide-bonded species (Fig. 4C, lane 3). When SP cells were
Fig. 1. Reduction of ER-localised disulfides by TCEP requires a
membrane component. A stable cell-line expressing ER-SFGFP-iE was
evaluated by live-cell imaging and was responsive to gross changes in redox
conditions. (A) Fluorescent images of untreated, diamide- (1 mM) or DTT-
treated (10 mM) cells. Fluorescence ratio changes are visualised using false
colours, with a more reducing ratio in blue and a more oxidising in yellow.
(B) Normalised fluorescent ratios of individual cells (n=37) are averaged
(mean±s.d.) and changes observed over time by the sequential addition of
diamide (1 mM) and DTT (10 mM). (C) Normalised fluorescence ratio changes
in microsomal membranes isolated from the cell line expressing ER-SFGFP-
iE, followed using a plate reader. An increase in ratio is seen following diamide
(1 mM) addition whereas a decrease is seen following DTT (1 mM) addition.
The ER-SFGFP-iE in untreated cells is, therefore, neither fully oxidised nor
reduced. The experiment was repeated four times (n=5). (D) Changes in
normalised fluorescence ratio following the addition of impermeable TCEP
in the absence (blue) or presence (black) of Triton X-100. After 35 min,
Triton X-100 (0.1% v/v) was added to solubilise the intact microsomes. Note
the slower rate of reduction and the lack of full reduction with TCEP unless the
membranes are solubilised. The experiment was repeated twice (n=3).
(E) ER-SFGFP-iE is reduced by TCEP immobilised on agarose beads, further
confirming that the reduction is not direct. The experiment was carried out
in triplicate with average (mean±s.d.) indicated for untreated (UT), buffer
preincubated with TCEP beads (wash) and TCEP beads (beads). (F-I) The
change in normalised fluorescent ratio was followed at various TCEP
concentrations as indicated either without (F) or with (H) detergent
solubilisation of microsomes. The rate of reduction at each TECP
concentration was calculated in triplicate with the average (mean±s.d.) plotted
versus the TCEP concentration (G,I).
Fig. 2. Thioredoxin-dependent reduction
of ER-localised disulfides. (A) The redox
status of Trx1 (trx) was determined by AMS
differential alkylation either before (lane 1) or
after (lane 2) incubation with TrxR1 and a
NADPH recycling system (C). Samples not
treated with AMS are shown in lanes 3 and
4. The experiment was carried out once.
(B) The normalised fluorescence ratio of
ER-SFGFP-iE was measured following
incubation with the reduction system without
Trx1 (C-Trx) or with the TrxR1 system
containing wild-type Trx1 (CXXC) or active
site mutants CXXS or SXXS. The experiment
was repeated twice (n=3) with the average
(mean±s.d.) presented.
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isolated from translations carried out in the absence of G6P and
incubated in buffer alone, no change to the banding pattern was
observed (Fig. 4C, lane 4). However, when the TrxR1 reduction
system was added to the isolated SP cells, rearrangement of
disulfides was observed and resulted in more distinct disulfide-
bonded species (Fig. 4C, lane 5). This change to the banding
pattern to more discrete disulfide-bonded species did not occur
when the isolated SP cells were incubated in the TrxR1 reductive
pathway lacking Trx1 (Fig. 4C, lane 6). We also demonstrated that
TCEP could substitute for G6P when added to translations or
to isolated SP cells post-translationally, giving rise to discrete
disulfide-bonded species (Fig. 4D, lanes 3 and 5). We have
previously shown that the disulfide-bonded products formed from
this ADAM10 construct are present in nascent chains translocated
into the ER lumen (Robinson et al., 2020). Taken together, these
results show that a source of non-membrane-permeable reducing
agent can resolve the non-native disulfides formed in nascent chains
within the ER lumen.
Fig. 3. See next page for legend.
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The thioredoxin reduction pathway reduces disulfides in
several secretory and ER resident proteins
The experiments with roGFP and ERp57 are dependent on the
reduction of a reversible disulfide that is solvent accessible in the
final protein structure. To determine whether our reconstituted
reductive system could reduce other disulfides within secretory or
membrane proteins, we carried out redox proteomics. Essentially,
microsomes were incubated with the TrxR1 system in either the
presence or absence of Trx1 for 60 min and the reversibly oxidised
thiol groups labelled with heavy iodoacetamide. The samples were
prepared for liquid chromatography with tandemmass spectrometry
(LC/MS/MS) analysis by trypsin digestion followed by tandem
mass tagging to enable quantification of the changes in the cysteine
oxidation levels between experimental conditions. The resulting
data were analysed by Perseus software and are presented as a
volcano plot indicating the statistically significant changes to the
reversibly oxidised cysteine residues upon incubation with Trx1
(Fig. 5A). The redox status of several peptides changed during the
incubation; specifically, there was a subset of cysteines whose
oxidised status decreased (became more reduced) in the reactions
containing Trx1, with the majority of the corresponding proteins
being located in the ER lumen (Fig. 5A, blue circles). Notably, the
regulatory cysteine (Cys131) in Ero1α was reduced (Appenzeller-
Herzog et al., 2008; Baker et al., 2008) as was the cysteine involved
in recycling VKORC1L1 (Cys50) (Tie et al., 2014). Changes to the
redox status of a few cytosolic and mitochondrial proteins also
occurred (Fig. 5A, orange circles), which probably co-purified with
our microsomal vesicles. The identity of all the proteins identified
whose redox status changed along with their ultimate subcellular
location is as illustrated (Fig. 5B) or detailed separately (Table 1).
The results demonstrate that several thiols within endogenous
proteins that are synthesised at the ER, including thiols that form
structural and regulatory disulfides, can be reduced by the
thioredoxin reduction system. The target proteins were localised
to the ER lumen and the TrxR1 reduction system was membrane
impermeable, illustrating the requirement to transfer reducing
equivalents across the membrane.
DISCUSSION
Our previous work provided the first indication that a cytosolic
reductive pathway was required to ensure correct disulfide
formation within the ER (Poet et al., 2017). Here, we demonstrate
that the thioredoxin pathway is sufficient to provide the reducing
equivalents to ensure the reduction of regulatory and non-native
Fig. 3. Thioredoxin-dependent reduction of ERp57 requires a membrane
protein. (A) The redox status of ER-localised ERp57 was determined following
differential alkylation with AMS. (Ai) In untreated SP cells, ERp57 exists as a
mixture of reduced and oxidised forms (lane 1) and becomes fully oxidised
(lane 2) or fully reduced (lane 3) following the addition of diamide (Dia) or DTT,
respectively. Partial reduction of ERp57 also occurs following incubation of
fully oxidised ERp57 with the membrane-impermeable reductant TCEP (lane
4). (Aii) Quantification of the fraction reduced in untreated SP cells (UT), SP
cells treated with diamide, DTT or TCEP. The experiment was repeated twice
(n=3). (B) Thioredoxin-dependent reduction of ER-localised ERp57. (Bi) SP
cells were treated with diamide before incubation with either the complete
TrxR1 reduction system (C; lane 3) or without (C–trx; lane 5) or with Trx1 alone
(trx; lane 4). ERp57 was partially reduced only by the complete system.
(Bii) Quantification of the fraction reduced in SP cells treated as for Bi. The
experiment was repeated twice (n=3). (C) The reduction of ERp57 by the
TrxR1 system needs Trx1with an intact active site. (Ci) Neither of the active site
mutants CXXS (lane 4) or SXXS (lane 5) can substitute for wild-type (CXXC)
Trx1. (Cii) Quantification of the fraction reduced in SP cells treated as for Ci.
The experiment was repeated twice (n=3). (Di) The reduction of ER-localised
ERp57 by the TrxR1 system is sensitive to prior treatment of the SP cells with
proteinase K (lane 4). (Dii) Quantification of the fraction reduced in SP cells
treated with diamide, DTTor a TrxR1 reduction system either before (C) or after
(protK) treatment of the SP cells with proteinase K. The experiment was
repeated twice (n=3). (Ei) SP cells were treated with proteinase K in the
absence of further treatment (UT) or after treatment with diamide, DTT or
TCEP. The reduction of ER-localised ERp57 by TCEP is not prevented by prior
treatment of the SP cells with proteinase K (lane 4). (Eii) Quantification of the
fraction reduced in SP cells treated as for Ei. The experiment was repeated
twice (n=3). All graphs show mean values; error bars indicate s.d.
Fig. 4. Thioredoxin-dependent post-translational rearrangement of
ER-localised nascent chain disulfides. (A) Cartoon depicting the
rearrangement of nascent chain disulfides in a stalled translocation
intermediate following the addition of a cytosol-localised reduction system. (B)
Schematic of the disulfide pattern within the disintegrin domain of ADAM10.
The stalled intermediate used in subsequent experiments has the indicated
disulfide-forming cysteines in the ER lumen. (C) Translations carried out in the
presence of DTT (5 mM) gave rise to distinct translation products that migrate
with the sizes of the pre-protein and mature protein as indicated (lane 1).
Translations were carried out in the absence of added G6P and SP cells
subsequently incubated post-translationally in a reticulocyte lysate (RRL) in
the absence (lane 2) or presence (lane 3) of G6P. SP cells were isolated from
the translations and resuspended in KHM buffer alone (−C) (lane 4). Note the
rearrangement of nascent chain disulfides when the TrxR1 system is included
in the incubation (lane 5) (+C) and the dependence of this rearrangement on
the presence of Trx1 (lane 6) (C-T). The experiment was repeated once (n=2).
(D) Similarly to the TrxR1 system, TCEP brings about the rearrangement of
nascent chain disulfides when added to SP cells post-translationally either in
the presence of RRL (lane 3) or in KHM buffer alone (lane 5). The experiment
was repeated once (n=2).
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disulfides within ER proteins. We have successfully reconstituted
the reduction of ER disulfides using a microsomal system in
the presence of purified components to demonstrate that the
thioredoxin pathway can drive the reduction of disulfides in
several ER-localised soluble and membrane proteins. In addition,
we show that the pathway is sufficient to facilitate the reduction of
disulfides formed in nascent chains entering the ER lumen but does
not prevent disulfide re-formation, a requirement for correct
isomerisation of non-native to native disulfides. Importantly, we
show that a membrane protein is required to facilitate the transfer of
reductant across the ER membrane, presumably via a disulfide
exchange mechanism as demonstrated for the transfer of disulfides
across the bacterial plasma membrane by DsbD (Cho et al., 2007).
The absolute requirement for the presence of thioredoxin in
our reconstituted system rules out a role for an NADPH-dependent
ER-localised reductase. Previously, it has been postulated that an ER
glutathione or thioredoxin reductase could utilise the ER pool
of NADPH to drive the reduction of disulfides (Bulleid and Ellgaard,
2011). As there is an ER-localised hexose 6-phosphate dehydrogenase
(Lavery et al., 2006), G6Pmight enter the ER via the G6P-transporter,
be metabolised to phosphogluconolactone and in the process
regenerate the ER pool of NADPH. Hence, the G6P effect we
previously observed during our in vitro translationsmight be the result
of a process independent of the thioredoxin pathway. This is clearly
not the case for the reduction of roGFP, ERp57, disulfides in nascent
chains and the range of proteins identified from the redox proteomics
whose redox state change depends on the presence of thioredoxin.
The reductive pathway driven by cytosolic thioredoxin is
versatile in terms of its target disulfides in the ER lumen. These
disulfides included those present within folded proteins such as
roGFP, in proteins undergoing folding during translocation and in
proteins that require reduction to maintain their activity. Such
versatility suggests a broad substrate specificity of the terminal
enzyme involved in catalysing reduction. Changes to the redox
status of ERp57 would suggest that this member of the PDI family
could act as a reductase, as suggested previously for newly
synthesised glycoproteins (Jessop et al., 2007) towhich it is targeted
via its interaction with calnexin or calreticulin (Oliver et al., 1997). It
is also likely that ERdj5 is reduced by the cytosolic reductive pathway
and targeted to substrate proteins through its interaction with BiP
(Cunnea et al., 2003). Our identification of one of the regulatory
disulfides within Ero1α (Baker et al., 2008) as a target for the cytosolic
reductive pathway suggests that this disulfide can be reduced by one of
the PDI family members, as demonstrated previously using purified
proteins (Shepherd et al., 2014). Whether the ER membrane protein
responsible for transfer of reducing equivalents directly reduces the
PDI reductase remains to be established.
The role of thioredoxin as reductant of theERmembraneprotein can
be replaced with the membrane-impermeable reducing agent TCEP.
However, in contrast to thioredoxin-mediated process, reduction of ER
proteins via TCEP was shown to be insensitive to protease digestion,
suggesting that this reagent can reduce theERmembrane protein in the
absence of a protease-sensitive cytosolic domain. This result probably
reflects the different requirements for reduction of the membrane
protein disulfide by thioredoxin and TCEP. The mechanism
underlying recognition and reduction of substrates by thioredoxin is
not completely understood given itswide rangeof substrate specificity.
However, it has been demonstrated that noncovalent interactions prior
to disulfide reduction are important, with recognition being due to the
conformational restriction afforded by the oxidised substrate (Palde
and Carroll, 2015). Hence, the proteolytic digestion of a protein
domain or loop might prevent thioredoxin interacting with the
membrane protein, thereby inhibiting activity. A chemical reductant
such as TCEP has no requirement for such noncovalent interactions
and only requires the target disulfide to be solvent accessible.
The identity of the membrane protein involved in connecting the
cytosolic thioredoxin couple with the ER remains unknown. One
resident ER membrane protein whose depletion leads to a more
oxidising ER and a specific defect in correct disulfide formation in
lipoprotein lipase is lipase maturation factor 1 (LMF1) (Roberts
et al., 2018). This protein contains several thiols in its cytosolic
loops, transmembrane regions and lumenal domain that are required
for activity and could be involved in disulfide exchange.
Unfortunately, we did not identify LMF1 in our proteomics data,
so we could not identify any changes to its redox status. Hence,
LMF1 remains a potential candidate for shuttling disulfides across
Fig. 5. Evaluation of the changes in the redox status of microsomal proteins following incubation with the TrxR1 system. (A) Volcano plot depicting
proteins with significant changes to their redox status where the modified cysteine is localised to the ER (blue) or the cytosol (orange). Proteins identified
by mass spectrometry whose redox status does not change significantly are also indicated (grey). (B) Cartoon illustrating the final cellular location of proteins
whose redox status changes significantly upon incubation of microsomes with the TrxR1 system. Proteins that enter the secretory pathway are in blue
whereas those that do not enter the ER are in yellow. Proteins that become more reduced are in normal text and those that become more oxidised are in italics.
Note that PBXIP1 associates with the cytoskeleton and is mainly in the cytosol but it does shuttle to the nucleus to act in addition to its role as a soluble
transcription factor (Abramovich et al., 2002).
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the ER membrane. Of the 41 microsomal proteins whose redox
status changed during incubation with the TrxR1 system, four are
multipass membrane proteins with VKORC1L1 and GPAA1 being
known resident ER proteins. GPAA1 is a subunit of the GPI-anchor
transamidase (Ohishi et al., 2000) whereas VKORC1L1 is a
paralogue of vitamin K epoxide hydrolase with a potential function
in vitamin K-dependent carboxylation (Tie et al., 2013). Whether
these proteins are directly involved in disulfide exchange across the
ER membrane is a focus of future studies.
MATERIALS AND METHODS
Generation of stable cell line expressing ER-SFGFP-iE
HT1080 cells were transfected with ER-SFGFP-iE using MegaTran 1.0
(OriGene, Cambridge, UK) following the manufacturer’s protocol.
Various dilutions (1:10 to 1:10,000) of transfected HT1080 cells were
plated on 15 cm2 dishes. Cells were grown in selective medium
containing G418 (1 mg/ml) until colonies appeared. Single colonies
were picked and transferred to 12-well plates (one colony per well)
using trypsin-soaked Scienceware cloning discs (Sigma, Dorset, UK).
Cells were grown until confluent and then transferred to 25 cm2 flasks.
The presence of ER-SFGFP-iE was confirmed by western blot using
rabbit anti-GFP antibody (Santa Cruz, California, USA; cat# sc-8334,
1:200 dilution). All cell lines were regularly tested for mycoplasma
infection.
Live cell microscopy and image analysis
HT1080 cells stably expressing ER-SFGFP-iE were seeded on coverslips.
The cells were washed with buffer [HEPES (20 mM) pH 7.4, NaCl
(130 mM), KCl (5 mM), CaCl2 (1 mM), MgCl2 (1 mM), D-glucose
Table 1. Proteins showing a significant change to their oxidised thiols along with information on their subcellular location, position and identity of
the modified cysteine(s)
Location of cysteine modified Gene name Protein location Type Cysteine modified More Red/Ox
Cytosol GAPDH Cytoplasm Soluble 152, 156 Red
CCS Cytoplasm Soluble 227 Red
WDFY3 Cytoplasm Soluble 952 Ox
RPL37A Cytoplasm Soluble 39, 42 Ox
PBXIP1 Nucleus Soluble 559, 565 Ox
Endomembrane system COL6A1 ECM Soluble 745 Red
COL6A3 ECM Soluble 1823, 1824 Red
EFEMP1 ECM Soluble 40, 47 Red
LAMB3 ECM Soluble 451, 453, 511, 534, 536 Red
LAMC1 ECM Soluble 416, 418, 474, 751, 804, 807, 954, 956 Ox
LAMC2 ECM Soluble 28, 30, 53, 56 Red
MMP9 ECM Soluble 256 Red
CALR ER Soluble 105 Red
ERO1L ER Soluble 131 Red
PLOD1 ER Soluble 267, 270 Red
POFUT1 ER Soluble 283 Red
TMX2 ER Single pass 59 Red
GPAA1 ER Multipass 266 Red
VKORC1L1 ER Multipass 50 Red
LMAN1 ER/Golgi Single pass 230 Red
LOXL2 ER/secreted Soluble 395 Red
PRDX6 Lysosomal Soluble 47 Ox
LAMP1 Lysosomal Single pass 338 Ox
CTSA Lysosomal Soluble 239 Red
IGF2R Lysosomal Soluble 1227 Red
CTSB Lysosomal Soluble 211 Red
KIDINS220 Endosome Multipass 705 Red
CD59 PM GPI anchored 70 Red
CPD PM Single pass 309 Red
MFI2 PM GPI anchored 199 Red
MGAT5 PM Single pass 338 Ox
NOTCH2 PM Single pass 1342, 1346 Red
PLXNA1 PM Single pass 358 Red
AGRN PM/secreted Soluble 650 Red
CYR61 Secreted Soluble 337, 314, 317 Red
ENDOD1 Secreted Soluble 34 Red
FN1 Secreted Soluble 87, 97, 135, 141, 179, 231, 508 Red
IGFBP7 Secreted Soluble 156 Ox
PLAT Secreted Soluble 419 Red
PLAU Secreted Soluble 45 Red
PSAP Secreted Soluble 42 Red
SPARC Secreted Soluble 130 Red
STC1 Secreted Soluble 170 Red
VEGFC Secreted Soluble 328 Red
Mitochondrion NDUFA8 Mitochondrion Soluble 66 Red
COA6 Mitochondrion Soluble 44 Red
Unknown NUMB Membrane Unknown 130, 132 Ox
DPY19L1 Unknown Multipass 647 Ox
ECM, extracellular matrix; PM, plasma membrane; Ox, oxidised; Red, reduced.
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(10 mM)] before imaging on a Zeiss Axio Observer A1 inverted microscope
equipped with a 40× FLUAR lens (Zeiss, Oberkochen, Germany). The cells
were sequentially excited by 385 and 470 nm LEDs with fluorescence
detection through a T495 lpxr beamsplitter (Chroma, Vermont). Images
were captured at 30 s intervals and analysed with AxioVision 4.8 software.
The 385/470 nm ratio images of untreated, diamide-treated (1 mM) and
DTT-treated (10 mM) cells were false-coloured using a rainbow look-up
table. The 385/470 nm ratio changes over time were quantified by defining
regions of interest for individual cells and plotted as the average ratio with
standard deviation.
Preparation of microsomal membranes
Cells were cultured using cell culture roller bottles (1700 cm2) (Greiner Bio-
One). Confluent cells were detached from the roller bottle by incubation
with 100 ml PBS containing EDTA (1 mM) for 15 min. Cells were pelleted,
washed three times in HEPES–KOH (35 mM) buffer at pH 7.5 containing
NaCl (140 mM) and glucose (11 mM) followed by washing once in
extraction [HEPES–KOH (20 mM) pH 7.5, KOAc (135 mM), KCl
(30 mM), MgOAc (1.65 mM)]. An equal volume of extraction buffer to
the cell volume was used for resuspension. The cells were disrupted in a
Mini-Bomb Cell disruption chamber (Kontes) using a nitrogen pressure of
1.0 MPa for 30 min. Cell homogenates were centrifuged at 6000×g for
5 min at 4°C and the post-nuclear supernatant retained. The supernatant was
centrifuged at 50,000×g (Optima Max-XP Ultracentrifuge, Beckman
Coulter) for 15 min at 4°C to pellet the membrane fraction. The
membrane pellet was resuspended in buffer A [Tris-HCl (50 mM) pH 7.4,
sucrose (0.25 M), KCl (50 mM), MgOAc (6 mM), EDTA (1 mM)] to give
an A280 value of 50 units/µl (the absorbance was determined in water in the
presence of 1% SDS). Aliquots of the microsomal membranes were frozen
in liquid nitrogen and stored at −80°C.
Measurement of changes to the redox state of microsomal
ER-SFGFP-iE
Microsomes were pipetted into Dulbecco’s phosphate-buffered saline (PBS)
(1.5 μl microsomes in 48.5 µl PBS) in the absence or presence of 0.1%
Triton X-100 (Thermo Fisher). The solution was added into a CELLSTA
96-Well Polystyrene Flat BottomCell CultureMicroplate (Greiner Bio-One)
(final volume 50 μl per well; three wells per condition). Fluorescence
intensities at 520 nm were measured following excitation at 390 nm and
460 nm excitations wavelengths using PHERAstar FS microplate reader
(BMG Labtech). After 10 min of measurement to obtain a baseline, DTT,
diamide or different concentrations of tris-(2-carboxyethyl)phosphine
(TCEP) (Thermo) were injected into the wells. Fluorescence intensities
were recorded for up to 50 min. In some experiments, the same amount of
microsomes were untreated or treated either with immobilized TCEP
Disulfide Reducing Gel beads (Thermo) that had been washed twice with
PBS to remove soluble TCEP or with PBS that had been preincubated with
TCEP beads for 60 min. The samples were incubated for 60 min and then
transferred into microplate wells to measure fluorescence intensity at
520 nm following excitation at 390 and 460 nm.
To calculate the rate of change of the redox status of ER-SFGFP-iE at
different TCEP concentrations, microsomes were treated with various
concentrations of TCEP in the absence or presence of Triton X-100 (0.1%
v/v). The fluorescence ratio (390/460 nm) change was followed over time
after addition of TCEP and the resulting time course fitted to an exponential
decay function [y=-A(e-k(t-t0)-1)+c] to calculate the rate (k), where t0 is time
of addition of TCEP, c the initial fluorescence ratio and A the difference in
fluorescence ratio between t0 and t. The rate was then plotted against TCEP
concentration. Measurement of the rate of reduction of ER-SFGFP-iE at
different concentrations of TCEP was performed in triplicate.
Recombinant protein purification
Recombinant human thioredoxins (Trx1), wild type and mutants, were
expressed and purified from Escherichia coli BL21-DE3 cells as described
previously (Schwertassek et al., 2007). Purification was by successive
HisTrap affinity and size exclusion (Superdex 200 10/300) chromatography
(GE Healthcare). The protein concentration was determined following
OD280nm measurement and calculated using an extinction coefficient of
12.49 mM−1 cm−1. The purified protein aliquots were flash frozen in liquid
nitrogen and stored −80°C.
Determining the redox state of Trx1
Purified thioredoxin (25 µM) was incubated in KHM buffer [HEPES
(20 mM) pH 7.2 containing KOAc (110 mM) and MgOAc (2 mM)] at 30°C
for 60 min in the absence or presence of NADPH (1 mM), human TrxR1
(16.25 nM; IMCO), G6P (1.25 mM) and G6PDH (10 U/ml). The reaction
was stopped by the addition of NEM (20 mM). Samples were incubated
with streptavidin agarose resin (Thermo) in isolation buffer (IB) [Tris-HCl
(50 mM) pH 7.5, Triton (1% v/v), NaCl (150 mM), EDTA (2 mM), PMSF
(0.5 mM), sodium azide (0.02% w/v)] at 4°C for 60 min. The streptavidin
beads were pelleted by centrifugation and washed three times in isolation
buffer to remove unbounded proteins. Trx1 was eluted from the streptavidin
beads by incubating at room temperature (RT) for 15 min with PBS
containing SDS (2% w/v) and biotin (3 mM). The samples were boiled at
105°C for 15 min and incubated with TCEP (10 mM) at RT for 10 min to
break existing disulfides, followed by a 1.5 h incubation with AMS (20 mM;
Invitrogen) in the dark to alkylate free thiols. The samples were separated by
SDS-PAGE and a western blot performed using Streptavidin Protein
DyLight 800 (ThermoFisher, cat#21851; 1:5000 dilution).
Preparation of SP cells
SP cells were prepared as described previously (Wilson et al., 1995).
Following digitonin treatment, cells were resuspended in KHM buffer
containing CaCl2 (1 mM) and treated with Staphylocossus aureus nuclease
(150 U/ml; Calbiochem) at RT for 12 min to remove endogenous mRNA.
The reaction was stopped with EGTA (4.5 mM; Sigma). SP cells were
pelleted by centrifugation and resuspended in 100 µl KHM buffer to be
used in translation reactions. For ERp57 redox state determination
experiments, SP cells were prepared from cells expressing V5-tagged
ERp57 (Jessop et al., 2007); nuclease treatment was not included during
the preparation.
Determining the redox state of ER-localised ERp57
The redox state of ERp57 in SP cells was determined as described
previously (Jessop and Bulleid, 2004). SP cells were either untreated or
treated with diamide (10 mM) at RT for 10 min. Samples werewashed twice
with 500 µl KHM buffer to remove diamide. Oxidised SP cells were
incubated at 30°C for 60 min in KHM buffer with or without DTT or with
the purified reductive pathway components NADPH (1 mM), human
Trx1 (25 µM), human TrxR1 (16.25 nM), G6P (1.25 mM) and G6PDH
(10 U/ml). The SP cells were pelleted by centrifugation at 14,800×g for
1 min and then incubated with 500 µl PBS containing NEM (25 mM) to
block free thiols. The samples were washed twice with 1 ml PBS to remove
excess NEM. The cells were lysed on ice with lysis buffer [Tris-HCl
(50 mM), NaCl (150 mM), EDTA (2 mM), PMSF (0.5 mM), Triton X-100
(1% v/v)] for 10 min. The lysate was centrifuged at 14,800×g at 4°C for
10 min. The supernatant was removed and boiled with SDS (2% w/v; VWR
chemicals) to denature the protein. Denatured samples were incubated at RT
with TCEP (10 mM) to break existing disulfide bonds, followed by a 1.5 h
incubation with AMS (20 mM; Invitrogen) in the dark. The samples
were separated by SDS-PAGE and a western blot performed with antibody
to V5-tag to detect different redox states of ERp57.
Western blotting
Following SDS-PAGE, proteins were transferred to nitrocellulose blotting
membrane (GE Healthcare). The membrane was blocked with 3% w/v dried
skimmed milk (Marvel) in TBST buffer [Tris-HCl pH 8.0 (150 mM), NaCl
(150 mM), Tween-20 (0.5% v/v)] for 1 h. The membrane was incubated in
TBST including V5-antibody (Invitrogen, cat#R960-25; 1:10,000 dilution)
for 1 h. After primary antibody incubation, the membrane was incubated in
5 ml TBST with secondary antibody (Fisher Scientific, cat #10751195;
1:10,000 dilution) in the dark for 45-60 min. The membrane was scanned
using a Li-Cor Odyssey 9260 Imager. Quantification of gel intensity was by
ImageJ (National Institutes of Health, Bethesda, MD); experiments were
carried out three times. Values quoted are averages, with error bars depicting
standard deviation.
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Proteinase K treatment
SP cells were incubated on ice with proteinase K (20 µg/ml; Roche) for
25 min in the presence of CaCl2 (10 mM). Proteinase K was inactivated by
incubation with PMSF (0.5 mM). Proteinase K and PMSF were removed by
washing twice with KHM buffer.
Preparation of ADAM10 domain construct and in vitro translation
The human ADAM10 construct codes for residues 456-550 and contains the
human-β2 M signal sequence residues (1-20). The generation of this
construct and its transcription and translation were described previously
(Robinson et al., 2020). Essentially, plasmid DNA was used as a template
for the polymerase chain reaction (PCR) using an appropriate forward
primer that adds a T7 promoter and a reverse primer that lacks a stop codon.
The PCR product was transcribed into an RNA template using T7 RNA
polymerase. Translations were performed using the Flexi Rabbit
Reticulocyte Lysate System (Promega) supplemented with DTT (10 mM)
or purified water but in the absence of added G6P. SP cells were added to a
concentration of ∼105 cells per 25 μl translation reaction. Following
assembly of components, translation reactions were incubated at 30°C for
15 min. For post-translational assays, G6P (5 mM) was added following
translation or the SP cells were isolated by centrifugation and resuspended in
KHM buffer in the presence or absence of a TrxR1 reduction system
[NADPH (1 mM), human Trx1 (25 µM), human TrxR1 (16.25 nM), G6P
(1.25 mM) and G6PDH (1 U) or TCEP (1 mM)]. An additional incubation
was carried out in the presence of the TrxR1 reduction system without Trx1.
The reactions were stopped after a 60 min incubation by the addition of
NEM (final concentration 25 mM) prior to immunoisolation, SDS-PAGE
and phosphorimage analysis.
Immunoisolation
SP cells from the translation reactions were resuspended in 1 ml IB
containing 50 µl 10% Protein A Sepharose FF Resin (Generon). After
30 min incubation, the beads were isolated by centrifugation at 16,000 g for
30 s. The supernatant was transferred into a new tube containing 10%
Protein A Sepharose (50 µl). Anti-V5 antibody (Invitrogen, cat #10751195;
1 µl) was added and the suspension incubated at 4°C overnight. The beads
were pelleted by centrifugation and washed three times with 1 ml IB buffer.
The beads were heated for 5 min at 105°C with SDS-PAGE loading buffer
[Tris/HCl (200 mM) pH 6.8, glycerol (10% v/v), SDS (2% w/v),
Bromophenol Blue (0.1% w/v)]. The samples were separated by SDS-
PAGE. Gels were fixed in 10% acetic acid and 10% methanol, dried and
exposed to a phosphorimager plate. A FLA-7000 bioimager (Fujifilm) was
used to scan the plate to obtain the image.
Sample preparation for mass spectrometry analysis
Samples were prepared for redox proteomics as previously described (van
der Reest et al., 2018) with somemodifications. Microsomes were incubated
in the presence of the reductive system as described above, either in the
presence or absence of Trx1. After 60 min incubation at 30°C, microsomes
were lysed in a buffer containing SDS (4%), triethylammonium bicarbonate
(50 mM) pH 8.5 and unlabelled iodoacetamide (55 mM; light IAA,
12C2H4INO; Sigma) to alkylate free cysteine thiols. For each experimental
replicate, 30 µg of protein was subsequently tagged with iodoacetamide
labelled with stable isotope (heavy IAA, 13C2D2H2INO; Sigma) to alkylate
reversibly oxidised cysteines. Differentially alkylated proteins were
precipitated using trichloroacetic acid (TCA) and digested first with
endoproteinase Lys-C (enzyme:lysate ratio 1:33) for 1 h, followed by
overnight digestion with trypsin (enzyme:lysate ratio 1:33). The digested
peptides from each experiment, and a pool sample, were differentially
labelled using the Tandem Mass Tag (TMT) 10-plex reagent set (Thermo
Scientific). Fully labelled samples were mixed in equal amounts and
desalted using 100 mg Sep Pak C18 reverse phase solid-phase extraction
cartridges (Waters).
LC/MS/MS protocol
We analysed three different experimental conditions. For each condition, we
analysed three biological replicates, which were labelled with nine tags of the
TMT 10-plex. The remaining TMT tag was used to label a pool generated by
mixing equal amounts of each sample, which was used to normalise the data
using the internal reference scaling method (Plubell et al., 2017).
TMT-labelled peptides were analysed as previously described (van der
Reest et al., 2018) with minor modifications. First, peptides were
fractionated using high pH reverse phase chromatography on a C18
column [150×2.1 mm internal diameter; Kinetex EVO (5 μm, 100 Å)] on a
HPLC system (LC 1260 Infinity II, Agilent). A two-step gradient was
applied: from 1-28% buffer B in 42 min, then from 28-46% buffer B in
13 min to obtain a total of 21 fractions for LC/MS/MS analysis.
Fractionated peptides were separated by nanoscale C18 reverse-phase
liquid chromatography using an EASY-nLC II 1200 (Thermo Scientific)
coupled to an Orbitrap Fusion Lumos mass spectrometer (Thermo
Scientific). Elution was carried out using a binary gradient with buffer A
(2% acetonitrile) and B (80% acetonitrile), both containing 0.1% formic
acid. Samples were loaded with 6 µl of buffer A into a 50 cm fused silica
emitter (New Objective) packed in-house with ReproSil-Pur C18-AQ,
1.9 μm resin (Dr Maisch, Ammerbuch, Germany). Packed emitter was kept
at 50°C by means of a column oven (Sonation) integrated into the
nanoelectrospray ion source (Thermo Scientific). Peptides were eluted at a
flow rate of 300 nl/min using different gradients optimised for three sets of
fractions: 1-7, 8-15 and 16-21. The initial percentage of buffer B (%B) was
kept constant for 3 min, then a two-step gradient was used, all with 113 min
for step one and 37 min for step two. The %B was changed as follows: for
F1-7, %Bwas 2 at the start, 17 at step one and 26 at step two. For F8-14, %B
was 4 at the start, 23 at step one and 35 at step two. For F15-21, %B was 6
at the start, 27 at step one and 43 at step two. All gradients were followed
by a washing step (95% B) of 10 min followed by a 5 min re-equilibration
step at the initial %B of each gradient, for a total gradient time of 168 min.
Eluting peptides were electrosprayed into the mass spectrometer using a
nanoelectrospray ion source (Thermo Scientific). An Active Background
Ion Reduction Device (ESI Source Solutions) was used to decrease air
contaminant signal level. The Xcalibur software (Thermo Scientific) was
used for data acquisition. A full scan over mass range of 350-1400 m/z was
acquired at 60,000 resolution at 200 m/z, with a target value of 500,000 ions
for a maximum injection time of 20 ms. Higher energy collisional
dissociation fragmentation was performed on the 15 most intense ions,
selected through an isolation window of 0.8 m/z, for a maximum injection
time of 100 ms, or a target value of 100,000 ions. Peptide fragments were
analysed in the Orbitrap at 50,000 resolution.
MS data analysis
TheMS Raw data were processed withMaxQuant software (Cox andMann,
2008) version 1.6.3.3 and searched with Andromeda search engine (Cox
et al., 2011), querying SwissProt (UniProt, 2010). First and main searches
were performed with precursor mass tolerances of 20 ppm and 4.5 ppm,
respectively, andMS/MS tolerance of 20 ppm. Theminimum peptide length
was set to six amino acids and specificity for trypsin cleavage was required,
allowing up to two missed cleavage sites. MaxQuant was set to quantify on
‘Reporter ion MS2’, and TMT 10-plex was chosen as isobaric label.
Interference between TMT channels were corrected by MaxQuant using the
correction factors provided by the manufacturer. The ‘Filter by PIF’ option
was activated and a ‘Reporter ion tolerance’ of 0.003 Da was used.
Modification by light [H(3)NOC(2)] and heavy [HNOCx(2)Hx(2)]
iodoacetamide on cysteine residues (carbamidomethylation) were
specified as variable, as well as methionine oxidation and N-terminal
acetylation modifications; no fixed modifications were specified. The
peptide, protein and site false discovery rate (FDR) was set to 1%.
MaxQuant outputs were analysed with Perseus software version 1.6.2.3
(Cox and Mann, 2008). The MaxQuant output ModSpecPeptide.txt file was
used for quantification of cysteine-containing peptide oxidation, whereas
the ProteinGroup.txt file was used for protein quantification analysis.
Peptides with a cysteine count lower than one were excluded from the
analysis, together with Reverse and Potential Contaminant flagged peptides.
From the ProteinGroups.txt file, Reverse and Potential Contaminant flagged
proteins were removed, as well as protein groups identified with no unique
peptides. The TMT corrected intensities of proteins and peptides were
normalised to the median of all intensities measured in each replicate. Only
cysteine-containing peptides uniquely assigned to one protein group within
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each replicate experiment, and robustly quantified in three out of three
replicate experiments, were normalised to the total protein levels and
included in the analysis. To determine significantly regulated cysteine-
containing peptides, a Student’s t-test with a 5% FDR (permutation-based)
was applied using normalised reporter ion intensities.
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